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Follicular dendritic cells (FDCs) are key elements of secondary lymphoid organs where 
they form the stromal component of B-cell follicles. FDCs possess extensive dendritic 
process that trap intact antigen via Fc and complement receptors on the cell surface. 
The antigen is displayed to B-cells, providing a basis for selection of high affinity B cells. 
FDC also have important roles in facilitating the clearance of apoptotic B cells by the 
secretion of the opsonising factor MFGE8. It is well established that lymphotoxin 
signalling is required for FDC maturation but the specific details of the molecular 
mechanisms that regulate FDC development and differentiation are not fully 
understood. MicroRNAs (miRNAs) are non-coding RNAs of approximately 18-25 
nucleotides in length that regulate gene expression at the post-transcriptional level. 
MiRNAs bind to their target gene transcripts as part of the RNA induced silencing 
complex and repress translation of the target gene product.  
The objective of this study was to identify miRNAs that play a role in the development 
and function of FDCs.  
An in vivo murine model of FDC de-differentiation was used to provide material for 
miRNA analysis. By comparison of miRNA profiles from spleen tissue with FDC at 
different stages of de-differentiation, we would be able to obtain a miRNA signature for 
mature FDC. Spleens were collected at various time points over a 28 day period 
following transient blockade of lymphotoxin signalling. A variety of methods were used 
to profile the miRNAs expressed at different time points during the suppression and 
recovery of the FDC network.  Comparison of the miRNA profiles of spleens containing 
mature, partially de-differentiated, and fully de-differentiated FDC identified a number 




To assess the role of specific miRNAs in FDC development, the mouse FDC-like cell line, 
FL-YB, was used as an in vitro model system. FL-YB cells were used to perform gain-of-
function and loss-of-function studies on selected miRNAs and to assess the effects of 
various stimuli/conditions on miRNA expression.  The effects of different treatments on 
cell proliferation, morphology and adhesion, and on gene expression by FL-YB, were 
monitored. Loss-of-function studies for one of the selected miRNA (miR-100-5p) 
revealed a significant effect on a number of gene transcripts involved in mediation of 
the germinal centre response (Il-6, Tlr4, Ptgs1/2). These data indicate that miR-100-5p 
has a role in regulating Il-6, Tlr4 and Ptgs1/2 transcripts. None of these transcripts 
contain predicted target sites for miR-100-5p and so the effect of miR-100-5p on these 
transcripts is likely to be indirect. Further studies on these miRNA: target interactions 
are required to elucidate the mechanisms and biological consequences of miRNA 
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1.1. Secondary lymphoid organs 
1.1.1. Stromal populations of secondary lymphoid organs 
Secondary lymphoid organs are highly specialised structures which allow initiation of 
the adaptive immune response by providing an environment in which antigen is 
encountered by lymphocytes. The principal secondary lymphoid organs are the spleen 
and lymph nodes, but there are a number of others, including the Peyer’s patches and 
isolated lymphoid follicles (iLFs) in the gut. In addition other mucosal surfaces also 
contain small lymphoid organs collectively named mucosal associated lymphoid tissue 
(MALT). In the spleen the white pulp, comprises T cell areas which form around central 
arterioles. Discrete B cell follicles are situated at locations around the periphery of the 
T cell area. Surrounding these T and B cell compartments is the marginal zone which 
separates the lymphocyte-containing white pulp from the red pulp (Figure 1.1). All 
these different areas have specialised stromal cells which, as well as providing 
structural support, also support the haematopoietic cells within their relevant niches. 
The stromal cells in the T cell areas are termed fibroblastic reticular cells (FRC) while 
the stromal cells in the B cell areas are follicular dendritic cells (FDC) and those in the 
marginal zone are marginal reticular cells (MRC). These three stromal populations are 
identified by both their specific locations and by functional markers which they 
express. FRC express the chemokines CCL21 and CCL19 which attract CCR7 expressing 
T cells, whereas FDC express the Chemokine CXCL13 which attracts CXCR5 expressing 
B cells. FDC are also identified by their expression of complement receptor 1 (CR1 
(CD35)). MRC express many of the same markers as FDC, such as CXCL13 and the 
adhesion molecules ICAM1 and VCAM1 but can be identified by high expression of 






                                         
 
 
1.1.2. Antigen encounter and germinal centre reactions 
When antigen is presented to T cells by professional antigen presenting cells (APC), T 
cells decrease expression of the chemokine receptor CCR7 which allows migration 
towards the B cell areas (B cell primary follicle). At the same time, B cells encounter 
native antigen which is displayed on the surface of FDC and increase expression of 
CCR7 causing migration to the periphery of the T cell area. This allows encounters 
between T and B cells which is important for the induction of a T cell-dependent 
antibody response. Interactions between the T and B cells cause T cell activation and 
expression of CD40 ligand and cytokines such as IL-4 and IL-2. This enables 
CD40:CD40L interactions and the activation of B cells to undergo proliferation and 
differentiation. These B cells migrate back to the follicle and through proliferation and 
Figure 1.1 The composition of splenic white pulp. T= T cell zone F= B cell 
follicle, MZ= marginal zone, Vess = entrance of central arteriole, RP= red 
pulp. Adapted from http://www.cell.com/immunity/image_resource-spleen 






differentiation processes form structures termed germinal centres. B cell follicles which 
contain germinal centres are referred to as secondary lymphoid follicles. Germinal 
centres (GC) themselves contain different zones, the outer-most of which is the mantel 
zone that is largely made up of recirculating B cells. The apical light zone contains 
mainly small centrocytes whereas the basal light zone contains large centroblasts. 
Finally the dark zone contains centroblasts (MacLennan, 1994). B cells migrating back 
into GC after encountering T cells are referred to as centroblasts and they undergo 
proliferation (clonal expansion) in the dark zone. Centroblasts then up-regulate surface 
expression of immunoglobulin to become centrocytes and migrate into the light zone 
where the majority of FDC also reside. If the surface immunoglobulins recognise and 
bind to antigen that is displayed on the cell surface of FDC, they then receive survival 
signals from the FDC and then undergo immunoglobulin class switching (MacLennan, 
1994). These centrocytes then become antibody secreting plasma cells, which migrate 
to areas of high antigen, or long-lived memory B cells, which stay in the follicle long 
after the GC has been cleared. The centrocytes that do not recognise FDC bound 
antigen, or do so only with low affinity, do not receive survival signals and undergo 
apoptosis. This is summarised in Figure 1.2.  
                         


















1.2. Follicular dendritic cells 
1.2.1. Discovery of FDC 
Follicular dendritic cells were first named in 1978 (Chen et al., 1978) in a publication 
describing them to be present in the GC and to be stellate in shape, sending out long 
thin sheets of cytoplasm. FDC are large cells that in the mature state extend long, 
slender dendritic processes that form a network throughout the B cell follicles of 
secondary lymphoid tissue (Allen and Cyster, 2008; El Shikh et al., 2007a; Endres et al., 
1999; Alimzhanov et al., 1997; Kuprash et al., 1999). FDCs are therefore closely 
associated with B cells and cross-talk between the two cell types is required by both 
cell types (Husson et al., 2000; Wang et al., 2011). One of the major function of FDCs is 
to trap immune complexes on their surface and display this to B-cells (Balogh et al., 
2001; Chen et al., 1978; Sukumar et al., 2008; Allen and Cyster, 2008; Cyster, 2010), 
Figure 1.2 Progression of the germinal centre reaction. Adapted from 









although many other functions of FDC have been described. FDC-associated antigen is 
displayed to developing centrocytes, and the recognition and binding of antigen by the 
surface bound immunoglobulin produced by the centrocyte results in signalling from 
the FDC which promotes survival of the centrocyte (MacLennan, 1994). In the absence 
of antigen recognition and binding, these survival factors are not delivered to the 
centrocyte and it will then undergo apoptosis (Lindhout and Groot, 1995). FDC also 
have an important role in the clearance of apoptotic B cells by secreting Milk fat 
globule-EGF factor 8 protein (MFGE8) which binds to the apoptotic B cells opsonising 
them for engulfment by tingible body macrophages (Kranich et al., 2008). Another 
important role of FDC is in the development and organisation of secondary lymphoid 
organs. The production of the chemokine CXCL13 by FDC attracts CXCR5 expressing B 
cells towards the FDC network, thus forming B cell follicles (Amft et al., 2001). These 
functions of FDC will be described in greater detail in the following sections. Although 
there has been considerable debate regarding the lineage of FDC (Bofill et al., 2000; 
Imai et al., 1993; Fliedner et al., 1990; Heinemann and Peters, 2005; Mabbott et al., 
2011; Szakal et al., 1995; Kapasi et al., 1998; Yoshida et al., 1995; Krautler et al., 2012; 
van Nierop and de Groot, 2002; Humphrey and Sundaram, 1985; Munoz-Fernandez et 
al., 2006) it is now widely accepted that FDC are stromal cells of mesenchymal origin 
(Kapasi et al., 1998; Munoz-Fernandez et al., 2006; Mabbott et al., 2011; Cho et al., 
2012). FDC have been reported to arise from ubiquitous perivascular precursors which 
express platelet-derived growth factor receptor β (PDGFRβ) (Krautler et al., 2012). 
Pericytes are specialised smooth muscle cells with mesenchymal stem cell (MSC) 
potential (Ozen et al., 2012). Other recent publications have found that stromal cells 
found early in developing lymphoid tissue can arise from other MSC sources. First it has 
been shown that adipose derived MSC can form the early stromal component of lymph 




associated with adipose tissue in vivo. Early stromal components of the spleen can also 
be derived from mesenchymal precursors that arise from the dorsal splenopancreatic 
mesenchyme in the developing mouse embryo at around embryonic day 10-10.5 
(Castagnaro et al., 2013). It has been suggested that FDC could differentiate from these 
early stromal components (Katakai et al. 2008) and thus it is possible that they can 
differentiate from different tissue-derived MSC dependent on their location in the body 
in keeping with the notion of high plasticity existing in mesenchyme tissue (Zipori, 
2006). 
1.2.2. FDC in the formation of lymphoid tissue 
1.2.2.1. Lymphotoxin-β receptor signalling 
From studies of lymphotoxin (LT)-deficient mice it is well established that LT-signalling 
is required for formation (De Togni et al., 1994; Rennert et al., 1996) and maintenance 
(Rennert et al., 1998; Kuprash et al., 1999; Wilhelm et al., 2002) of mature FDC 
networks. LT is a member of the tumour necrosis factor (TNF) superfamily of 
cytokines. Two forms of LT exist, a soluble homotrimeric form, LTα3, and a membrane 
bound heterotrimeric form ,LTα1β2 (Browning et al., 1993).  In Lymphotoxin-α (LTα)-
deficient mice, which are deficient for both the soluble and membrane bound forms of 
LT, there are no Peyer’s patches or lymph nodes and the spleen lacks GCs and FDC 
networks (De Togni et al., 1994; Matsumoto et al., 1997). Lymphotoxin-β 
(LTβ)-deficient mice lack Peyer’s patches, peripheral lymph nodes, GCs in the spleen 
and FDC, and although these mice do develop mesenteric and cervical lymph nodes, 
they lack FDC networks and GC (Koni et al., 1997; Ngo et al., 1999). Early LTα1β2 
production in lymph nodes and Peyer’s patches has been attributed to lymphoid tissue 
inducer (LTi) cells (Mebius et al., 1996; van de Pavert et al., 2009; Kim, 2008; Bénézech 
et al., 2010). LTi cells are hematopoietic innate lymphoid cells which are crucial for 




the foetal and neonatal spleen, it has been found that B cells are the main source of 
LTα1β2 that leads to CXCL13 and CCL21 production by stromal cells and the infiltration 
of lymphocytes to the developing spleen (Vondenhoff et al., 2008; Withers et al., 2007). 
The stromal cells that LTi or B cells signal to, express the adhesion molecules vascular 
cell adhesion molecule 1 (VCAM1) and intracellular cell adhesion molecule 1 (ICAM1) 
at intermediate levels. LTβR signalling by these stromal cells further up-regulates 
VCAM1 and ICAM1 and induces expression of an additional adhesion molecule mucosal 
vascular addressin cell adhesion molecule 1 (MADCAM1) (Katakai et al., 2008; 
Bénézech et al., 2010). These VCAM1hi, ICAM1hi, MADCAM1+ cells produce the 
chemokines CXCL13 and CCL21 and the cytokine IL-7 (Bénézech et al., 2010; Song et al., 
2007) and have been described as lymphoid tissue organiser (LTo) cells as they attract 
further LTi cells and lymphocytes and are critical for the development of lymph node 
anlagen into functional lymph nodes (Bénézech et al., 2012). It has been suggested that 
adult splenic stromal cell populations arise from LTo cells (Katakai, 2012; Katakai et al., 
2008; Roozendaal and Mebius, 2011) although the exact mechanisms of differentiation 
of the adult stromal cells is still unclear. LTo cells of lymph nodes have been described 
to arise from adipose derived stem cells upon engagement and signalling through the 
LTβR which activates the non-canonical form of the transcription factor NFκB 
(Bénézech et al., 2012). This may explain why lymph nodes are associated with a 
nodule of adipose tissue or ‘fat-pad’. The spleen possesses a more complex structure 
because of the presence of the filtering red-pulp which means the lymphoid 
compartments are not in direct association with adipose tissue. Using a genetic lineage-
tracing approach Castagnaro et al. (2013) have recently shown that FRC, FDC, MRC and 
mural cells of the spleen all derive from mesenchymal precursors which arise from the 
dorsal splenopancreatic mesenchyme from the developing embryonic liver. It was 




cells are capable of initiating lymphoid organ development and contribute to the 
stromal component. This and the expression of markers suggest that these cells have an 
LTo cell-like phenotype. LTo cells of different lymphoid organs may therefore arise 
from different precursor cell types of the MSC lineage. Independent of the source of 
FDC, it is well established that LTβR-signalling is required for both maturation and 
maintenance of FDC networks. The membrane bound form, LTα1β2, signals through the 
LTβR, whereas the soluble form, LTα3, signals through the TNF receptors TNFR1 and 
TNFR2. LTβR signalling can activate both canonical and non-canonical NFκB signalling 
pathways. Elegant studies have revealed that activation of the non-canonical NFκB 
pathway requires internalisation of the receptor while activation of the canonical 
pathway does not (Ganeff et al., 2011). It was shown that LTβR trimers form clusters 
triggering internalisation, this endocytosis was found to be dependent upon dynamin-2 
GTPase activity. Once internalised the ‘cytoplasmic portion’ of the LTβR competes for a 
NFκB-inducing kinase (NIK)-inhibitory complex. This allows stabilisation of NIK, which 
in turn causes IκB kinase alpha (IKKα) activation and p100 processing leading to 
formation of the non-canonical NFκB complex p52/RelB (Ganeff et al., 2011). The 
differential activation of the canonical and non-canonical NFκB pathways by LTβR 






1.2.2.2. CXCL13 production 
FDC secrete the chemokine CXCL13 (Förster et al., 1996; Legler et al., 1998; Cupedo et 
al., 2004) and generate a CXCL13 gradient around the FDC, which attracts B cells 
expressing the chemokine receptor CCR5 (Förster et al., 1996; Legler et al., 1998; Allen 
et al., 2004). Secretion of CXL13 by FDC is therefore important for the attraction of B 
cells into the GC enabling efficient GC reactions. CXCL13 induces increased LTα1β2 
expression on naïve B-cells which then interacts with the LTβR expressed on FDCs, 
promoting their maturation and hence completing a positive feed-back loop for CXCL13 
(Ansel et al., 2000). However, B cell specific LTβ knockout mice only have a 30 -50% 
decrease in Cxcl13 expression in the spleen, whereas full LTβR knockout mice have a 
complete lack of Cxcl13 expression (Tumanov et al. 2002). This suggests that Cxcl13 
expression may also be partially dependent on a non-B-cell lymphotoxin expressing cell 
type. Another source of CXCL13 production in the germinal centre is germinal centre T 
Figure 1.3 Differential mechanisms of activation of the canonical and non-canonical 




helper cells which deliver signals such as cytokines which help direct class switching 
(Ansel et al., 1999).  
1.2.2.3. Formation of tertiary lymphoid tissue 
The importance of FDC for optimal organisation of the microarchitecture of secondary 
lymphoid organs is clear. FDC also play a similar role in the formation of tertiary 
lymphoid tissue that can arise spontaneously during chronic inflammation (Neyt et al., 
2012). Several human and experimental mouse tertiary lymphoid organs arising both 
as a result of autoimmunity and chronic inflammation have been found to contain FDC 
networks by immunohistochemical analysis (Ghosh et al. 2005; Amft et al. 2001; 
Drayton et al. 2003). Adipose tissue is found throughout the body and so it has been 
proposed that, as happens with lymph node stroma, the stromal cell population of 
tertiary lymphoid tissue could arise from adipose tissue-derived stem cells (Bénézech 
et al., 2012). 
1.2.3. Functions of FDC 
1.2.3.1. Immune complex trapping and B cell activation 
FDC were first described in relation to the localisation of antigen (Szakal and Hanna, 
1968; Nossal et al., 1968). Antigen-antibody (immune) complexes, which sometimes 
also include complement (Kavai, 2008) are needed to activate effector mechanisms of 
the immune system such as the classical complement cascade and phagocytic effector 
cell responses (Nimmerjahn and Ravetch, 2008).   Immune complexes (IC) are held on 
the surface of FDC either by engagement of complement (Reynes et al., 1985; Fang et 
al., 1998) or Fc receptors (Qin et al., 2000). It has been shown that in primary follicles, 
complement receptor is sufficient for IC trapping but in secondary follicles both 
complement receptors and Fc receptors, that also interact with the antibody tail, are 
utilised (Yoshida et al., 1993; El Shikh et al., 2006). The purpose of IC trapping is to 




2000; Fang et al., 1998; Wu et al., 2008). Antigen in ICs are multimerised and arranged 
at optimal periodicity to enable efficient  cross-linking of the B cell receptor (BCR) 
complex causing B cell activation (Sukumar et al., 2008; Wu et al., 2008). This manner 
of B cell activation induces cell proliferation (Li and Choi, 2002) and somatic 
hypermutation (SHM) (Wu et al., 2008). FDC are long-lived and thus antigen can be 
present on their surfaces for months allowing long-term maintenance of memory B 
cells (Bachmann et al., 1994; Zinkernagel et al., 1996). The immune complexes that are 
trapped on the surface of FDC are delivered directly to FDC by noncognate B cells 
(Suzuki et al., 2009; Heesters et al., 2013). Shortly after transfer to FDC, ICs are 
internalised by the FDC and are periodically returned to the cell surface by cycling 
endosomes (Heesters et al., 2013). The rapid internalisation of immune complexes 
helps facilitate the unidirectional transfer of antigen from B cells to FDC even though 
the ICs are held by complement receptor 2 by both cell types (Heesters et al., 2013). 
1.2.3.2. Maintenance of germinal centre B cells  
When B cells interact with FDC through antigen displayed on its cell surface, various 
other molecules are involved in this binding and synapse formation (Park and Choi, 
2005). The adhesion molecules, VCAM-1 and ICAM-1, are expressed by FDC and up-
regulated on immune-complex stimulated FDC (Victoratos et al., 2006). VCAM-1 
interacts with very-late activation antigen 4 (VLA-4) on B cells and ICAM-1 interacts 
with lymphocyte function-associated antigen 1 (LFA-1). These interactions serve to 
form a stronger interaction between the B cell and FDC which lowers the threshold of B 
cell activation in the germinal centre (Koopman et al., 1994; Carrasco et al., 2004). 
Many other molecular interactions between FDCs and GC B cells take place, some of 




The TNF family member B-cell activating factor (BAFF) is secreted by FDC in the GC 
and prevents apoptosis of B cells by signalling through various receptors (BCMA, TACI 
and BAFF-R) (Park and Choi, 2005). The most important interaction in terms of 
promoting B cell survival is through BAFF receptor (BAFF-R), which has been 
described to exert it’s effects by activation of the non-canonical NFκB pathway leading 
to transcription of pro-survival genes (Hase et al., 2004; Zhang et al., 2005; Gardam et 
al., 2008). It has also been shown that interaction between the notch ligands, JAGGED 1 
and Delta-like 1, expressed by FDC and the notch receptors, 1 and 2 on GC B cells, 
prevents GC B cell apoptosis early in the germinal centre reaction (Yoon et al., 2009). 
The cytokines IL-6 and IL-15 are secreted by activated FDC and they engage IL-6 and 
IL-15 receptors on germinal centre B cells. It has been shown that blocking IL-6 
signalling in germinal centre B cells leads to reduced IgG responses and impaired SHM 
(Wu et al., 2009). IL-6 has also been described to be involved in tolerance in germinal 
centre B cells (Yan et al., 2012). IL-15 is produced by FDC and is bound by IL-15Rα on 
the surface of FDC. This membrane bound form of IL-15 can then be bound by signal 
transducing components IL-2/15βγ, expressed by germinal centre B cells, and induce B 
cell proliferation. Additionally, FDC produce sonic hedgehog ligand which signals 
through hedgehog receptors on germinal centre B cells, promoting their survival 
(Sacedón et al., 2005) 
1.2.3.3.  Toll-like receptor-4 signalling  
Toll-like receptors (TLRs) are receptors that recognise structurally conserved 
molecular patterns, which are usually derived from microbes (PAMPs; pathogen 
associated molecular patterns). When TLRs bind their ligands they up-regulate various 
processes of the innate immune response. The classical ligand of toll-like receptor 4 




However, a number of other bacterial and host proteins can engage TLR4 (Tsan and 
Gao, 2004; Gay and Gangloff, 2007). Engagement of TLR4 leads to activation of various 
signalling pathways including the non-canonical NFκB signalling pathway(Gay and 
Gangloff, 2007). TLR4 expression is up-regulated on FDC in mice injected with LPS (El 
Shikh et al., 2007b) and TLR4 signalling up-regulates expression of Fc receptors and 
adhesion molecules (ICAM-1 and VCAM-1). TLR4 up-regulation can occur on FDC in 
germinal centres even without LPS stimulation. It has been shown that endogenous 
ligands of TLR4 (such as oxidised phospholipids) are produced as a consequence of B 
cell apoptosis within the germinal centre. There is evidence that TLR4 signalling is 
important for driving the maturation of FDC and, as such, strongly impacts the adaptive 
immune response by influencing the extent of somatic hypermutation and 








Figure 1.4 Molecular mechanisms of interaction between FDC and germinal centre B 





1.2.3.4. Clearance of apoptotic B cells 
Another role of FDC is mediated by the production of MFGE8. MFGE8 is secreted by 
FDCs in the germinal centre, and binds to exposed phosphatidylserine on the surface of 
apoptotic B-cells. MFGE8 on the apoptotic B cells is then bound by integrin expressed 
on the cell surface of tingible-body macrophages, enabling them to engulf the apoptotic 
B cells (Kranich et al., 2008) (Figure 1.5). FDCs therefore provide pro-survival 
signalling to high affinity B cells, and also control the clearance of B cells which do not 
receive these stimuli. Accordingly, mice deficient in MFGE8 develop spontaneous 
splenomegaly and glomerulonephritis and auto-reactive antibodies (Hanayama et al., 
2004). When apoptotic B cells are not cleared efficiently they can undergo secondary 
necrosis and release components such as double stranded DNA which can then be 
recognised as antigen, causing auto-antibody production (Kruse et al., 2010).  
 








Figure 1.5 The role of Mfge8 in the clearance of apoptotic B cells. Mfge8 (red squares) 
produced by FDCs binding to apoptotic B-cells allowing the binding of a tingible body 
macrophage via integrin, thus facilitating engulfment of the apoptotic B-cell. Adapted 




1.2.4. Follicular dendritic cells in disease 
FDC have been associated with a number of diseases and disease processes (Rezk et al., 
2013; El Shikh and Pitzalis, 2012; Smith et al., 2001; Mcculloch et al., 2011). The 
involvement of FDC in some of these diseases is described below. 
1.2.4.1. Transmissible spongiform encephalopathy (TSE) 
TSEs are fatal neurodegenerative disorders which occur in a number of mammalian 
species including sheep, cows and humans. They are characterised by the accumulation 
of amyloid plaques and eventual vacuolation of neurons in the grey matter of the brain. 
The amyloid plaques that form are made up of an abnormally folded, disease-
associated isomer of the cellular prion protein (PrPc) which is termed PrPsc. The normal 
cellular form of the prion protein is widely expressed but is most highly expressed in 
the central nervous system. Within lymphoid tissues FDC also express PrPc at high 
levels (Thielen et al. 2001). During peripherally acquired TSE disease, PrPsc associates 
with FDC, and PrPc expressing FDC are required for replication of the TSE agent within 
secondary lymphoid tissues and the spread of infection to the brain (Mcculloch et al., 
2011).  
1.2.4.2. Human immunodeficiency virus 
During the early stages of human immunodeficiency virus (HIV)-1 infection, large 
quantities of the virus are trapped in immune complexes on the surface of FDC 
dendritic processes (Haase et al., 1996). Murine studies have revealed that FDCs can 
retain infectious virus for at least nine months after infection (Smith et al., 2001).  
Additionally this study also found that human FDCs in culture were able to maintain 
HIV infectivity for at least 25 days compared to just a few days without FDCs. CD4+ T 
cells can also become infected from FDC-trapped virus while trafficking through 




with drug therapy, none are available that can completely eradicate the virus. This is 
because the virus persists in reservoirs in the body, one of which may be FDC networks 
(Zhang and Perelson, 2013). The low serum titres that persist in patients between 
around 39-200 weeks after the start of treatment could be explained by shedding of 
virus from FDC reservoirs (Zhang and Perelson, 2013). FDC therefore may be a 
significant factor in the persistence of HIV infection even in patients receiving 
aggressive antiretroviral therapy. 
1.2.4.3. Autoimmune diseases and chronic inflammation 
As previously mentioned MFGE8-deficient mice have been found to develop 
autoimmune diseases as a result of the development of autoantibodies (Hanayama et 
al., 2004; Kruse et al., 2010). The gene, T cell immunoglobulin and mucin domain 
containing-4 (Timd4) encodes a membrane bound protein expressed by a subset of 
macrophages (including marginal zone macrophages). TIMD4 also binds to 
phosphatidylserine and supports engulfment of apoptotic cells.  Mice deficient in both 
Mfge8 and Timd4 develop a more severe phenotype which is exacerbated by blocking 
of TNFα or increasing the inflammatory cytokine interferon-γ (IFN-γ) (Miyanishi et al., 
2012). In some patients with systemic lupus erythematosus (SLE) it has been found 
that clearance of apoptotic B cells does not occur efficiently. This is possibly due to 
aberrant expression of MFGE8 (Yamaguchi et al., 2008). If apoptotic B cells are not 
cleared swiftly, they can undergo secondary necrosis, which releases auto-antigens 
(such as double stranded DNA) which are then trapped on the surface of FDC and 
presented to B cells. This allows affinity maturation of B cells producing auto-
antibodies which drives autoimmune disease (Muñoz et al., 2010; Baumann et al., 
2002). Additionally, FDCs produce IL-6 which is important in driving germinal centre 
reactions (Wu et al., 2009) and patients with SLE are known to have increased IL-6 




roles for FDC in the pathogenesis of SLE; aberrant Mfge8 expression, presentation of 
auto-antigen and aberrant expression of IL-6. These functions of FDC also have the 
potential to be involved in other systemic autoimmune diseases. For example, high 
expression of IL-6 is found in patients with Castleman’s disease, which is characterised 
by a hyper-proliferation of B cells (Leger-Ravet et al., 1991), and may support the 
abnormal proliferation of B cells in this disease. Hyper-proliferation of FDC has also 
been described in Castleman’s disease (Leger-Ravet et al., 1991).  
1.2.4.4. Follicular lymphomas 
Castleman’s disease sometimes precedes the development of FDC sarcoma which is a 
very rare neoplasm (Chan et al., 1997). Follicular lymphomas arise when germinal 
centre B cells become neoplastic. Follicular lymphoma cells undergo spontaneous 
apoptosis in culture which is mediated by activation of Caspase-8 and -3 (Hengartner, 
2000). Co-culture of follicular lymphoma cells with FDC reduces this spontaneous 
apoptosis by preventing the activation of caspase-8 and -3 (Goval et al., 2008). It was 
also shown that VCAM-1 and ICAM-1 interactions are important for this reduction in 
apoptosis indicating that direct cell-cell contact is needed. The production of the 
tumour suppressive signalling protein WNT5A by FDC has also been shown to reduce 
spontaneous apoptosis of follicular lymphoma cells by increasing CD40 expression 
(Kim et al., 2012b). Tumorigenic follicular lymphoma cells are attracted to FDC in 
culture by CXCL12/CXCR4 stimulation (Lee et al., 2012), which appears to make 
follicular lymphoma cells resistant to chemotherapy. Finally, drug resistance in 
follicular lymphoma is associated with the expression of the ATP-binding cassette, sub-
family B (MDR/TAP), member 1B (MDR1), which is a transporter molecule which can 
actively remove therapeutic drugs from the cell. It was found that follicular lymphoma 
cells that express MDR1, are those that are in close association with FDC, and further, 




(Yagi et al., 2013). All these studies clearly show that FDC appear to have a role in 
supporting and sustaining follicular lymphomas.   
1.2.5. The study of FDC 
FDCs were initially discovered by the examination of antigen localisation, where it was 
discovered that the pattern of antigen followed the cytoplasmic protrusions of 
dendritic reticular cells (Mitchell and Abbot, 1965; Szakal and Hanna, 1968; Chen et al., 
1978). Ultrastructural studies were extended by the development of antibodies that 
stain FDC. The monoclonal antiboby FDC-M1 (formally 4C11) (Tew et al., 1990) was 
found to react with MFGE8 protein (Kranich et al., 2008). The monoclonal antibody 
FDC-M2 had also been used to identify FDC for many years before it was found to react 
with the activated complement component C4b (Taylor et al., 2002). The complement 
receptors CR1 and CR2 (CR35/21) have also been used widely for FDC immunostaining 
(Reynes et al., 1985; Yoshida et al., 1993). High expression of PrPc has also been 
associated with FDC (McBride et al., 1992). The isolation of FDC is challenging because 
the large size and complexity of their dendritic processes means mechanical stress on 
the cells during isolation is often high. The strong association of B cells with FDC also 
means that obtaining a pure population of FDC is difficult.  However, various methods 
of FDC isolation have been used (Schmitz et al., 1993; Usui et al., 2012; Sukumar et al., 
2006; Sellheyer et al., 1989; Schriever and Freedman, 1989) to achieve almost pure 
populations of FDC that retain many markers and functional activity.  The method to 
isolate FDC from human tonsils (Schriever and Freedman, 1989) was further extended 
by subsequent culturing and purification steps (Kim et al., 1994) and the resulting cells 
were termed HK. This method of isolation and subsequent culture has been widely 
used as a method of in vitro study of FDC (Choe et al., 1996; Cho et al., 2011b; Kim et al., 
1995; Park et al., 2004; Kim et al., 2012a, 2006; Choe et al., 2000; Lin et al., 2011). More 




2006) that can be cultured for extended periods of time (months). This cell line 
retained many markers and functional activities of FDC, such as the ability to support B 
cells in co-culture. FL-Y cells were subsequently transformed by expression of the 
murine BAFF gene, and a clone stably expressing BAFF was selected (Magari et al., 
2011). The increased BAFF expression in these cells was similar to levels detected in 
freshly isolated FDC and the so called FL-YB cells were found to be more effective in 
supporting B cells than the original FL-Y cells. 
The display of antigen and provision of co-stimulatory signals to B cells by FDC are 
critical for an efficient GC reaction. FDC also play a role in many diseases processes 
such as HIV-1 latency, autoimmune disorders and lymphomas. Knowledge of the 
development and function of FDC is increasing. However, the broader picture of how all 
the known functions of FDC are regulated is still unclear. A greater understanding of 
FDC regulation is needed, and could potentially lead to future therapeutic 
interventions.  
1.3. MicroRNAs 
1.3.1. Discovery and history of microRNAs 
MicroRNAs (miRNAs) are short non-coding single-stranded RNA molecules. The first 
miRNA to be discovered was designated lin-4 and was found in the nematode worm 
Caenorhabditis elegans (Lee et al., 1993). Lin-4 was found to be a RNA of 22 nucleotides 
which supresses the production of lin-14 protein from the first larval stage. The 3’-UTR 
of the lin-14 mRNA was found to contain multiple repeats copies of a sequence that is 
partially complementary to the lin-4 sequence. The authors proposed that lin-4 
supresses lin-14 production by direct RNA:RNA binding. Later, another miRNA, let-7, 
was discovered in C. elegans and found to target both lin-41 and lin-42 during the later 
stages of larval development (Reinhart et al., 2000). Later in the same year let-7 was 




sea squirt, molluscs and drosophila (Pasquinelli et al., 2000). This lead to the rapid 
identification of a variety of other miRNA in different species (Lee and Ambros, 2001; 
Lau et al., 2001; Lagos-Quintana et al., 2001). Lee & Ambros (2001) and Lau et al. 
(2001) identified further miRNAs in C. elegans, whereas Lagos-Quintana et al. (2001) 
discovered miRNAs in drosophila and Hela cells. These three studies lead to the 
concept that miRNAs are abundantly expressed in most species, and represent a whole 
level of previously unrecognised genetic control. It was acknowledged, even at this 
early stage of miRNA discovery that because of the partial complementarity to their 
miRNA targets, identification of the mRNA targets would be challenging. 
1.3.2. miRNA biogenesis 
The acknowledged challenges in the discovery of miRNA targets reiterated the need for 
an understanding of the mechanisms that regulate miRNA biogenesis and function. It 
had been described in the previously mentioned studies (Lee and Ambros, 2001; Lau et 
al., 2001; Lagos-Quintana et al., 2001) that precursor miRNAs of around 70 nucleotides 
were discovered for most miRNA, and that these pre-miRNA were predicted to form 
stem-loop structures. The enzyme Dicer, had already been discovered to be key in the 
biogenesis of small RNAs in the RNAi pathway (Bernstein et al., 2001) and it was found 
that the same enzyme was involved in the production of mature miRNA (Hutvágner et 
al., 2001). Primary or pri-miRNA that could include either a single or multiple 
precursor miRNA were described by Y. Lee et al. (2002). The same group later showed 
that pri-miRNAs  are cleaved by the RNAse III enzyme Drosha (Lee et al., 2003b) and 
that pri-miRNAs are transcribed by RNA polymerase II (RNA pol II) (Lee et al., 2004). 
The products of Drosha cleavage, pre-miRNA, are then translocated into the cytoplasm 
by Exportin-5 (Yi et al., 2003). In the cytoplasm the RNAse III enzyme Dicer further 
cleaves the pre-miRNA (Bernstein et al., 2001; Hutvagner et al., 2002; Jakymiw et al., 




2003; Schwarz et al., 2003). The mature miRNA is incorporated into the RNA-induced 
silencing complex (RISC) (Hutvagner et al., 2002). This process of miRNA biogenesis 































Figure 1.6 miRNA biogenesis. (a) Primary miRNA (pri-miRNA) are transcribed by 
RNA pol II.(b) Pri-miRNA are cleaved by the Drosha/DGCR8 complex into pre-
miRNA.(c) Pre miRNA are then exported into the cytoplasm by Exportin-5. (d) In 
the cytoplasm the pre-miRNA is further processed by Dicer, and inserted into the 
RNA-induced silencing complex (RISC). (e) The miRNA-RISC complex can then 




1.3.2.1. miRNA transcription 
MiRNA genes can be located within intergenic regions of the genome or within the 
introns of protein coding genes (Ying and Lin, 2006). Intronic miRNAs have often been 
found to have their own promoter sequence rather than simply being transcribed along 
with the host gene (Marsico et al., 2013). Some miRNAs are located adjacent to each 
other in the genome and can be transcribed in one pri-miRNA, this is referred to as a 
miRNA cluster. It is estimated that almost 50% of miRNA are transcribed with at least 
one other miRNA and it has been suggested that different miRNAs transcribed in the 
same cluster can function co-ordinately to regulate multiple members of the same 
signalling pathways or interaction networks (Becker et al., 2012). 
1.3.2.2. The RISC complex and miRNA strand selection 
In the cytoplasm, Dicer is recruited to the pre-miRNA by the transactivation response 
(TAR) RNA binding protein (TRBP) (Chendrimada et al., 2005). Dicer cleaves the pre-
miRNA at the stem-loop and is thought to initiate unwinding of the miRNA duplex 
(Vermeulen et al., 2005). The argonaute protein, AGO2, is then recruited to the complex 
and binds the 2-nucleotide 3’ overhang that is created by Dicer processing (Figure 1.7). 
Only one strand of the miRNA is chosen to be incorporated into the forming RISC 
complex, although the alternative strand may be selected in different tissues or 
situations (Yang et al., 2010). Nomenclature was set-up so that the more abundant 
miRNA that was found initially was referred to as the lead strand and the miRNA found 
in less abundance was referred to as the star (or passenger) strand (Griffiths-Jones et 
al., 2006). However because it is now known that the most abundant miRNA in one 
tissue can be the least abundant in another tissue of the same organism (Griffiths-Jones 
et al., 2011), the suffixes -5p or -3p are now used (denoting the 5’ or 3’ strand). 




structural stability were crucial (Khvorova et al., 2003), it is still not known how 
different strands are selected in different tissues. 
1.3.2.3. miRNA target recognition 
Although in animals most miRNA bind with imperfect complementarity to their target 
mRNA, a region of conserved base pairing termed the seed region or seed sequence has 
been identified (Stark et al., 2003; Lewis et al., 2003). This region is located from 
nucleotide 2 to 7 at the 5’ end of the miRNA. In addition, perfect complementarity is 
sometimes found to extend to nucleotide 8 and an adenine residue at position 1 is also 
often seen(Bartel, 2009). Although binding at the 3’ end often occurs this is variable 
and it has been suggested that high 3’ end pairing can compensate for weaker seed 





Figure 1.7 Assembly of the of the RISC-miRNA complex and mRNA targeting. Adapted 




1.3.3. Mechanisms of miRNA function  
In animals, miRNAs generally bind with partial complementarity to their target mRNAs 
and cause translational repression and, in the majority of cases, transcriptional 
degradation (Janas and Novina, 2012). The exact mechanisms of translational 
repression and transcriptional degradation are still being elucidated (Wahid et al., 
2010). Several different mechanisms of translational repression have been proposed 
(Fabian et al., 2010) the main ones of which will be described briefly here and are 
summarised in figure 1.8. 
1.3.3.1. Inhibiton of translation 
One proposed mechanism for inhibition of translation is through miRNA-RISC–
mediated interference with recognition of the 5’ cap by the eiF4F complex which in 
turn inhibits recruitment of the 40S ribosomal subunit (Zinovyev et al., 2008). 
Alternatively, it has been suggested that the 60S subunit may be prevented from 
binding to the 40s subunit to form the functional 80S subunit (Wang et al., 2008a). The 
GW182 protein which forms part of the RISC complex has been reported to interact 
with the poly(A)-binding protein (Fabian et al., 2009). This interaction lead to the 
hypothesis that the miRNA-RISC complex could interfere with circularisation of the 
transcript (Zekri et al., 2009), thus slowing the rate of translation (Figure 1.8a).  
1.3.3.2. Inhibition of translation at a post-initiation stage 
Theories behind inhibition of translation at a post-initiation stage are that miRNA-RISC 
complex binding might cause ribosomal drop-off (Rand et al., 2005) or could increase 







1.3.3.3. Transcriptional degradation 
More recently it has been proposed that deadenylation and transcript degradation 
occurs in the majority of cases following inhibition of translational initiation (Bazzini et 
al., 2012; Janas and Novina, 2012). Ribosome footprinting techniques have been used in 
combination with RNA-Seq to show that in zebrafish embryos the natural induction of 
miR-430 at 2 h post fertilisation leads first to a decrease in the number of ribosomes 
associated with the miRNA target at 4 hours post fertilisation, followed by subsequent 
decrease in mRNA levels or poly(A) tail lengths of the same targets at 6 hours post 
Figure 1.8 Proposed mechanisms of translational repression by the miRNA-RISC 
complex. (a) Inhibition of transcriptional initiation by prevention of ribosomal subunit 
binding. (b) Inhibition of transcriptional progression by causing ribosomal drop-off or 




fertilisation (Bazzini et al., 2012). It is therefore proposed that miRNA transcripts 
undergo translational inhibition and transcriptional degradation (Figure 1.9). 
                            
 
1.3.3.4.  Localisation of miRNA targets to processing bodies 
Observed localisation of RISC proteins, miRNA and targeted mRNA transcripts to 
processing bodies (p-bodies) lead to the theory that targeted transcripts are sent to p-
bodies either to be sequestered or to be degraded (Pillai et al., 2007). However it has 
also been shown that cells devoid of p-bodies have normal miRNA-mediated 
transcriptional silencing and thus p-bodies may be a consequence of miRNA-mediated 
gene silencing rather than a cause of it (Eulalio et al., 2007). Recently, it was shown that 
the E3 ubiquitin ligase, Malin, regulates miRNA gene silencing activity by causing the 
degradation of the decapping enzyme DCP1A. Loss of malin in cells resulted in altered 
miRNA gene silencing activity (Singh et al., 2012). 
 
Figure 1.9 Steps of miRNA action. 1) Inhibition of transcriptional initiation 2) 




1.3.4. Biological functions of miRNAs 
The first miRNAs were discovered because their loss conferred a dramatic effect upon 
C. elegans larval development (Lee et al., 1993; Reinhart et al., 2000). Subsequently 
other miRNA that have major roles in different processes have been discovered. For 
example, a single nucleotide mutation in miR-96 is associated with autosomal 
dominant hearing loss in humans (Mencía et al., 2009; Lewis et al., 2009). Additionally, 
knock-down of miR-155 has a variety of deleterious effects on the immune system 
including promoting T helper cell differentiation, germinal centre responses, and 
reduced responses to viral and bacterial challenge (Rodriguez et al., 2007; Thai et al., 
2007; Worm et al., 2009; Dorsett et al., 2008). While 24,521 mature miRNA products 
across 206 species (www.miRBase.org  (Griffiths-Jones et al., 2006)) have been 
identified to date, loss of the majority of these miRNAs does not cause obvious 
phenotypic effects (Hornstein and Shomron, 2006; Ebert and Sharp, 2012). Rather, it 
has been proposed that the majority of miRNAs actually confer robustness to a 
biological system or network rather that playing major regulatory roles on specific 
genes. Two main modes of action for how miRNAs add to the robustness of a biological 
system have been proposed (Hornstein and Shomron, 2006; Ebert and Sharp, 2012). 
The first scenario is a positive feed-forward loop (Tsang et al., 2007) where the miRNA 
target genes is being repressed at the transcriptional level, and the genes that are 
repressing the target, also up-regulate the miRNA (Figure 1.10a). In this way the 
miRNAs are ‘insurance’ against rogue expression of mRNA that may still get through 
the transcriptional repression. In this scenario the miRNA is expected to be highly 
expressed at the same time that the target is not expressed or expressed at very low 
levels. A biological example of this could be suppression of genes that are highly 
expressed in a sibling tissue but not in the tissue of interest. A classic example of this is 




both neurons and epidermis. During development miR-124 is up-regulated in neurones 
whereas miR-9 is up-regulated in the developing epidermis. Neurons highly express 
many mRNA that contain target sites for miR-9, whereas cells in the epidermis express 
many genes which contain miR-124 target sites. The presence of these miRNAs 
‘protects’ against aberrant expression of the wrong genes (Farh et al., 2005; Stark et al., 
2005; Sood et al., 2006; Tsang et al., 2007).  
 The second scenario is where the miRNA target is being transcriptionally activated  
and the genes that cause this activation also cause transcription of the miRNA which 
then acts to fine-tune the amount of target being produced (Figure 1.10b). In this case 
both the miRNA and target transcript would be expected to be expressed at 









Figure 1.10 Proposed modes of action for miRNA conferring robustness upon a 
biological system. (a) The target transcript(s) are transcriptionally repressed the 
genes that cause this repression also up-regulate miRNA expression. The miRNA act to 
repress post-transcriptionally any target transcript that has been made, thus ensuring 
that no protein is produced. (b) The target transcript(s) are transcriptionally activated 
(or repressed) and the genes which cause this activation (or repression) also up-
regulate miRNA expression. The miRNA then act to keep the target transcript 
producing protein at a steady rate. Proposed by (Hornstein and Shomron, 2006; Ebert 




1.3.5. miRNAs in the immune response 
The possibility of using miRNA therapeutics has led to considerable research focused 
on the roles of miRNAs in various aspects of the immune response (Lu and Liston, 
2009; Navarro and Lieberman, 2010; Ha, 2011; Sonkoly et al., 2008; Asirvatham et al., 
2009; Cullen, 2013; Ramiro, 2010; Bronevetsky and Ansel, 2013; Chen et al., 2013a).  
Although there has been no published material looking at miRNAs in follicular dendritic 
cells to date, abundant miRNAs have been identified in other cells of the immune 
system. Of particular significance to this thesis are miRNAs that have roles in the 
germinal centre reaction.  
1.3.5.1. FDC-mediated miRNA expression in B cell lymphoma cell lines 
Two publications have described FDC-mediated induction of miRNA expression in cell 
lines derived from B cell lymphoma cells and in normal germinal centre B cells.  
One study examined the mechanism of terminal differentiation of germinal centre B 
cells into plasma or memory B cells (Lin et al., 2011). This terminal differentiation is 
driven by the suppression of the transcription factor B cell leukemia/lymphoma 6 
(BCL-6) and the increased expression of the transcription factor PR domain containing 
1, with ZNF domain (PRDM1) (Crotty et al., 2010; Shaffer et al., 2002). It was shown 
that co-culture of the human B cell lymphoma cell line Su-4 with FDC-like HK cells, lead 
to a number of expression level changes in the Su-4 cells (Lin et al., 2011). As BCL-6 and 
PRDM1 are known to be key transcription factors that regulate terminal differentiation, 
the 3’ UTRs of these genes were examined for miRNA target sites of miRNAs found to 
be regulated by HK cell-B cell co-culture. It was found that Bcl-6 had target sites for the 
miR-30 family of miRNA, 3 of which were found to be up-regulated after 24 hours of co-




resulted in a significant reduction in the HK-induced repression of Bcl-6. In addition, 
let-7a and miR-9 (which were both down-regulated upon co-culture) had putative 
target sites in the Prdm1 3’UTR.  Introduction of a let-7a mimic into the Su-4 cells 
induced similar levels of down-regulation of Prdm1 in the absence of HK cell co-culture. 
These actions were shown to be dependent upon direct HK cell-B cell contact as 
culturing in a trans-well system did not induce changes in the expression levels of the 
miRNA in Su-4 cells(Lin et al., 2011). 
The second study focused on miR-181a that had also been shown to be up-regulated 
upon HK-Su-4 cell contact (Lwin et al., 2010). miR-181a was found to target the gene 
encoding the pro-apoptotic protein, BCL-2-interacting mediator of cell death (BIM). 
miR-181a was up-regulated 24 hours after co-culture of Su-4 and HK cells, whereas 
BIM was down-regulated in B cells (Yau et al., 2013). The authors demonstrated that 
loss of miR-181a increased cell death of the Su-4 cell line, indicating that miR-181a is 
an important regulator of BIM. 
These two studies provide examples of miRNAs conferring robustness in a biological 
system. In these situations the gene targets are transcriptionally regulated but as a 
robust change in gene expression is critical for these biological processes, miRNAs are 
also activated as ‘insurance’ against any transcription that is allowed to take place. 
1.3.6.  miRNAs in development 
Differential miRNA expression in B cells through their many developmental stages has 
been extensively studied (Davidson-Moncada et al., 2010; Zhang et al., 2009; Yébenes, 







miR-181a was the first miRNA recognised to be involved in early B cell differentiation. 
Overexpression of miR-181a in lymphocyte progenitor cells caused a bias  towards 
development of B cell lineages (Chen et al., 2004). The RNA binding protein lin-28 is 
identified as a target of miR-181a, and it is proposed that miR-181a targeting of lin-28 
disrupts the lin-28-let-7 regulatory loop, leading to up-regulation of let-7 which in turn 
causes differentiation (Li et al., 2013). However the exact mechanisms of miR-181a  





Figure 1.11 miRNA control of B-cell differentiation. Red arrows indicate down-regulation by 
a miRNA, green dashed arrows indicate indirect upregulation by the indicated miRNA. CLP = 
common lymphoid precursor, Imm-B = immature B-cell, MN-B = mature naïve B-cell. 




1.3.6.2. miR-17~92 cluster 
The miR-17~92 cluster encodes six miRNAs. Deletion  of this cluster in hematopoetic 
stem cells causes a block in subsequent B cell differentiation at the pro- to pre-B cell 
stage (Ventura et al., 2008). Cells deficient for miR-17~92 also have increased levels of 
the pro-apoptotic protein BIM, and repression of BIM has been shown to partially 
rescue the phenotype (Koralov et al., 2008). 
1.3.6.3. miR 34a 
The overexpression of miR-34a has also been described to block B cell differntiation at 
the pro- to pre-B cell stage (Rao et al., 2010). This occurs by miR-34a targeting of the 
transcription factor FOXP1 which is required for early B cell devlopment (Rao et al., 
2010). 
1.3.6.4. miR-150 
It has been shown that miR-150 is expressed highly in mature and resting B- and T-
lymphocytes but not their progenitors (Xiao et al., 2007) indicating a role in 
lymphocyte development or function. The study showed that the pattern of c-Myb 
expression is opposite to that of miR-150 during lymphocyte development. Reporter 
assays revealed that miR-150 over-expression reduced reporter gene expression 
containing the wild-type c-Myb 3’-UTR, by seven fold. In miR-150-deficent B-cells, the 
induction of c-Myb protein upon IgM cross-linking was increased 2.6 fold as compared 
to controls. Together these results strongly suggest that miR-150 controls B-cell 
development by targeting the transcription factor c-Myb. These findings are consistent 
with a study where the authors ectopically expressed miR-150 in haematopoietic stem 
and progenitor cells and blocked B cell differentiation from the pro-B to pre-B cell stage 




1.3.6.5. miR-155 in the germinal centre reaction 
miR-155 has been found to be widely expressed in lymphoid organs but not in non-
lymphoid organs (Thai et al., 2007). miR-155-deficient mice have reduced numbers and 
size of germinal centres compared to wild-type mice (Baltimore et al., 2008; Thai et al., 
2007). miR-155 targets the transcription factor PU.1 in B cells  which causes a loss of 
class switching to IgG1 (Vigorito et al., 2007). miR-155 has also been shown to target 
activation-induced cytidine deaminase (AID) (Dorsett et al., 2008; Teng et al., 2008). 
AID de-aminates cytosine residues and introduces U:G mismatches in DNA inducing 
class-switch recombination and somatic hypermutation (Hogenbirk et al., 2013). miR-
155 then has a role in controlling the amount of mismatches and mutations that are 
introduced. Deregulated expression of AID can cause oncogenic transformation and 
Burkitt lymphoma which is characterised by AID-induced mutation and reciprocal 
translocation of the c-MYC oncogene (Borchert et al., 2011) miR-155 therefore has an 
important role in the prevention of lymphomas (Lawrie et al., 2007; Borchert et al., 
2011; Deng et al., 2011). 
 
 
1.3.7. Methods used to study miRNAs 
Since the introduction of high through-put sequencing technologies, thousands of novel 
miRNAs have been identified in a relatively short period of time. The most widely used 
platform for miRNA sequencing is Illumina next generation sequencing (NGS). The 
illumina method uses a cluster generation approach, where for each single short RNA in 
the sample that is bound to the chip, a bridge amplification step is used to generate 
hundreds of identical copies which are then sequenced in parallel. This means that the 
fluorophore signal during the sequencing reaction is much greater, which allows very 




sequences to be mapped to the genome. The advantage of miRNA sequencing over 
miRNA microarray is the ability to discover novel miRNA. 
MiRNA microarray technologies are now also very widely used to identify the 
expression levels of known miRNAs in the samples of interest. This method is faster 
and simpler compared to miRNA sequencing as the sample preparation is less 
complicated and because the probes correspond to known miRNA the analysis of the 
data is simpler. However, the small size of miRNA does pose problems for this method 
because there is little choice in the sequence that can be used as a probe. These limited 
choices mean that obtaining equally optimal conditions for hybridisation for all probes 
is very difficult, meaning that the hybridisation of some miRNA is going to be more 
efficient than others.  
The small size of miRNA therefore makes the challenges faced with both these high 
through-put technologies greater than that for mRNA. It is particularly important 
therefore that miRNA expression is also confirmed experimentally. 
Quantitative real-time PCR (qPCR) is often used to confirm expression of miRNAs 
(Schmittgen et al., 2004; Chen et al., 2005; Raymond et al., 2005; Jiang et al., 2005). The 
same probe design problems encountered with miRNA microarray also exist for miRNA 
qPCR. However, because a much smaller number of miRNAs are analysed at a time, the 
conditions can be adjusted between experiments meaning that optimal conditions can 
be used for all miRNAs. This does however mean that comparisons between 
experiments cannot easily be made, but comparisons can be made between different 
samples for the same miRNA which is a common experimental goal. The advantage of 




Northern analysis is a robust technique for the identification of miRNA. However, the 
small size of miRNA poses the same problems of probe design encountered by 
microarray and qPCR methods. The small size of the probes also means that they can 
only be labelled with a single fluorescent or radioactive label. This originally meant that 
miRNA northern analysis was a less sensitive method than standard mRNA northern 
analysis and as such required large amounts of starting RNA. However, the advent of 
locked nucleic acid (LNA) technology (Satoshi Obika, Daishu Nanbu, yoshiyuki Hari, 
Ken.ichiro Morio, Yasuko In, Toshimasa Ishida, 1997; Koshkin et al., 1998) has allowed 
vast improvements in sensitivity of miRNA northern analysis and also microarray and 
qPCR where LNA probes are now also used. The LNA probes bind with greater 
specificity because a methylene bridge between the 2’-O atom and the 4’-C atom ‘locks’ 
the oligonucleotide in a more open confirmation that is optimal for Watson-crick base 
pairing. Pairing is therefore more rapid and gives greater stability to the resulting 
duplex. A higher melting temperature also results, meaning that the specificity can be 
increased by carrying out more stringent washes than could otherwise be used. Further 
advances to the miRNA northern analysis protocol include chemical cross-linking using 
EDC rather than UV cross-linking (Pall and Hamilton, 2008). EDC cross-linking binds 
the 5’-phosphorylated miRNA to primary amine groups on the surface of the nylon 
membrane. While this 5’-end cross-linking is sufficient to hold the short miRNA 
strongly onto the nylon membrane it leaves most of the miRNA ‘free’ thus making 
binding of the labelled probe to the miRNA quicker and easier. 
1.3.8. MiRNA target identification 
The imperfect base pairing and diverse elements found to be involved in miRNA target 
recognition has meant that target identification has proved the most difficult element of 




however, the majority of these use seed sequence complementarity as the key element 
of prediction. Dependence on such a short sequence means that many false positive 
targets are predicted by the majority of these algorithms. Many of the algorithms take 
into account additional features such as secondary structure and the energy needed for 
the association. A number of the more commonly used algorithms along with their 





FDCs play a central role in driving and regulating germinal centre responses. The 
display of antigen on the surface of FDC as well as the production of various molecules 
to support plasma and memory B cell development is vital for driving and maintaining 
efficient humoral immune responses. FDC are therefore pivotal in host defence against 
external pathogens. The correct functioning of FDC is also essential for tolerance, and 
as such, dis-regulation of FDC can be a significant driver in autoimmune disorders.   The 
development and function of FDC are likely to be regulated at a variety of 
transcriptional and post-transcriptional levels. MiRNAs are a small non-coding class of 
small RNA which function to post-transcriptionally control gene expression and have 
Table 1.1 Various features that some common target prediction algorithms use for 




been shown to act upon many processes of the immune system. However, to date, 
miRNAs have not been identified in FDC. The overall aim of this thesis was therefore to 
identify miRNAs that are involved in the development and function of FDC. 
1.5. Aims 
The overall aim of this thesis was to identify miRNAs with roles in the development and 
function of FDC.  
An initial objective was to characterise an in vivo model of FDC de-differentiation and to 
identify differentially regulated miRNAs in this system.  
To identify miRNAs, a subset of the samples with FDC at various stages of de-
differentiation were used for miRNA microarray analysis. MiRNAs that correlated with 
the de-differentiation of FDC were identified and a subset selected for functional 
analysis.  
To identify functional roles of these miRNA, loss- and gain- of function studies were 
carried out in the FL-YB cell line. Both growth and morphological characteristics were 
examined using a live cell monitoring system and the transcription of genes known to 
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Chapter 2: Materials and Methods 
2.1. Mice and LTβR-Ig treatment 
Age matched C57BL/6 mice were given a single intravenous (i.v.) injection of 100 μg of 
a fusion protein containing the soluble lymphotoxin β receptor (LTβR) domain linked 
to the Fc portion of human immunoglobulin G1, LTβR-Ig (Biogen, UK) (Force et al., 
1995). After 1, 2, 3, 5, 7, 10, 14, 19, 21, 24 or 28 days four mice (two male and two 
female) were culled and spleens taken, portioned into three and snap frozen in liquid 
nitrogen. 
LTβ-/- mice were obtained from B & K Universal Ltd (Hull, UK). The Ltb gene was 
rendered non-functional by insertion of a neomycin resistance cassette in reverse 
orientation in exon I (Wilhelm et al., 2002; Ngo et al., 1999). Mice were maintained on a 
C57BL/6 background. 
2.2. Immunohistochemistry 
Frozen sections of 8 μm were cut using a cryostat from tissue embedded in 
Tissue-Tek® O.C.T compound (VWR International Ltd, UK).  Sections were fixed in 
acetone for 10 min, blocked with normal mouse serum and primary antibody was 
added to the sections (table 2.1). For light microscopy, if the primary antibody was not 
biotin conjugated a species specific biotin conjugated antibody was added. The biotin 
was then detected by alkaline phosphatase (AP) which was bound to the avidin-biotin 
complex (Vector Laboratories). Vector Red was used as the substrate (Vector 
Laboratories). The sections were then counter-stained with haematoxylin and 
cover-slipped. Light microscopy was carried out using a Nikon Eclipse E800 
microscope (Nikon, UK). For fluorescent microscopy, after the primary antibody was 
added, a species specific secondary antibody with conjugated fluorophore was added. 
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RNA methods 
2.3. RNA Extraction  
RNA-Bee (AMS biotechnology) was added to tissue samples which had been stored 
at -80°C. The tissue was homogenised and 0.2 volumes of chloroform was added and 
samples were shaken vigorously for 30 seconds. For RNA extraction from cultured 
cells, the cells were harvested by scraping from the culture plate with RNA-Bee and 
transferred into a 2 ml microcentrifuge tube before 0.2 volumes of chloroform was 
added. Samples were left on ice for 5 min before being centrifuged at 12,000x g, at 4°C 
for 20 min. The aqueous phase was removed and dispensed into a fresh 1.5 ml 
microcentrifuge tube. 0.7 volumes of isopropanol was added and samples left on ice for 
15 min before being centrifuged at 12,000x g at 4°C for at least 20 min. The 
supernatant was then removed from the pellet and 85% cold ethanol was added. The 
samples were again centrifuged at 12,000x g for 10 min before the supernatant was 
once again removed.  The samples were then put on ice for 10 min to dry. Nuclease-free 
water (Ambion, life technologies) was added and the sample vortexed. RNA was either 
stored short-term (< 4 weeks) at -80°C or long-term as an ethanol precipitate; 0.1 




volumes of 3M NaAc and 2.5 volumes of 100% ethanol was added before storage 
at -80°C. 
2.3.1. Recovery of RNA from precipitate 
The samples were centrifuged at 12,000x g, at 4°C for at least 20 min before the 
supernatant was removed from the RNA pellet. Cold 85% ethanol was added to the 
samples before being centrifuged at 12,000x g, at 4°C for 10 min. The samples were 
then air-dried on ice for 10 min and an appropriate volume of nuclease-free water was 
added to the sample and vortexed. 
2.3.2. Quantitative and qualitative analysis of RNA 
To assess the quantity and quality, RNA was routinely assessed using a nanodrop 
spectrophotometer (Thermo scientific) according to the manufactures instructions. 
Sample pedestals were cleaned before each measurement and the spectrophotometer 
was blanked using a nuclease-free water sample. 1ul of each sample was pipetted onto 
the pedestal and absorbance read at a path-length of 0.05-1 mm. A rough assessment of 
quality and purity of the RNA samples was gained from the 280/260 nm and the 
260/230 nm ratios. RNA quality was also assessed using an Agilent Bioanalyzer 2100 
(Agilent technologies) using the Agilent RNA 6000 Nano kit, according to manufactures 
instructions. 
2.3.3. DNase treatment of RNA 
DNase treatment was carried out using DNA-free kit (Ambion, Life technologies). 0.1 
volumes of 10X DNase 1 buffer and 1 μl of rDNase 1 was added to the RNA sample, 
mixed, and incubated at 37°C for 1 h. 0.1 volumes of inactivation reagent was then 
added, mixed and incubated at room-temperature for 2 min with occasional mixing. 




transferred into a fresh microcentrifuge tube. Following DNase treatment the samples 
were precipitated by adding 0.1 volumes of 3M NaAc and 2.5 volumes of 100% ethanol 
and precipitated at -80°C for at least 1 h before recovery according to section 3.1. 
2.4. Quantitative PCR analysis (qPCR) of gene expression 
RNA was prepared according to section 2.3. RNA used to create cDNA for qPCR was 
always DNase treated (section 2.3.3). 2-5ug of RNA was used for cDNA synthesis using 
first-strand cDNA synthesis kit (GE healthcare) according the manufactures 
instructions. The resulting cDNA was aliquoted before being stored at -20°C. qPCR was 
carried out using Platinum® SYBR® Green qPCR SuperMix-UDG kit (Life technologies). 
6-32 ng of cDNA was used per reaction in either 4.75 μl or 9.5 μl of nuclease-free water. 
6.25 μl or 12.5 μl of Sybr Green mastermix, 0.625 μl or 1.25 μl of each forward and 
reverse primer (see table 2.2) was used at a concentration of 20 μM. The thermal 
profile was set according to the manufactures instructions for 40 cycles of amplification 
on a stratagene lightcycler 3000P QPCR machine. Mx Pro software (Agilent 
technologies) was used for analysis of the qPCR data and Ct (threshold cycle) values 
were normalised to either β-actin (cell experiments) or HPRT (hypoxanthine guanine 
phosphoribosyl transferase) (spleen samples). 
2.4.1. Quantitative PCR analysis of miRNA expression 
MiRNA qPCR was performed using the miScript PCR system (Qiagen) according to the 
manufactures protocol. miRNA qPCR probes for specific miRNA were also obtained 







Gene symbol Column1 Primer sequence 
Actb Forward TGACAGGATGCAGAAGGAGA 
 Reverse GTACTTGCGCTCAGGAGGAG 
Hprt Forward GCAGTACAGCCCCAAAATGG 
 Reverse AACAAAGTCTGGCCTGTATCCAA 
Cxcl13 Forward ACAGACTCCGAGCTAAAGGTTG 
 Reverse AATGGGCTTCCAGAATACCG 
Mfge8 Forward TTCTGTGACTCCAGCCTGTG 
 Reverse GGAGCATGGTCCTCTCTCAG 
Ccl19 Forward GATCGCATCATCCGAAGACT 
 Reverse GAGGCCTGGTCCTCTCTTCT 
Tnfsf13b Forward GGACCAGAGGAAACAGAACAAG 
 Reverse TTTCTGAGGTTCATTCCATTATCA 
Tlr4 Forward ACTCTGATCATGGCACTGTTCTT 
 Reverse GCTCAGATCTATGTTGGTTGA 
Vcam-1 Forward CCGGCATATACGAGTGTGAA 
 Reverse GGAGTTCGGGCGAAAAATAG 
Il-15 Forward CGTGCTCTACCTTGCAAACA 
 Reverse TCTCCTCCAGCTCCTCACAT 
Ltbr Forward CAGAGAGCTGGAGGCTGAAC 
 Reverse TATGTAGATGTTGCCGGTGA 
Ptgir Forward CTCCCTGCCTCTCATGATCC 
 Reverse GAGGAGGTCCCCCATCTCT 
Il-6 Forward CAAAGCCAGAGTCCTTCAGAG 
 Reverse GCCACTCCTTCTGTGACTCC 
Ptgs1/2 Forward TGTACAAGCAGTGGCAAAGG 
 Reverse TTCTGCAGCCATTTCCTTCT 
Prnp Forward CTGAAGCATTCTGCCTTCCT 
  Reverse GCCGACATCAGTCCACATAG 
 
2.5. Illumina sequencing 
Illumina sequencing libraries were prepared according to the Illumina small RNA v1.5 
sample preparation guide. RNA (prepared according to section 2.3) from the spleens of 
two sex-matched mice from the same time-point were pooled in equal quantities. 
Libraries were prepared from 8 time points each with a female pool sample and a male 
pool sample to give a total of 16 samples. 5 ug of total RNA was used as input for the 
protocol. The 5’ adapters, PCR primers and sequencing primers were designed and 




provided by the sequencing service provider (Ark Genomics) sequences are provided in 
table 2.3. 15 cycles of PCR amplification was run for each sample. Following library 
preparation, 1 ul of each library was analysed by nanodrop spectrophotometer and 
Agilent Bioanlyzer using DNA 1000 series II chips (as section 2.3.2). Samples were then 
diluted to 10 nM and given to Ark Genomics to assess cDNA concentration using KAPA 
Library Quantification Kit (Kapa Biosystems, US). 5 fM of cDNA four samples were 
pooled, representing the samples that were to be loaded onto a single lane of the flow 
cell. Each of these pools was subject to the cluster generation protocol for single reads 
(Illumina), before diluting with Illumina hybridisation buffer HT1 to a concentration of 
8 pM and being loaded onto the flow cell. 
5’ Adapter sequences sequence 
Index 1 GUUCAGAGUUCUACAGUCCGACGAUCGCUAG 
Index 2 GUUCAGAGUUCUACAGUCCGACGAUCCAUGA 
Index 3 GUUCAGAGUUCUACAGUCCGACGAUCUAGUC 
Index 4 GUUCAGAGUUCUACAGUCCGACGAUCCGACU 
  
RT primer AGCATACGGCAGAAGACGAAC 
PCR primer 1 AATGATACGGCGACCGACAGGTTCAGAGTTCTACAGTCCG 
PCR primer 2 AGCATACGGCAGAAGACGAAC 
Sequencing primer CGACAGGTTCAGAGTTCTACAGTCCGACGATC 
 
2.5.1. Data analyis of Illumina sequencing data 
 Data were analysed and mapped to the mouse genome by Ark Genomics using 
Novoalign software (Novocraft Technologies). From the text files provided by Ark 
Genomics, any reads which did not map to a mature mouse miRNA were deleted (R 
code in appendix A) and data were ‘collapsed’ so that only one read value was obtained 
for each mature mouse miRNA (R code in appendix A). Separate data files for each 
sample were then merged into one (R code in appendix A) and trimmed mean of M-




value (TMM) normalisation factors were calculated using the bioconductor package 
‘edgeR’ (Robinson and Oshlack, 2010; Robinson et al., 2010) (R code in appendix A). 
After, it was discovered that a single miRNA was making up the majority of the sample 
content in half of the samples, the normalisation factors were recalculated after 
deletion of this miRNA from the samples (R code in appendix A). After tag bias was seen 
in the data, normalisation was attempted within ‘low read’ tags and ‘high read’ tags 
separately to see if these data could be used in this way (R code in appendix A). The 
sequencing service ran a principal component analysis (PCA) on these data and it was 
found that the tag bias meant these data could not reliably be used.  
2.6. Gene expression microarray analysis 
2 μg of each RNA sample, prepared as in section 2.3, was provided to the sequencing 
service provider (Ark Genomics, UK). Samples were hybridised to Affymetrix Mouse 
430 2.0 3'IVT Expression arrays (Affymetrix, UK). Raw data files in the .CEL format 
were provided after analysis. The .CEL files were read using the Bioconductor package 
“Affy” (Gautier et al., 2004) in R. 
2.7. miRNA microarray analysis 
RNA was prepared according to section 2.3 and 5 μg was sent to Exiqon (Denmark) for 
quality analysis and miRNA microarray analysis (Array 208400, 6th Gen). 2 μg was 
given to Ark Genomics (UK) for Affymetrix miRNA microarray analysis. Data obtained 
from both platforms were normalised by robust multi-array analysis using the 







2.8. Web-based miRNA target prediction and gene enrichment analysis 
Web-based miRNA target prediction was carried out using 4 different algorithms; 
DIANA-microT (http://diana.cslab.ece.ntua.gr/microT/, (Maragkakis et al., 2009)), 
 RNA22 (http://cbcsrv.watson.ibm.com/rna22.html, (Miranda et al., 2006)),  
miRDB (http://mirdb.org/miRDB/, (Wang, 2008)),  
microRNA.org (http://www.microrna.org/microrna/home.do, (Johnnidis et al., 
2008)(Betel et al., 2008)) the top 300 predictions from each programme were taken for 
each miRNA of interest (see section 4.2.4). 
2.9. miRNA northern analysis 
RNA prepared as previously described in section 2.3 was used. 2-5 μg of RNA was 
mixed with an equal amount of 2X TBE-urea sample buffer (Life technologies), 
denatured at 70°C for 3 min and loaded onto a 15% polyacrylamide TBE-urea gel 
(Criterion, Bio-rad, UK). The RNA was separated by gel electrophoresis at 125 V for 90 
min. The RNA separation was visualised using Sybr®Gold nucleic acid dye (Life 
technologies). RNA was transferred to a nylon membrane, Amersham Hybond-NX (GE 
healthcare) by sandwiching the gel and 0.5 X-TBE soaked membranes between 
0.5X-TBE soaked filter papers in a Bio-rad semi-dry transfer system at 220 mA for 1 h. 
RNA was cross-linked to the membrane using 
1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride  (EDC)-cross linking 
solution according to the protocol described by (Pall and Hamilton, 2008). To  prepare 
EDC cross-linking solution 245 μl of 12.5 M 1-methylimidazole  was added to 9 ml 
nuclease-free water and the pH adjusted to pH 8.0 with 1 M HCl, 0.753 g of EDC 
(Thermo Scientific) was then added and the volume made up to 24 ml with nuclease-




solution before the membrane was placed on top with the RNA facing up, the 
membrane and EDC soaked filter paper were wrapped in cling film and placed in a 
hybridisation oven at 60°C for 1 h. After this time the membrane was removed and 
washed with nuclease-free water.   
For detection of specific miRNA molecules membranes were pre-hybridised with 
ULTRAhyb Oligo buffer (Ambion, Life technologies) at 42°C for a least two h and then 
incubated overnight at 42°C with complementary radiolabelled locked nucleic acid 
(LNA)-modified oligonucleotides in ULTRAhyb Oligo buffer (Ambion, Life 
technologies). LNA-modified oligonucleotides were obtained from Exiqon with LNA 
nucleotides placed approximately every 3 nucleotides (Table 2.5). Oligonucleotides 
were radiolabelled at the 5’ end with ATP[γ-32P] using mirVana probe and marker kit 
(Ambion, Life technologies) according to manufactures protocol. After removal of 
unbound oligonucleotide (2 x 15 minute washes in 2 X SSC, 0.1 % SDS at 42°C), 
membranes were wrapped in saran wrap, placed in an exposure cassette and exposed 
to autoradiograph film (Kodak, Biomax MS film) at -80°C in the presence of a maximum 
sensitivity intensifying screen (Kodak) for between 4 and 24 h. Autoradiographs were 
developed using a Konica SRX-101A X-ograph machine. If non-specific signals were 
observed, the membrane went through further wash steps with 0.1 X SSC, 0.1% SDS at 
increasing temperatures from 50°C until all non-specific signals were removed. 
Exposure times of up to 8 d were used to obtain optimum signal. To completely remove 
bound LNA-modified oligonucleotides membranes were washed in boiling 0.1 X SSC 
and checked for residual signal by exposure to autoradiograph film. Membranes were 






2.9.1. Phosphorimager quantification 
To quantitate hybridised radiolabelled nucleic acid after miRNA northern analysis, 
membranes were exposed to phosphorimager screens at room temperature for the 
required length of time. For quantification screens were scanned using a Typhoon FLA 
7000 system (GE healthcare life sciences) and quantification was performed using 
ImageQuant TL software (GE healthcare life sciences). 
 
Cell Culture Techniques 
2.10. FL-YB cell culture 
FL-YB cells were kindly provided by Hitoshi Ohmori (Okayama University, 
Japan)(Nishikawa et al., 2006). Culture medium was prepared as follows; 1:1 ratio of 
low glucose Dulbecco's Modified Eagle Medium (Gibco, life technologies) and RPMI 
1640 (Gibco, life technologies), 10 % heat-inactivated foetal bovine serum (FBS) (Gibco, 
life technologies), 2-Mercaptoethanol at 50 μM, 1 X penicillin:streptomycin. Cells were 
routinely cultured in the presence of 5 ng/ml recombinant murine TNFα (Peprotech, 
UK) in T75 tissue culture treated flasks (Sigma-aldrich) at a density of ~5x 104 to ~1x 
105 cells/ml and passaged every 3 days at 37°C, 5% Co2. To subculture the cells were 
washed 2-3 times with sterile 1 X PBS and 2 ml of 1 X TrypLE™ Express (Gibco, life 
technologies) was added before incubation at 37°C for 2 min. Complete culture media 
(8 ml)was then added, and a cell suspension created and transferred to a sterile conical 
centrifuge tube and centrifuged at 600x g for 5 min at 4°C. The cells were re-suspended 






2.11. Raw 264.7 cells  
The macrophage cell line Raw 264.7 (Raschke et al., 1978) was cultured in RPMI 1640 
(Gibco, life technologies) with 5% FBS (Gibco, life technologies) and 1 X 
penicillin:streptomycin in 10 cm square bacteriological plates (Sterilin, Thermo 
scientific). Cells were passaged every 3-4 days and detached by washing with a blunt 
18 gauge needle in complete media to give a single cell suspension. 70-80% of the cell 
suspension was removed and replaced with fresh medium.  
2.12. Cell stimulation experiments 
FL-YB cells were plated at a density of 5x 104 cells/well in a 6-well tissue culture 
treated plate (Corning life sciences). To each well, one of the treatment options below 
was added. Cells were harvested 96 h later in RNA-Bee. 
1 No supplements 
2 recombinant murine TNFα (Peprotech) at 5 ng/ml 
3 Recombinant murine TNFα at 5 ng/ml and agonistic LTβR MAb at 2.5 μg/ml (AbD 
serotec) 
4 Recombinant murine TNFα at 5 ng/ml and recombinant mouse IL-4 at 5 ng/ml 
(R&D systems) 
  
2.13. xCELLigence analysis 
To perform real-time analysis of cell growth and spreading, 50 ul-100 μl of media was 
dispensed into each well of a 96-well E-view plate (ACEA Biosciences). A background 
sweep was performed on the xCELLigence SP instrument (Roche) using RTCA software 
(Bucher biotec) which sets this baseline value to a ‘Cell Index’ of 0. Cells and treatments 
were then added as appropriate in 100 μl of media. Cell index readings were taken 
every 15 min for the first ~40 h then every 30 min thereafter.  





2.14. CyQUANT direct cell proliferation assay 
The CyQUANT Direct Cell Proliferation Assay Kit (Life technologies) was used to assess 
cell viability according to the manufacturer’s instructions. To measure cell viability 
after IL-4 treatment FL-YB cells were plated into 96-well plates at a density of 4,000 
cells/well with 5ng/ml TNFα and/or 5ng/ml IL-4, the CyQUANT assays were carried 
out in the plates at the appropriate time-points after plating. To measure cell viability 
after loss or overexpression of specific miRNA, FL-YB cells were plated out at 4,000 
cells/well and incubated at 37°C overnight before the medium was replaced with 
antibiotic-free medium containing the specific miRNA mimic or inhibitor and 
lipofectamine. Cells were transfected for 4 h before medium was replaced with 
complete media and the cyQUANT assays were again carried out directly in the plate 
after the appropriate length of time. 
2.15. Live cell imaging 
FL-YB cells were plated in a 6-well plate at a density of 6x 105 cells/well and treated 
with either TNFα at 5 ng/ml alone or in combination with IL-4 at 5 ng/ml. The plate 
was then placed into a plate holder in the chamber of a Zeiss live cell axio observer 
(Carl Zeiss) and then using Zen software, images were collected every 5 to 30 min in 
over a 5 d period.  
2.16. miRNA gain- and loss-of-function experiments 
FL-YB cells were transfected using lipofectamine 2000 (Life technologies) according to 
the manufactures protocol. Briefly, FL-YB cells were plated in 6-well or 96-well tissue 
culture plates at a density of 4x 105 cells/ml and incubated overnight with 5ng/ml 
TNFα. The media was then removed and replaced with 1 ml for (6-well) or 50 μl (for 96 




every 1µg of nucleic acid) was diluted in opti-MEM (Life technologies) and incubated at 
room temperature for 5 min and the nucleic acid to be transfected was diluted in opti-
MEM. An equal volume of diluted Lipofectamine was added to each tube of diluted 
nucleic acid and incubated at room temperature for at least 30 min. An appropriate 
volume of transfection mixture was added to each well of cells and incubated at 37°C 
for 4 h before the transfection media was diluted with 2 X volumes of complete media 
and incubated for a further 2 h before being replaced with complete media plus 5 
ng/ml TNFα as appropriate.  
2.16.1. miRNA loss-of-function  
miRNA expression was inhibited by transfection with LNA-modified DNA 
oligonucleotide (Exiqon) with complementary sequence to the miRNA being targeted 
(Table 2.5) at a concentration of 150nM. 






2.16.2. miRNA gain-of-function  
miRNA overexpression was achieved by transfection of mirVana miRNA mimic 
(Ambion, life technologies) at a concentration of 30nM. mirVana miRNA mimics consist 
of a stem-loop structure to mimic a natural pre-miRNA with a chemical modification to 
ensure incorporation of the desired mature miRNA sequence into the RNA-induced 
silencing complex (sequences in table 2.6 below) 
 
Table 2.5 Sequences of LNA-modified oligonucleotides used for 






























Table 2.6 The functional sequence of miRNA mimics used 
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Chapter 3. Characterisation of a model of FDC de-differentiation 
 
3.1. Introduction 
A lack of genuinely specific histological markers for FDCs as well as the close 
association of FDCs with germinal centre B cells has meant that isolation of a pure FDC 
population has proven to be very difficult (Munoz-Fernandez et al. 2006; Aguzzi & Nike 
J Krautler 2010). This difficulty is compounded by the dependency of FDCs on signals 
from their microenvironment to keep them in their mature, fully functional state 
(Nishikawa et al. 2006; Malhotra et al. 2012). To avoid the problems associated with 
FDC isolation, an in vivo FDC de-differentiation protocol (Mackay & Jeffrey L. Browning 
1998; Mabbott et al. 2000) was used to enable the identification of genes and miRNAs 
relevant to FDC differentiation. 
LTβR-blockade by treatment with LTβR fusion proteins (LTβR-Ig) was first described 
by Rennert et al. (1996) to investigate the role of lymphotoxin (LT) signalling in 
immune system development. Introduction of LTβR-Ig into murine embryonic 
circulation by injection of pregnant mice abrogated the development of lymph nodes 
and caused disruption of splenic microarchitecture in the developing mice. Both TNF 
and lymphotoxin are needed for the development of a mature FDC network and 
constant signalling through the LTβR on FDCs is needed for the maintenance of a 
mature FDC network (Matsumoto et al. 1997; D. D. Chaplin & Y. Fu 1998). The 
introduction of LTβR-Ig blocks signalling through the LTβR on FDCs and causes rapid 
de-differentiation of the FDC network (Mackay & Jeffrey L. Browning 1998; Mabbott et 
al. 2000). 
LTβ-/- mice lack B cell follicles and mature follicular dendritic cells, as well as marginal 
zone macrophages (Koni et al. 1997). These mice also display disrupted T/ B cell 




(Ngo et al. 1999). The chemokine CXCL13 is expressed by mature FDCs. Förster et al. 
(1996) demonstrated that CXCL13 is important for correct segregation and 
arrangement of CXCR5 expressing B-cells in the spleen and later Ansel et al. (2000) 
found this to be the same in the lymph nodes. It was found that CXCL13 induced 
increased LTα1β2 expression on naïve B-cells which then interacts with the LTβR 
expressed on FDCs, promoting FDC maturation and hence completing a positive feed-
back loop for CXCL13 (Ansel et al. 2000). Unlike LTα-/- mice, LTβ-/- mice have cervical 
and mesenteric lymph nodes, although these lack FDCs, suggesting a role for the soluble 
LTα3 complexes in the development of these lymph nodes (Koni et al. 1997). 
Follicular dendritic cells express various surface molecules which are often used to 
identify the location of mature FDCs within secondary lymphoid organs. In 2008 
Kranich and colleagues (Kranich et al. 2008) showed that the mAb FDC-M1 recognises 
Mfge8 (milk fat globule-EGF factor 8 protein) and that FDCs are the major producer of 
Mfge8 in the spleen. The FDC-M1 mAb has also been found to stain tingible-body 
macrophages (Kosco-Vilbois, 2003). FDC-derived Mfge8 binds to phosphatidylserine on 
apoptotic B-cells which in turn is bound by membrane bound integrin on tingible-body 
macrophages allowing engulfment of the apoptotic B-cells by the tingible-body 
macrophages (Kranich et al. 2008). 
One of the primary functions of FDCs is to trap and retain intact antigen in the form of 
immune complexes (ICs) on the cell surface where it is displayed to germinal centre B 
cells aiding in the selection of B cell expressing high affinity antibodies (Fütterer et al. 
1998; Li & Choi 2002). Antibodies to the complement receptors CD21 (CR2) and CD35 
(CR1) recognise FDCs in both primary and secondary follicles (Allen & Jason G. Cyster 
2008). Cell surface CD35 and CD21 expressed by FDCs mediates trapping of 





The objective here was to use LTβR-Ig treatment to de-differentiate FDCs in vivo. 
Spleen samples were taken at different time points after LTβR-Ig treatment and 
assessed for the extent of FDC de-differentiation as well as for changes in other cell 
types that could potentially be influenced by the LTβR-Ig treatment. Data from this 
analysis was then used to select the most appropriate spleen samples for subsequent 























3.3.1. In vivo LTβR-Ig treatment causes rapid FDC de-differentiation in the 
spleen 
LTβR signalling blockade leads to rapid de-differentiation of FDCs in secondary 
lymphoid organs including the spleen. In order to generate material containing FDCs at 
various stages of de-differentiation, age and sex-matched C57BL/6 mice were given a 
single intraperitoneal injection of 100 μg of LTβR-Ig (Force et al. 1995). Spleen tissue 
from four treated mice (two male and two female) was collected at 1, 2, 3, 5, 7, 10, 14, 
19, 21, 24 and 28 days following injection, and from four untreated control mice. For 
comparison, spleens were also collected from four LTβ-/- mice which lack mature FDCs 
(Koni et al. 1997; Ngo et al. 1999). In order to assess the degree of FDC de-
differentiation, a third of each spleen was snap frozen and processed for histology. 
Sections of spleens were prepared and immunostained for the expression of typical 
FDC markers (CD35 and MFGE8) (Kranich et al. 2008). Immunostained sections were 
examined by light microscopy, and representative images were collected (summarised 
in Table 3.1). Immunohistochemical (IHC) analysis revealed the presence of extensive 
CD35+ FDC networks and MFGE8 staining in the sections prepared from spleens of 
control mice (Figure 3.1). As early as two days following LTβR-Ig treatment there was a 
clear reduction in CD35 and MFGE8 staining. Analysis of spleen sections from other 
time points in this experiment revealed that by day three following LTβR-Ig treatment, 
CD35 and Mfge8 immunostaining was either completely absent or greatly reduced. 
There was no evidence of CD35+ FDC networks or MFGE8 immunostaining in the 
spleens collected from mice between 3 days and 21 days after treatment, (the spleens 
collected 21 days following treatment showed wide variance). There was evidence of 
low levels of CD35 from 21 days following LTβR-Ig treatment, but even after 28 days 




observed in two animals at 21 days after treatment. As expected, no CD35 or MFGE8 





Group No. of CD35 positive spleens No. of MFGE8 positive spleens 
Untreated 4/4 4/4 
Day 1 4/4 4/4 
Day 2 4/4 3/4 
Day 3 2/4 0/4 
Day 5 0/4 0/4 
Day 7 0/4 0/4 
Day 10 1/4 1/4 
Day 14 0/4 0/4 
Day 19 0/4 0/4 
Day 21 2/4 2/4 
Day 24 2/4 0/4 
Day 28 2/4 0/4 
LTβ
Δ/Δ
 0/4 0/4 
Table 3.1 Summary of immunostaining for mature FDC markers in untreated, 
LTβR-Ig treated and LTβ
Δ/Δ
 mice. In order to assess the degree of de-
differentiation at different time points following LTβR-Ig treatment, a portion of 
each spleen was fixed and processed for histology. Sections were 
immunostained for the expression of the typical FDC markers CD35 and MFGE8. 
Immunostained sections were examined by light microscopy, and representative 
images were collected. The table shows a summary of the number of spleens 




































Figure 3.1 Loss of follicular dendritic cell markers following LTβR-Ig treatment. IHC 
analysis of CD35 and Mfge8 expressed by FDCs (red). The untreated spleen shows 
extensive follicular dendritic cell networks and MFGE8 immunostaining. CD35 staining 
reveals a dramatic reduction in the FDC network by day 2 and a complete loss of CD35
+
 
FDCs by day 3. MFGE8 is also lost between day 2 and 3. A small amount of CD35 
staining is seen between day 21 and 28 but no MFGE8 staining is observed. LTβ
-/-
 mice 
lacked CD35 and Mfge8 positive FDCs. Sections counterstained by haematoxylin (blue). 




3.3.2 Disruption of splenic microarchitecture following de-differentiation of 
follicular dendritic cells 
FDCs play an important role in the maintenance of splenic microarchitecture through 
expression of the chemokine CXCL13 (Alimzhanov et al. 1997; Ettinger et al. 1996). To 
determine the extent and timing of microarchitecture disruption seen after LTβR-Ig 
treatment in this experiment, the distribution of T and B cells was compared by IHC. 
Cryosections were co-stained with MAb for B220 (CD45R) to detect B cells and anti-
CD3 to detect T cells. Sections were analysed by confocal microscopy and 
representative images were collected. Spleens from untreated mice showed the 
expected distinct B cell follicles around the T cell area (Figure 3.2a). In the sections 
prepared from the spleens collected two days after LTβR-Ig treatment it is evident that 
some B cells (arrows) were beginning to migrate out of the B cell follicles and encroach 
on the T cell area. This migration of B cells out of the follicles appears to progress over 
time following LTβR-Ig treatment. In spleen sections collected fourteen days following 
LTβR-Ig treatment the B cells appear to entirely surround the T cell area in a ring 
rather than in discrete follicles. The disruption of the B cell follicles continues to 
progress right up to the final time point at 28 days after LTβR-Ig treatment, where 
there is little segregation of B cells from T cells. As seen in Figure 3.2f the LTβ-/- mice 
clearly lack proper segregation of B cells and T cells. These observations suggest that 
although the return of some CD35 staining is observed from 21 days after treatment, 
these CD35+ FDCs are unlikely to secrete sufficient quantities of CXCL13 to have an 
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Figure 3.2 Splenic microarchitecture is disrupted following LTβR-Ig 
treatment. IHC for B cells (B220 positive cells, red) and CD3 marking 
T cells (Green). The untreated spleen shows the B cells in distinct 
follicular areas at points around the T cell zone. B cells appear to 
progressively disperse from the B cell follicles (arrows) to surround 
(dashed lines) and eventually invade the T cell area (day 28). In LTβ
-/-
 
mice there again seems to be only modest segregation of the B and T 







3.3.3 The effect of LTβR-blockade on gene expression in the spleen 
To gain a more global picture of the changes that occur in the spleen following LTβR-Ig 
treatment, gene expression was monitored by microarray analysis (Affymetrix mouse 
genome MOE430 2.0 expression arrays). Immunohistochemistry data (Figure 3.1) was 
used to select time points for microarray analysis. 1.) Spleens collected from mice two 
days after the LTβR-Ig treatment. At this time point the immunostaining revealed that 
the mice still had CD35 positive FDC networks but they were much reduced in size and 
minimal Mfge8 staining was seen indicating the FDCs are considerably less mature than 
in the untreated spleen samples. 2.) Spleen samples collected fourteen days after LTβR-
Ig treatment were also chosen as no CD35 or MFGE8 staining was seen in any of these 
spleen sections indicating there are no mature FDCs present in these spleen samples. 
3.) For comparison, spleens from LTβ-/- mice which lack mature FDCs were also 
included. 4.) Spleen tissue from untreated control mice which were seen to contain 
large, mature FDC networks.  RNA was prepared from a portion of the spleens from 4 
mice from each of the four selected groups and pooled so that there were two sex 
matched pools of two from each group. These pooled RNA samples were profiled for 
gene expression using Affymetrix Mouse 430 2.0 3'IVT Expression arrays. The resulting 
data sets were normalised using robust microarray analysis, or RMA (Irizarry 2003) 
and the expression values averaged within each group. To identify transcripts with 
expression profiles that correlated with a loss of FDCs, the fold-change in expression 
value was calculated between the untreated group and the other three groups for each 
gene. Genes showing the largest fold-changes between the spleens collected 14 days 
after LTβR-Ig treatment and the untreated spleens are shown in Table 3.2. Many of the 
genes showing decreased levels as a result of the LTβR-Ig treatment have previously 
been described to be highly expressed in FDCs as indicated in the references column of 




changes in silico gene enrichment analysis was undertaken. The 50 genes that show the 
largest increase and the largest decrease in the day 14 post treatment spleens 
compared to the untreated spleens were used as input for the functional analysis that 
was carried out using the web-based software ToppFun (Chen et al. 2009). This 
analysis showed that the genes with decreased expression upon LTβR-Ig treatment 
were enriched for genes involved in immune and inflammatory responses as well as 
those involved in cell adhesion and motility. The genes found to have increased 
expression levels following LTβR-Ig treatment were enriched for genes involved in 
erythrocyte development and homeostasis as well as general homeostatic processes. 
Comparing expression in untreated and LTβΔ/Δ mice revealed 27 genes that were in the 
top 50 decreased, and 14 genes that were in the top 50 increased 14 days following 
LTβR-Ig treatment (Table 3.3). The 27 genes showing a decrease in expression again 
were enriched for genes that have functions in the immune response and cell 
movement. This indicates that the LTβR-Ig treatment is having an negative effect on the 

































  Fold change in gene expression vs.  


































t Mfge8 0.504 0.212 0.172  
Ttn 0.393 0.240 0.168 (Kranich et al. 2008) 
Ryr3 0.390 0.258 0.218  
Bst1 0.497 0.260 0.180  
Cxcl13 0.664 0.269 0.105 (Ngo et al. 1999) 
Dsc3 0.552 0.290 0.226 (Gunn et al. 1998) 
Clec4g 0.352 0.297 0.207 (Huber et al. 2005) 
Bex6 0.822 0.299 0.418  
Il22ra2 0.318 0.302 0.308  
Sulf1 0.563 0.307 0.178 (Ota et al. 2011) 
S1pr3 0.571 0.308 0.204  
Dsc2 0.517 0.311 0.296 (Zindl et al. 2009) 
Clu 0.636 0.316 0.184 (Malhotra et al. 2012) 
Prg3 0.678 0.327 0.287 (Huber et al. 2005) 
Cilp 0.693 0.354 0.155  
Pla2g2d 0.609 0.355 0.078 (Wilke et al. 2010) 
Timd4 0.680 0.357 0.179 Similar role to Mfge8 
Gpm6b 0.649 0.363 0.321  
Enpp2 0.698 0.366 0.158 (Huber et al. 2005) 
Dclk1 0.651 0.378 0.238 (Wilke et al. 2010; Huber et al. 
































Tmem56 2.01 3.08 2.57  
AI661323 1.29 2.78 1.59  
Car1 1.76 2.68 2.76  
Rhd 1.28 2.64 1.52  
Asns 1.70 2.64 2.02  
Cldn13 1.37 2.62 1.66  
Epb4.2 1.08 2.61 1.35  
Apol8 1.29 2.60 1.60  
Klf1 1.54 2.57 1.74  
Kel 1.18 2.56 1.73  
Gypa 1.22 2.53 1.16  
Pdia2 1.86 2.51 1.58  
Rhag 1.22 2.51 1.72  
Ypel4 0.97 2.49 1.41  
Ccl8 1.02 2.48 2.09  
Ermap 1.39 2.47 1.81  
Slc38a5 1.38 2.46 1.94  
Sox6 1.17 2.46 1.55  
Tal1 1.36 2.45 1.84  
Fam132a 1.73 2.45 2.13  
Table 3.2 Top 20 differentially regulated genes at Day 14 following LTβR-Ig 
treatment. Gene expression microarray data from LTβR-Ig treated and LTβ
-/-
 mouse 
spleen tissue. The fold change from untreated mice for the 20 genes with expression 
levels that were most decreased 14 days following LTβR-Ig treatment are shown at 
the top of the table. The 20 genes with expression levels that were most increased 14 
days following LTβR-Ig treatment compared to untreated samples are shown at the 
bottom of the table. References indicate those genes that have previously been 




3.3.4 Confirmation of microarray predicted gene expression changes 
To confirm the reliability of the microarray data set, quantitative real-time PCR (qPCR) 
was carried out for some of the genes that showed altered expression levels as a result 
of FDC depletion. Two genes known to be highly expressed by FDCs, Mfge8 and Cxcl13, 
were selected for measurment by qPCR.  RNA prepared from the same tissues used for 
microarray analysis was also used to generate cDNA for qPCR analysis. In addition, 
qPCR was also performed on cDNA generated from spleens selected at all other time 
points following LTβR-Ig treatment. As can be seen in Figure 3.4 the relative levels of 
gene expression between the groups agree very well for both Cxcl13 and Mfge8 when 
comparing the microarray and qPCR data. Furthermore, the time points after LTβR-Ig 
treatment that were not analysed by microarray showed a trend that fitted very well 
with the gene expression levels seen at the day 2 and day 14 time points. The only 
exception to the general trend of down regulation of both Cxcl13 and Mfge8 was seen 
for two of the spleens collected 21 days following LTβR-Ig treatment. The spleens from 
this day 21 time point were seen to have a wide variation in the expression levels of 
Mfge8 and Cxcl13 mRNA for measurements by qPCR and protein levels by IHC for 
Mfge8, as well as in the disruption of splenic B cell follicles. This data suggests a large 



























Table 3.3 Genes regulated in LTβR-Ig treated and LTβ
-/-
 mice.  The table shows 
gene expression microarray data from which the fold change in expression 
value is calculated by dividing the LTβR-Ig treated or LTβ
-/-
 expression value by 
the untreated expression value. 27 genes that were in the top 50 decreased 
upon LTβR-Ig treatment and in LTβ
-/-
 mice are shown at the top of the table 
marked in red. Those genes that were identified to be in the top 50 increased in 
the LTβR-Ig treated and LTβ
-/-
 spleens compared to the untreated spleens are 




Fibroblastic reticular cells (FRC) are the main stromal cell population situated within 
the T cell area and it has previously been reported that these cells also express the 
LTβR (Ngo et al. 1999). To evaluate whether the FRC were also de-differentiated 
following LTβR-Ig treatment we looked at the expression of Ccl19. This chemokine is 
expressed by FRC and attracts CCR7 expressing T cells into the parafollicular areas. The 
microarray data suggests that the expression levels of Ccl19 dropped to ~70% in the 
spleens collected 14 days following LTβR-Ig treatment compared to untreated spleens. 
qPCR analysis of Ccl19 expression levels (Figure 3.4) suggested a slight increase 
immediately following LTβR-Ig treatment followed by a return to levels similar to those 
seen in the untreated mice by day 5. The Ccl19 gene expression levels seen in the 
spleens collected from the LTβ-/- mice were seen to be half that seen in the untreated 
mice as measured by microarray and the qPCR data suggested a similar if not slightly 
more severe decrease in the LTβ-/- mice. Taken together it is likely that mature FRC are 
not affected as much as that of the FDC following LTβR-Ig treatment. 
3.3.5 The effect of the LTβR-Ig treatment on B and T lymphocytes 
The major cell types in the splenic white pulp are the B and T lymphocytes which, as 
illustrated in Figure 3.2, have a disrupted localisation in LTβR-Ig treated mice. 
However, gene expression microarray data reveals expression levels for typical B and T 
cell markers was unchanged in the spleens of LTβR-Ig treated mice compared to 
untreated mice (Figure 3.5). This indicates that the segregation but not the proportion 
of B and T cells have been significantly affected by LTβR-Ig treatment.  Further, slight 
changes in the LTβ-/- mice compared to the untreated mice suggests that the lack of 
LTβR signalling through development causes some more severe changes to other 



































































Figure 3.3 Microarray data for FDC and FRC genes is confirmed by qPCR. RNA 
extracted from spleen tissue from each of the four animals at each time point 
following LTβR-Ig treatment and from the LTβ
-/-
 mice, was used to generate cDNA 
for qPCR analysis of FDC genes Cxcl13 and Mfge8 and FRC gene Ccl19. The 
expression levels from the microarray data from the same samples is shown by 







































































































Figure 3.4 Expression levels of typical B cell and T cell marker genes are 
largely unchanged after LTβR-Ig treatment. Gene expression microarray 
data from untreated (Day 0) spleens, spleens from mice 2 days and 14 days 
after LTβR-Ig treatment and spleens from LTβ
-/-
 mice. Although it was shown 
that B cells migrate out of their normal follicles following LTβR-Ig treatment 
(figure 3.2), the spread seen between the groups for these typical marker 
genes of B and T cells suggest the actual numbers of T and B cells do not 





Treatment of mice with LTβR-Ig blocks LTβR-signalling and causes rapid de-
differentiation of FDCs. Data presented in this chapter characterised the effect of this 
treatment on FDCs up to 28 days following injection. This characterisation enabled the 
identification of spleen tissue with FDC networks at different stages of de-
differentiation. Gene expression microarray data from these spleen samples with full, 
small or absent FDC networks indicated that gene transcripts that are known to be 
highly expressed in FDCs could readily be identified. This method of identification of 
FDC transcripts is important as it gives us the opportunity to study FDCs without 
isolation which has proven to be difficult and sometimes inaccurate because of the high 
dependency of FDCs on signalling from their microenvironment.  
The spleens collected from mice 21 days after LTβR-Ig injection showed wide diversity 
as indicated in Figure 3.3. It is not clear why such diversity in terms of the FDC network 
was seen between the animals. It could have been due to a number of factors including 
variation in the efficiency of LTβR-Ig injection, an unusually rapid clearance of the 
LTβR-Ig injected. 
The CD35 staining (figure 3.1) for mature FDC networks showed a small amount of 
staining returning at the two latest time points looked at, day 24 and 28. The pattern of 
staining in most of the sections is not typical of fully mature FDC networks. It is likely 
that it is the case that fully mature FDC networks have not formed at these time points. 
From the B and T cell staining it is also seen that the microarchitecture of the white 
pulp in the spleen is still disrupted which would account for the more spread out 
appearance of the CD35 staining seen in some of the sections at these later time points. 
It has been proposed that FDCs arise from perivascular precursors (Krautler et al., 




marginal zone. It is possible that the CD35 staining that is seen at these later time 
points is from premature FDCs that could be located in the re-forming marginal zone. 
However without staining for marginal zone markers it is impossible to tell if the CD35 
staining is in this area, or if the microarchitecture is still too disrupted to define the 
different area. 
A comparison of the gene expression array data from the untreated spleen tissue and 
the spleen tissue collected 14 days after LTβR-Ig treatment, or spleen tissue from 
LTβR-/- mice enabled the identification of many genes that have been previously 
described to be highly expressed in FDCs (Table 3.2). It is to be noted that some genes 
identified in this way have not previously been described to be highly expressed in 
FDCs. Some of these genes have roles in the immune response such as proteoglycan 3 
which is highly expressed by eosinophils (Tang et al., 2009) , and phospholipase A2 
which is an effector molecule of T-reg cells (Von Allmen et al., 2009). However, the 
majority of these genes are fairly ubiquitously expressed genes such as titin (involved 
in muscle elasticity (Minajeva et al., 2001)) and Sulf1 (involved in signalling 
transduction (Dhoot et al., 2001)), and are therefore unlikely to be closely related to the 
effect on the follicular dendritic cells. 
Although the B and T cell staining showed extensive disruption of the 
microarchitecture and these two cell types. Microarray data showed that the gene 
expression levels for general markers of B and T cells were changed very little between 
the four groups. This implies no significant change in the numbers of B and T cells 
present in the untreated, LTβR-Ig treated, or LTβ-/- spleen tissue. 
Overall data in this chapter show the efficacy of using spleen tissue from LTβR-Ig 




this chapter will be used in the next chapter to select LTβR-Ig-treated samples for 
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Chapter 4: The effect of LTβR blockade on microRNA expression in the murine spleen 
 
4.1. Introduction 
MiRNAs regulate many aspects of the immune system and development. To date there 
are no published data describing miRNAs expressed by FDCs. Two papers however 
have described how miRNA expression in B-cells isolated from non-Hodgkin’s 
lymphomas can be influenced by direct cell contact with FDCs. The first of these papers 
(Lwin et al., 2010) showed that co-culture of non-Hodgkin’s B-cell lymphoma cells with 
human FDC cells induced miR-181a expression in the B cells which targeted Bim, 
causing increased cell survival. This fits with data showing (Ramkissoon et al., 2006) 
that miR-181 is expressed at higher levels in leukaemia B cell lines when compared to 
normal B cell lines. The second paper (Lin et al., 2011) showed that in similar 
experiments FDC-B cell contact induced the expression of the miR-30 family in B cells 
causing a decrease in Bcl6 expression, and a decrease in the expression of the miRNA 
let-7a causing an increase in Prdm1 expression.  These papers clearly show that 
miRNAs play an important role in finite regulation of the humoral immune response. 
Differential expression of miRNAs controlling the development and maturation of 
different B cell lineages have also been described (reviewed by Davidson-Moncada et 
al. 2010).  
The identification of miRNAs that play a role in the differentiation or functioning of 
FDCs could lead us to the identification of the genes and pathways that regulate those 
processes. As they are under miRNA regulation these pathways are presumably very 
important to the normal functioning of FDCs. 
The small size of miRNAs along with the close sequence similarity that two different 




challenging. Many methods however have been developed to achieve this and each 
method has different merits and limitations.  
The first method for identification of miRNAs that is used in this chapter is small RNA 
Illumina deep sequencing (Bentley et al., 2008). This method was chosen initially 
because it allows identification of potentially novel miRNAs as well as all known 
miRNAs. Illumina sequencing of small RNAs involves ligation of adaptors on to both the 
5’ and 3’ ends of small RNA. Both the adapters are needed for the reverse transcription 
of the small RNA prior to PCR amplification and the 3’ adapter is additionally needed 
for attachment to the flow cell via the amplification primer. The 5’ adaptors used here 
additionally had a unique 5 nucleotide sequence at the 3’ end of the adaptor that was 
used as a ‘barcode’ for multiplexing the samples on the flow cell.  After reverse 
transcription, 12 cycles of PCR amplification are carried out before gel purification of 
the product. Matched quantities of the cDNA libraries are then attached to the flow cell 
and amplified to form clusters. A sequencing-by-synthesis approach is then used where 
each of the cDNA molecules serves as a template for the generation of a complement 
with fluorescently labelled nucleotides. At each addition of a nucleotide an image is 
created and the nucleotide that was added identified from the fluorescent wavelength 
emitted. The next nucleotide is added, and the cycle is repeated. All the sequences 
generated from a single cluster are used to identify the most likely sequence of the 
original cDNA, thus reducing the error rate. The adaptor sequences are ‘trimmed’ from 
the small RNA sequences and the 5 nucleotide ‘barcode’ is used to assign the sequence 
to its appropriate library. The small RNA sequences are then compared against the 
annotated sequences in miRBase. Any novel small RNAs that are not identified to be 
‘contaminating’ RNA (rRNA, primer dimer etc.) are aligned to the mouse genome and 





The other high through-put method of miRNA identification used in this chapter is 
miRNA microarray. There are several platforms for miRNA microarray produced by 
different companies. The most commonly used of these are Affymetrix, Agilent, Exiqon 
and Invitrogen. In this chapter both the Affymetrix and Exiqon platforms were used 
because each has different strengths. Exiqon miRCURY LNA miRNA Arrays use locked 
nucleic acid probes (LNAs) which improve specificity and sensitivity compared to DNA 
probes (Rajwanshi et al., 2000). Exiqon recommends two colour arrays for single 
experiment samples, these arrays use a common reference sample that is hybridised to 
each array slide along with the sample, this reference is then used for intra- and inter-
slide normalisation. Affymetrix is one of the most widely used array platforms and the 
miRNA arrays offer high specificity and sensitivity combined with affordability. 
Quantitative real-time PCR for miRNAs has increasingly become a standard method for 
the quantitation of miRNAs in biological samples. There are however various 
limitations of miRNA qPCR compared to mRNA qPCR which should be recognised. The 
short nature of miRNAs means that there is very limited primer choice to amplify the 
miRNA. Additionally only one primer is specific for the miRNA, the other primer is a 
universal primer that is directed against a sequence that is added to the small RNA 
sequence during the reverse transcription reaction via the reverse transcription 
primer. This increases the chances of amplification of another small RNA that has a 
similar sequence to the miRNA of interest. This is a particular concern when 
discriminating against related miRNAs that may only have one nucleotide difference in 
their sequences. For these reasons miRNA northern analysis will be used where 
possible. 
miRNA Northern analysis is a fairly slow and expensive method for miRNA 




good level of sensitivity. Northern analysis allows you to visualise the product band and 
additional washing steps can be performed to reduce the amount of probe that is bound 
weakly, leaving only very strong, specific signal. 
4.2. Aims 
The main aim of this chapter was to use spleen samples from animals with FDCs at 
various stages of de-differentiation to identify miRNAs that are associated with FDC 
differentiation and maturation. This required accurate profiling of the miRNAs in the 
spleen tissues. Profiling of the miRNAs was first carried out using a high through-put 
method, and then the differential expression of a number of these were confirmed 




















4.3.1.  Profiling of miRNAs from LTβR-Ig treated and LTβ
-/-
 spleen tissue by 
illumina next-generation sequencing 
In order to identify miRNAs that may play a role in FDC differentiation we compared 
untreated control spleen samples with spleens from mice treated with LTβR-Ig chosen 
on the basis of the immunohistochemistry data (see section 3.2.1). RNA from the 
spleens of control and LTβR-Ig treated animals collected 1, 3, 5, 14, 21 and 28 days 
following treatment, and LTβ-/-  spleen tissue were selected to give the best 
comparisons of mature (untreated mice), de-differentiating (day 1 and 3 post 
treatment), de-differentiated (day 5 and 14 post treatment), and re-differentiating  
(day 21 and 28) FDCs. RNA was pooled into two groups of two mice for each time point, 
with one male group and one female group. Small RNA libraries were prepared using 
the alternative v1.5 sample preparation guide from illumina. Library preparation (see 
materials and methods section 2.5) involves ligation of adapters on to either end of the 
small RNA, followed by reverse transcription and PCR amplification to generate the 
cDNA library. A ‘tagging’ approach was used where by the 5’ adapter has a unique 5 
nucleotide tag at the 3’ end, thus giving each small RNA a tag to identify the library 
from which it came. Four different tags (sequences in Table 4.1) were used to allow 
sequencing of four different samples in the same lane of a sequencing flow cell. 
Libraries for 4 samples with the same 5’ adapter tag were prepared simultaneously. To 
reduce the risk of user bias four of the samples were prepared by an independent 
researcher (Derek McBride). Table 4.1 illustrates the group, tag and lane of the flow cell 
for each sample. After preparation and purification of the libraries, 1ug of each library 
was assessed for concentration and quality by Nanodrop 1000 (Thermo scientific) 
measurements and Agilent Bioanalyser RNA 6000 nano assay. Illumina next generation 




Pool Samples Tag Lane Library prepared by 
Untreated F B59400 and B59401 4 (CGACU) 1 S. Aungier 
Untreated M B60778 and B59403 2 (CAUGA) 4 S. Aungier 
Day 1 F B58907 and B58908 3 (UAGUC) 1 S. Aungier 
Day 1 M B58909 and B58910 1 (GCUAG) 4 D. McBride 
Day 3 F B58966 and B58967 2 (CAUGA) 1 S. Aungier 
Day 3 M B58968 and B58969 4 (CGACU) 4 S. Aungier 
Day 5 F B58981 and B58982 1 (GCUAG) 1 D. McBride 
Day 5 M B58983 and B58984 3 (UAGUC) 4 S. Aungier 
Day 14 F B59098 and B59099 3 (UAGUC) 2 S. Aungier 
Day 14 M B59100 and B59101 1 (GCUAG) 3 D. McBride 
Day 21 F B59180 and B59181 2 (CAUGA) 2 S. Aungier 
Day 21 M B59184 and B59185 4 (CGACU) 3 S. Aungier 
Day 28 F B59287 and B59289 1 (GCUAG) 2 D. McBride 
Day 28 M B59184 and B59291 3 (UAGUC) 3 S. Aungier 
LTβ
-/-
  F B59292 and B59293 4 (CGACU) 2 S. Aungier 
LTβ
-/-




The data files received from the array service provider (Ark Genomics) included the 
mature mouse miRNA name, the count for that sequence, and the coverage including 
the isomiRs (sequences which have small variations compared to the reference 
sequence). To analyse these data, first the miRNAs deemed ‘dead’ by miRBase or 
ambiguous small RNAs were deleted; the remaining data were then collapsed so the 
read counts for each mature miRNA were merged with any other counts for that 
mature miRNA (R scripts in appendix A). To allow normalisation of the sixteen samples 
with each other, the files from the sixteen different libraries were merged into one data 
table with only the mature miRNA name and read counts for each miRNA in each 
library. To normalise for differences in sequencing depth between the samples the read 
counts were normalised by dividing by the library size for the sample to be normalised, 
then multiplying by the average library size. The two most highly expressed miRNAs  in 
the untreated spleen samples were miR-142-3p and miR-143 which have both been 
described to be highly expressed in murine spleen tissue (Lagos-Quintana et al., 2003; 
Table 4.1 Small RNA library preparation for Illumina sequencing. RNA from the 
indicated samples was combined in equal quantities into the indicated pools before 
library preparation using 5’ adaptors with the indicated tag. Four libraries were pooled 




Landgraf et al., 2007). However, it was observed that the profiles of these two miRNAs 
(Figure 4.1a and b), had an unusual pattern. MiR-142-3p had a much higher expression 
level (~20-fold) in the untreated, day 3, day 21, and LTβ-/- samples, compared to the 
day 1, 5, 14 and 28 samples. MiR-143 had the opposite expression pattern to that of 
miR-142-3p. In the samples in which miR-142-3p was high, this single miRNA 
comprised 47-81% of the total libraries. This raised the concern that the coverage of 
the other miRNAs may be skewed against these samples due to miR-142-3p comprising 
the majority of the coverage of these libraries. Robinson & Oshlack (2010) describe a 
normalisation method, termed trimmed mean of M-values (TMM), which attempts to 
address this kind of problem where transcripts that are highly expressed in limited 
samples potentially lead to reduced sequencing coverage available for other 
transcripts. The normalisation factors for this trimmed mean of M-values (TMM) 
normalisation method were calculated using the R Bioconductor software package 
edgeR (Robinson et al., 2010) (R scripts in appendix A). Figure 4.1c and d show the 
expression profiles for miR-142-3p and miR-143, after TMM normalisation. The bias of 
miR-143 against the samples in which miR-142-3p is very high looks as though it has 
been evened out by the TMM normalisation so that the expression levels of miR-143 at 
1,3,14 and 28 day time points are not so low compared to the other time points. Figure 
4.2 shows the expression profiles for two other miRNAs that were expressed at fairly 
high levels in the female untreated sample having been normalised to library size (a 
and b) or with the TMM normalisation (c and d). Following normalisation by library 
size(a and b) the expression profile for miR-29a showed a clear bias towards the 
untreated female (f), day 3 male (m), day 21 m, and LTβ f samples. It was noted that 
those samples were prepared with the 5’ adapter with tag 4 (CGACU); Table 4.1. The 
expression profile of miR-30a showed no clear bias towards any sample. Application of 




of miR-29a, and in the case of miR-30a, actually seemed to bias the expression profile 
towards those samples that were miR-142-3p high, perhaps suggesting an over 
compensation for the expected reduction in coverage in these samples. Additionally, it 
was noted that those samples that had high miR-142-3p expression levels were 
prepared using 5’ adapters with tags 2 and 4. Together these data strongly suggested 
sequencing bias due to the 5 nucleotide tags introduced at the 3’ end of the miRNA via 














Figure 4.1 The effect of TMM normalisation on Illumina small RNA sequencing data. 
The figure shows that TMM normalisation corrects for the apparent bias caused by 
the high incidence of miR-142-3p in some samples. The high incidence of miR-142-3p 
in the untreated, day 3, day 21 and LTβ
-/-
 samples can be seen (a), and a converse 
pattern is seen in the next most abundant miRNA, miR-143 (b). After TMM 
normalisation the bias seen with miR-142-3p (c) is still largely the same but the 
distribution of miR-143 appears to be more even (d). Each bar represents a 
sequencing sample (n=2), there are two samples for each time point with the female 






Where this apparent bias was introduced was unknown. To check whether this pattern 
of expression was seen in the RNA that the libraries were prepared from, the patterns 
were analysed by miRNA northern analysis. Figure 4.3b shows miRNA northern 
analysis of miR-142-3p expression compared with the sequencing data (Figure 4.3a). 
The expression profile for miR-142-3p obtained by Illumina sequencing appeared to be 
different to the miRNA northern data obtained from the same samples. This was also 
true for miR-29a. The sequencing service was notified of this apparent tag bias and 
they carried out a principal component analysis (PCA) on the data. The PCA plot can be 
seen in Figure 4.4 and it shows that the data points cluster (indicating similarity) by tag 
rather than biological similarity. This analysis clearly indicates that the sequencing data 
could not be used to give a reliable measure of miRNA expression levels between the 
samples studied. 
It was noted that although northern analysis data and sequencing data indicated 
different patterns of miR-142-3p expression between spleen samples, in both data sets 
the levels of miR-142-3p were widely disparate between samples. This could indicate 
that the differential expression of miR-142-3p is a biological phenomenon rather than 
an artifact. Later, Exiqon miRNA microarray data from a subset of the spleen samples 
did not show any differences between the levels of miR-142-3p expression in the 
treated and untreated spleen samples and a relatively modest 32% reduction in the 
lymphotoxin beta knock-out mice (Appendix C, page 224). Interestingly, although the 
Exiqon miRNA microarray showed very high levels of miR-142-3p, the Affymetrix 
miRNA microarrays performed on the same samples did not detect miR-142-3p at 
levels above that used for the threshold cut-off. This perhaps indicates that miR-142-3p 
is very sensitive to small differences in processing of the samples in preparation for 
miRNA arrays or sequencing. It is unclear why this would be so, however relatively 




lymphoma (Kwanhian et al. 2012). If miR-142-3p is more prone to mutation it could be 
a source of the variation seen, particularly using methods of miRNA profiling that are 














Figure 4.2 The effect of TMM normalisation on small RNA sequencing data. The figure 
shows that TMM normalisation does not help large biases in data (a and c), and in some 
cases apparently causes bias (b and d). The top two graphs show the expression profile 
of miR-29a and miR-30a from the sequencing data normalised to the library sizes, miR-
29a shows a clear bias for those samples with tag1, whereas miR-30a shows no obvious 
bias. The bottom panel shows the same data which has been TMM normalised. miR-29a 
still shows the same bias, whereas miR-30a now appears to be biased towards samples 
with tag 2 and 4 suggesting that the TMM normalisation may be over compensating for 
the reduced coverage in these samples. Again each bar represents a sequencing sample 
(n=2), there are two samples for each time point with the female pool represented in 





















Figure 4.3 Comparison of sequencing data with miRNA northern analysis.  MiRNA northern 
analysis was carried out to confirm the pattern of expression seen in the sequencing data 
was caused by tag bias rather than true expression from the samples. The same RNA 
samples that the sequencing libraries were prepared from were used to run a miRNA 
northern analysis, and the membrane was probed for miR-142-3p. As can be seen, the 
pattern of expression seen from the sequencing data bears no resemblance to the 
expression seen with miRNA northern analysis from the same samples. 
Tag 1 GCTAG 
Tag 2 GATGA 
Tag 3 TAGTC 
Tag 4 CGACT 
Figure 4.4 The miRNA sequencing data clusters by Tag rather than biological similarity. 
Principal component analysis was carried out on the miRNA sequencing data. As can be 
seen the samples with the same tags cluster together showing that the tags have caused a 











































4.3.2. Profiling of miRNA expression in spleens from LTβR-Ig treated and LTβ
-/-
  
mice by microarray 
As the miRNA sequencing data could not be reliably used Affymetrix miRNA 
microarrays (GeneChip Mouse Genome 430 2.0 Array) were used. The samples selected 
for this analysis were the same as those used for gene expression microarrays, see 
section 3.3.3, (untreated, day 2 and 14 after LTβR-Ig treatment and LTβ-/-). 
Considerable variation is seen between different miRNA microarray platforms (Sato et 
al., 2009; Git et al., 2010). It was therefore decided to also analyse the same samples by 
Exiqon miRNA microarray (miRCURY LNA miRNA Array 6th GEN) to reduce the risk of 
false positives. RNA samples from untreated control spleens, day 2 and day 14 after 
LTβR-Ig treatment and spleens from LTβ-/- mice were again pooled in two samples of 
two for each group. 5ug of RNA was sent to Exiqon for QC analysis and microarrays 
(miRCURY LNA miRNA Array 6th GEN) whereas 2ug of the same RNA pools were given 
to Ark genomics to carry out Affymetrix microarrays (GeneChip Mouse Genome 430 2.0 
Array). 
 
4.3.3. Analysis of miRNA microarray profiling 
The Exiqon microarrays were analysed by the company using global lowess regression 
normalisation(Milan et al., 2011). The raw affymetrix CEL files received from Ark 
Genomics were analysed in R using the bioconductor package EximiR (Sylvain Gubian 
et al. 2010) to perform robust multi-array analysis (RMA) (Irizarry, 2003). Previous 
data suggest that the use of different normalisation methods can result in fairly large 
differences between data sets. The background subtracted Exiqon results were 




normalisation (R scripts in appendix B). In each of these datasets the two samples from 
each group were averaged unless a very large disparity was seen between the samples 
(Appendix C). The fold-change from the Day 0 sample was calculated for each of the 
treated time points and the LTβ-/- sample (Appendix C). Those miRNAs with a 2-fold or 
greater difference in expression between Day 0 and LTb-/- samples, with a change in the 
same direction at day 2 and day 14 were considered for further analysis. Only one up-
regulated miRNA fitted these criteria in the Affymetrix data set (although with low 
expression levels), and while 12 up-regulated miRNA from the Exiqon data set did fit 
these criteria, the vast majority were up-regulated less than 0.2-fold in the day 2 and 
day 14 treated samples (Appendix C). It was therefore decided to focus on the miRNAs 
that were seen to be down-regulated in line with decreased numbers of mature FDC, 
indicating that these miRNAs could be high in mature FDC and decrease in de-
differentiated FDC. 
Taking the twenty miRNAs that showed the biggest reduction in the LTβ-/- samples 
compared to the untreated samples in the RMA normalised Exiqon data it was found 
that 14 of these miRNAs were also present in the lowess normalised data. Of the twenty 
miRNAs that were most reduced in the LTβ-/- spleens compared to the untreated 
spleens in the RMA normalised Exiqon dataset, six were also in this top twenty in the 
Affymetrix dataset. Four of those six were also present in the lowess normalised Exiqon 
data. Table 4.2 shows the 20 miRNAs that had the largest reduction in expression levels 
in the LTβ-/- samples compared to the untreated samples from each array platform. 
Looking at the most down regulated miRNAs in the day 14 samples, again 6 miRNAs 
were in the top 20 down-regulated lists for both platforms, 5 of which are the same 






Fold-change in expression levels 
Affymetrix Day 0 Day 2 Day14 LTb
-/-
 
mmu-miR-708 1.00 0.78 0.64 0.20 
mmu-miR-138 1.00 0.98 0.48 0.36 
mmu-miR-2137 1.00 0.85 0.57 0.41 
mmu-miR-187 1.00 0.93 0.52 0.46 
mmu-miR-466h 1.00 1.02 1.43 0.49 
mmu-miR-1893 1.00 0.80 0.66 0.50 
mmu-miR-762 1.00 0.76 0.59 0.50 
mmu-miR-100 1.00 0.78 0.72 0.53 
mmu-miR-1224 1.00 0.62 0.61 0.54 
mmu-miR-1937a 1.00 0.92 0.79 0.56 
mmu-miR-139-3p 1.00 1.20 0.77 0.56 
mmu-miR-1894-3p 1.00 0.66 0.69 0.57 
mmu-miR-1937b 1.00 0.84 0.82 0.58 
mmu-miR-2133 1.00 0.99 0.63 0.60 
mmu-miR-151-3p 1.00 0.84 0.73 0.61 
mmu-miR-193b 1.00 1.10 0.66 0.62 
mmu-miR-1959 1.00 0.59 0.68 0.63 
mmu-miR-466f 1.00 1.20 1.12 0.66 
mmu-miR-455 1.00 0.97 0.94 0.67 











Day 2/ Untreated Day 14/ Untreated LTβ
-/- 
/ Untreated 
miR-100 miR-100 miR-100 
- miR-2137 miR-2137 
miR-762 - miR-762 
miR-2861 miR-2861 - 
miR-1894-3p miR-1894-3p miR-1894-3p 
- miR-138 miR-138 
- miR-187 miR-187 
miR-339-5p - - 
 
 
4.2.4. miRNA target prediction using web-based software 
 Fold-change in expression levels 
Exiqon Day 0 Day 2 Day14 LTb
-/-
 
mmu-miR-100 1.00 0.82 0.68 0.27 
mmu-miR-592* 1.00 0.66 0.56 0.29 
mmu-miR-2137 1.00 0.91 0.62 0.34 
mmu-miR-3102* 1.00 0.82 0.70 0.34 
mmu-miR-762 1.00 0.72 0.65 0.35 
mmu-miR-33 1.00 1.57 0.86 0.36 
mmu-miR-138 1.00 0.97 0.59 0.38 
mmu-miR-3090* 1.00 0.86 0.75 0.40 
mmu-miR-487b 1.00 1.10 1.12 0.41 
mmu-miR-2861 1.00 0.81 0.63 0.42 
mmu-miR-1894-3p 1.00 0.73 0.68 0.43 
mmu-miR-25* 1.00 0.69 0.65 0.44 
mmu-miR-32 1.00 1.18 0.93 0.46 
mmu-miR-187 1.00 0.83 0.54 0.47 
mmu-miR-99a 1.00 0.83 0.76 0.47 
mmu-miR-10b 1.00 0.78 0.77 0.47 
mmu-miR-101b 1.00 1.00 0.93 0.48 
mmu-miR-711 1.00 0.94 0.76 0.48 
mmu-miR-28 1.00 0.67 0.76 0.50 
mmu-miR-151-5p 1.00 0.78 0.76 0.51 
Table 4.2 Top 20 down-regulated miRNAs from Exiqon and Affymetrix microarray data. 
Exiqon and Affymetrix miRNA microarray were carried out on the same samples. Data 
were normalised to the untreated sample and fold-change from untreated calculated for 
the day2, day 14 and LTβ
-/-
 samples. The tables show the top 20 down regulated miRNAs in 
the LTβ
-/-
 samples compared to the untreated (Day 0) samples. Highlighted in red are those 
miRNAs that appear in this category in the data from both platforms. 
Table 4.3 miRNAs consistently down regulated with de-differentiation of FDCs. The 
miRNAs listed in the table are those that appeared in the top 20 down-regulated in both 
the Exiqon and Affymetrix at the noted time points. Highlighted in red are those that 
appeared down-regulated at all three time points and in blue those that were down-
regulated 14 days post LTβR-Ig treatment and in the LTβ
-/-




MiRNAs function as part of the RNA induced silencing complex (RISC) to post-
transcriptionally repress expression of their target genes. Identification of the genes 
targeted by miRNAs is central to understanding their biological roles. The diversity of 
targets that a single miRNA can have has made identification of miRNA targets 
problematic (Barbato et al., 2009; Liu et al., 2010; Kast, 2011). However, many 
computational algorithms and approaches have been developed to identify the likely 
target genes of either a single or group of miRNAs of interest. Several web-based 
packages that integrate a number of these algorithms to identify fewer, more likely 
miRNA target genes also exist (Liu et al., 2010; Tsang et al., 2010; Lu et al., 2012). We 
used one of the most recent of these, miRsystem (Lu et al., 2012), which also integrates 
function and pathway analyses. The eight miRNAs listed in Table 4.3 which are in the 
top 20 down regulated genes for both microarray platforms in LTβR-Ig treated and 
LTβ-/- spleen tissue were entered into miRsystem for target prediction. This analysis 
failed to come up with any predicted target genes for three of the miRNAs, miR-2861, 
miR-1894-3p and miR-2137. This is likely to be due to the fact that these are newly 
described miRNAs and the databases have not been updated to include them. Four 
target prediction algorithms were found that did supply target predictions for these 
newer miRNAs. The predicted targets for these miRNAs were therefore taken from 
DIANA micro-T (Maragkakis et al., 2009), miRNA.org (Betel et al., 2008), miRDB (Wang, 
2008) and RNA22 (Loher and Rigoutsos, 2012). If the programmes gave over 300 
predictions only the top 250 predictions were used. The lists of predicted gene targets 
were cross referenced and those genes that were predicted to be miRNA targets by 
three or more of the target prediction programmes were selected. Similarly for the 
miRNAs that miRSystem suggested genes that were predicted to be targeted by the 
same miRNA by three or more target prediction programmes were selected. These 




more of the miRNAs were predicted to target were selected. In this way a list of eight 
genes that are predicted to be targeted by three or more of the eight miRNAs, by three 
or more target prediction programmes was produced. These eight genes and the 
miRNAs they are predicted to be targeted by are set out in Table 4.4. Some of these 
genes could have roles in the biological functions affected by LTβR-Ig, particularly 
Gnai2 which has been described to be involved in the organisation of secondary 
lymphoid organs (Hwang et al., 2010). It has been described that target genes of 
miRNAs often change at the transcript level if the repression is strong (Ruike et al., 
2008; Guo et al., 2009). The expression of these eight genes was viewed over the de-
differentiation from the gene expression array data (Chapter 3, section 3.3.3). It was 
found that while the level of expression of six of the genes (including Gnai2) did not 
change at all, the expression of Arrdc3 was down by around 22% at day 2 after LTβR 
treatment but higher at day14 and in the LTβ-/- spleens. The expression of Dnmt3a was 
unchanged 2 days after LTβR-Ig treatment but was decreased by around 23% after 14 
days but was not significantly changed in the LTβ-/- spleens. As previously mentioned 
miRNA target prediction algorithms tend to make many false positive predictions, and 
because the mRNA levels of these genes were not changed it was decided to narrow-
down the miRNA selection rather than immediately follow up any of these genes. 
4.3.4. Confirmation of miRNA profiling by miRNA northern analysis and miRNA 
quantitative PCR. 
In order to validate the miRNA microarrays, miRNA northern analysis was carried out 
for some of the miRNAs that were seen to be down-regulated upon LTβR-Ig treatment 
and also in the LTβ-/- spleen tissue (Table 4.3). The five miRNAs selected to follow-up 
initially were miR-100-5p, miR-2137, miR-138-5p, miR-592* and miR-3102*. These 







Gene name miRNAs predicted to 
target the gene 
Arrdc3 arrestin domain containing 3 miR-138-5p, miR-187-3p, 
miR-339-5p 
Gnai2 guanine nucleotide binding protein (G protein), 
alpha inhibiting 2 
miR-138-5p, miR-339-5p, 
miR-762 
Lphn1 latrophilin 1 miR-138-5p, miR-339-5p, 
miR-762 
Pik3r1 phosphatidylinositol 3-kinase, regulatory subunit, 
polypeptide 1 (p85 alpha) 
miR-138-5p, miR-339-5p, 
miR-762 
Znrf1 zinc and ring finger 1 miR-138-5p, miR-339-5p, 
miR-762, miR-2137 
Dnmt3a DNA methyltransferase 3A miR-138-5p, miR-762, 
miR-2137 
Sox12 SRY-box containing gene 12 miR-138-5p, miR-762, 
miR-2137 





treatment/ transgenic groups compared to untreated controls. These miRNAs were 
also selected because they had higher expression levels in the untreated spleens as 
measured by both array platforms than other miRNAs with the same pattern of 
expression. The two star strand miRNAs, were only included in the Exiqon dataset, but 
were both measured to have relatively high expression levels in the untreated spleens. 
Figure 4.5 shows miRNA northern analysis for the three lead strand miRNAs that were 
down-regulated with FDC de-differentiation as measured by the microarrays. The 
miRNA northern analysis shows a general pattern of down regulation of the miRNAs in 
the LTβR-Ig treated and the LTβ-/- tissue. MiR-2137 was found to be at the limits of 
detection by northern analysis. This was unexpected because miR-2137 expression was 
approximately 6 times higher than miR-100-5p according to Exiqon array data, and 
around 10 times higher according to Affymetrix array data. These discrepancies could 
Table 4.4 Genes predicted to be targets of three or more miRNAs. Target prediction was 
carried out using at least four different target prediction programmes for the eight 
miRNAs that are listed in Table 4.3. The eight genes shown in the table were predicted by 





be due to a number of reasons related to both the array and the northern analysis. miR-
2137 has a very G/C rich (86%) sequence, meaning that it is more likely that the LNA 
probes directed against the miRNA will form secondary structures which could prevent 
efficient end labelling of the probe. The northern analysis (Figure 4.5) shows that the 
expression level of one of the miRNAs, miR-138-5p, drops between the day 2 and day 3 
time points and stays at this lower level of expression up to the final 28 day time point 
after LTβR-Ig treatment. This is a very similar pattern of expression as the FDC marker 
Mfge8 as assessed both by immunohistochemistry and qPCR (Figure 3.1 and 3.3). Two 
of the miRNAs miR-100-5p and miR-2137, show a decrease in expression following 
LTβR-Ig treatment, with an increase in expression at day 21 echoing the 
immunohistochemistry data for the FDC marker CD35 (Figure 3.1). It can be seen that, 
as measured by northern analysis, miR-2137 had a peak in expression level at day 10. A 
relatively small amount of CD35 expression was observed by IHC at day 10 (Figure 3.1), 
indicating that there is a biological difference in some of the day 10 sections. 
Additionally, this day 10 increase may be artificially exaggerated because miR-2137 
was found to be close to the limits of detection by northern analysis in the spleen 
tissue. 
Northern analysis was also carried out for the two star strand miRNAs, miR-592* and 
miR-3102*. However a signal from these miRNAs could not be detected. The expression 
of these star strand miRNAs in the spleen was therefore measured by quantitative PCR. 
The high Ct values obtained from the qPCR strongly suggest that these miRNAs are only 
expressed at very low levels in these spleen tissues contrary to what was suggested by 
the microarray results. However, miR-592* did have a pattern of down-regulation upon 
LTβR-Ig treatment and in the LTβ-/- spleen tissue as suggested by the microarray 





Figure 4.5 miRNA northern confirmation of miRNA microarray data. RNA samples that 
the microarrays were carried out on were used for miRNA northern analysis. Top panel 
shows a northern membrane probed for miR-2137 and bottom panel shows a 
membrane that was prepared in parallel and probed for miR-100 and miR-138. Bar 
graphs show the phosphoimager quantification of the signal from the northern 
membranes (blue line) along with the two sets of microarray data (red and green bars). 

























































4.3.5. Expression analysis of genes containing differentially represented miRNAs 
Three of the five miRNAs that were selected for further study were found to be located 
within the introns of protein coding genes. The two star strand miRNAs, miR-592* and 
miR-3102*, are located within the genes Grm8 and Arbgef17 respectively (Kozomara 
and Griffiths-Jones, 2011). Both miR-100-5p and miR-138-5p are located within 
intergenic regions of the genome (Kozomara and Griffiths-Jones, 2011). miR-2137 is 
located within intron1 of Zfp185 (Kozomara and Griffiths-Jones, 2011), a protein that 
associates directly with F-actin (Wang et al. 2008a) and has been shown to have roles 
in the development and activation of T lymphocytes (Wang et al. 2008b). ARHGEF17 is 
also implicated in actin cytoskeleton organisation (Rümenapp et al., 2002). To ascertain 
if these miRNAs were being transcribed as part of the gene that they are located within, 
gene expression microarray data for these genes was assessed. Both Grm8 and Zfp185 
had very low levels of expression, whereas Arhgef17 had relatively high levels of 
expression. All three genes were found to have stable levels of expression between the 
untreated, LTβR-Ig treated, and the LTβ-/-  samples, suggesting that the miRNAs, at least 





























































Figure 4.6 miRNA qPCR confirmation of microarray data. The same RNA samples that 
were used for miRNA microarray were used to carry out miScript reverse transcription 







Data in this chapter show that during Illumina small RNA sequencing the 5 nucleotide 
tag introduced at the 3’ end of the 5’ adaptor that was added to the RNA samples during 
library preparation unfortunately caused considerable sequencing bias. This 
sequencing bias was identified first of all through the variable expression of miR-142-
3p across the samples. Although miR-142-3p has been identified previously to be 
highly expressed in spleen tissue (Landgraf et al., 2007), this study found that by far the 
most abundant miRNA in murine spleen tissue was miR-143.  miR-143 was found to be 
the second overall most abundant miRNA in our sequencing data. However, miR-142-
3p was over 12 times more abundant than miR-143 in some samples but over 15 times 
less abundant in other samples. It was noticed that those samples in which miR-142-3p 
was very abundant either had tag 2 or tag 4 in the 5’ adaptor. A bias based on the tag 
was confirmed by principal component analysis. Due to these reasons, it was decided to 
analyse miRNA expression in a subset of the samples by miRNA microarray. 
Previous data show that there is a significant amount of variation in data obtained from 
different miRNA array platforms (Sato et al., 2009; Git et al., 2010). Here two different 
miRNA microarray platforms, Affymetrix and Exiqon, were used to analyse the same 
samples to attempt to reduce the frequency of false positives. There was a fairly large 
discrepancy between data obtained from the Affymetrix and Exiqon arrays. Looking at 
the 50 miRNAs that were decreased the most between the untreated samples and the 
samples collected 14 days after LTβR-Ig treatment, only 11 were identified by both 
platforms, and from the top 20 only 3 agreed between the platforms. When the two 
datasets were normalised using the same method, a small increase in agreement was 
seen. Again looking at the 50 miRNAs that were most decreased in the samples 




appeared in this list for both platforms and when looking at the top 20 miRNAs, 6 
appeared in the lists from both platforms. The fairly large differences seen between the 
two platforms were not unexpected because the two platforms use very different 
methods and probes. However, agreement that was observed between the two 
different methods gave a good basis for selection of miRNAs, with a much reduced 
chance of false positives.  
A list of 8 miRNAs which were in the top 20 most decreased miRNAs in at least two of 
the LTβR-Ig treated spleen samples or the transgenic samples when compared to the 
untreated samples was created. This list of miRNAs was used as input for 
computational target prediction using online software. Unfortunately, many of these 
data bases do not include some of the more newly discovered miRNA. Therefore, four 
databases that were found to have predictions for all of the 8 miRNAs were selected to 
be used for target prediction (DIANA micro-T (Maragkakis et al., 2009), miRNA.org 
(Betel et al., 2008), miRDB (Wang, 2008) and RNA22 (Loher and Rigoutsos, 2012)). 
Some of these databases included hundreds of predicted target genes for a single 
miRNA. This is because of the diversity that has been seen in miRNA:mRNA target 
pairings, specificity of the generated predicted targets is often sacrificed in order to 
gain a good sensitivity from the algorithm (Zhang and Verbeek, 2010; Witkos et al., 
2011). When hundreds of predictions are made, the algorithms often also rank the 
predictions so that the user can decide to increase the specificity as wanted. An 
arbitrary cut-off of 250 predictions was used for when there was more than this 
number of predictions for a single miRNA.  
Some studies show that miRNAs  that have similar expression patterns in a particular 
tissues or cell types can act in concert to regulate different genes of the same pathway 




2011), or even the same gene (Doench and Sharp, 2004; Lim et al., 2005; Saetrom et al., 
2007). For this reason, the target gene predictions for all 8 of the selected miRNAs were 
combined. Eight genes were found that were predicted to be targeted by three or more 
of the miRNAs, at least three of the four target prediction programmes. However, 
because none of these genes were either found to be closely related in terms of 
function, or have obvious roles in the typical functions of FDCs, it was decided to carry 
out some more validation of the miRNAs before following up potential gene targets (see 
chapter 5). 
To confirm the expression of the miRNAs in the untreated, treated and transgenic 
spleen tissue miRNA northern analysis was performed. The log ratios of the LTβR-Ig 
treated and transgenic samples compared to the untreated samples were generally 
seen to correspond very well for the samples looked at by both methods. For one of the 
miRNAs, miR-2137 the correspondence between the array and northern data was 
generally poorer. It was noted that this miRNA has a very high GC content (86%) which 
could cause an artificially high intensity values from the arrays if other small RNA with 
a high GC content binds to the probes for miR-2137. This could also potentially cause 
difficulties in labelling of the probe for miRNA northern analysis because secondary 
structures would be more likely to form because of the high GC content, which could 
prevent end labelling if there is not a free-end.  This, coupled with the fact that the 
signal from the northern analysis was close to the limits of detection for this miRNA 
could explain the discrepancies. 
A signal for miR-592* (miR-592-3p), or miR-3102* (miR-3102-5p) could not be 
obtained by northern analysis. qPCR was carried out for these two miRNAs because it is 
a more sensitive method than northern analysis. The Ct values obtained from the qPCR 




samples. These data are in agreement with Illumina sequencing data on B cells isolated 
from murine spleen (Yamane et al., 2011), where both these miRNAs were found to be 
expressed, but only at very low levels. 
The aim of this chapter was to identify miRNAs that were likely to be expressed by FDC 
and to be important for the development or function of FDC. Profiling of miRNAs was 
performed on spleen samples that had previously been identified by immunostaining to 
contain FDC at different stages of maturation following LTβR-Ig treatment. Due to 
technical difficulties, data from Illumina small RNA sequencing could not be used for 
these purposes. However, miRNA microarray analysis was successfully used to identify 
miRNAs that had a pattern of down-regulation similar to that seen by 
immunohistochemistry for FDC (Figure 3.1). The expression pattern of some of these 
miRNAs in the spleen samples were confirmed by miRNA northern analysis. In the 
following chapters functional studies for some of these miRNAs will be carried out to 
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Chapter 5: Characterisation of an in vitro murine FDC model 
5.1. Introduction 
Isolation of FDC in a fully mature and functional state is problematic (Sukumar et al., 
2006; Myers et al., 2013) and isolation of sufficient numbers of FDC to carry out 
functional studies of miRNA will be challenging. The primary aim of this chapter is to 
assess the suitability of a murine FDC cell line, termed FL-Y and FL-YB, that has 
previously been established(Nishikawa et al., 2006; Magari et al., 2011).  
FL-Y cells are a rapidly growing clone selected from a cell line that was established 
using 3D culture of lymph nodes from immunised mice (Nishikawa et al., 2006). FL-Y 
cells were found to retain many phenotypic features of FDC, including expression of 
Mfge8, Ltβr, Vcam-1, FcγRII/III, Cd21, and Baff. However the authors found the 
expression levels of BAFF in the original cell line to be significantly higher than in the 
FL-Y cell line. The authors therefore created the FL-YB cell line which has levels of 
BAFF expression similar to the original cell line. FL-YB cells were generated by 
retroviral transfer of the murine Baff gene into FL-Y cells followed by selection of a 
clone stably expressing BAFF (Magari et al., 2011). The FL-YB cell line was found to 
have superior ability to support B cells compared to the FL-Y cell line. 
In this chapter the xCELLigence system (Ke et al., 2011) is used to phenotypically 
compare the FL-YB cells under different conditions. Once the FL-YB cell phenotype has 
been characterised under different conditions, these phenotypes can then be used as a 
measureable output for loss and gain of function experiments for the selected miRNAs. 
The xCELLigence system is based on real-time cell electronic sensing (RT-CES) 
technology (Solly et al., 2004) developed by ACEA Biosciences and Roche Applied 
Science (Ke et al., 2011). Micro-electrodes in the bottom of a specially designed 96-well 




when cells are adhered to the electrodes on the bottom of the well. This means that 
when more cells are adhered, the impedance is higher which the RTCA software 
translates into a higher cell index value. The impedance is also higher if the cells are 
more spread-out or are adhered with greater strength to the plate. This means that the 
cell index provides an indication of cell proliferation, cell spreading, adherence and 
morphological changes. 
A number of different stimuli are used in this chapter to measure the response of FL-YB 
cells. FL-YB cells are usually grown in the presence of recombinant murine TNFα at a 
concentration of 5ng/ml. The group who established the cell line also sometimes 
culture in the presence of an agonistic LTβR MAb which causes signalling through the 
receptor, which was reported to increase proliferation of the FL-Y cell line (Nishikawa 
et al., 2006). It is possible that the identified miRNAs would be involved in this 
signalling pathway, because they were identified by the in vivo blockade of this 
pathway. IL-4 was one of the cytokines added in the initial cultures when the original 
cell line was being isolated (Nishikawa et al., 2006). IL-4 is produced mainly by Th2 
cells and stimulates isotype switching to IgE by activated B-cells (Coffman et al., 1986). 
It also plays a role in the selection and expansion of memory B cells during the GC 
reaction. Pre-treatment of human FDC-like cells, HK, with IL-4 can  repress 
cycloxygenase2 (COX2) which abrogates prostaglandin production by the cells (Lee et 
al., 2008; Cho et al., 2013, 2011a). Lipopolysaccharide (LPS) has also been used as a 
treatment to stimulate FL-YB cells in some experiments in this chapter. The LPS 
receptor TLR4 has been shown to be expressed on murine FDCs in vivo, and LPS 
treatment in vivo confers an activated FDC phenotype  (El Shikh et al., 2007b). The 
production of IL-6 has been reported to be induced in immune complex-activated FDCs, 
which both promotes GC reactions, IgG responses and somatic hypermutation (Wu et 




LTα1β2 treatment (Husson et al., 2000) and FL-Y cells have been shown to express IL-6 
and up-regulate the transcript upon TNFα stimulation (Nishikawa et al., 2006). The 
intergrin VCAM-1 is expressed on the surface of FDCs and is important for the 
formation of synapses between FDCs and B cells, which are important for B cell 
activation (Kosco et al., 1992; Maeda et al., 1995). Again VCAM-1 has been shown to be 
up-regulated in immune complex-activated FDCs (El Shikh et al., 2006). Cultured 
human FDC-like cells have also been described to up-regulate VCAM-1 upon TNFα, 
LTα1β2 and IL-4 stimulation (Husson et al., 2000). IL-15 is secreted by FDC in vivo and 
in the HK cell line, it has been shown to enhance germinal centre B cell proliferation 
(Park et al., 2004). IL-15 has also been shown to enhance the proliferation of and 
chemokine secretion from FDC (Gil et al., 2010).  
5.2. Aims 
The main aim of this chapter was to assess whether FL-YB cells would be a suitable in 
vitro model for functional analysis of the miRNAs identified in Chapter 4. It was first 
established that all three miRNAs that were confirmed to be expressed in spleen 
samples in chapter 4 were expressed at detectable levels in FL-YB cells. Further 
characterisation studies of the FL-YB cells confirmed that they highly expressed many 
typical markers of FDC, and responded to TNFα stimulation. Treatment of the cells with 
different stimuli and real-time monitoring of the cells using the xCELLigence system 
allowed measurement of the cellular response to these stimuli. Quantitative real-time 
PCR analysis revealed some gene transcript changes in FL-YB cells upon treatment with 
different stimuli. These parameters will be used in chapter 6 to determine whether any 







5.3.1. Expression of miRNAs by FL-YB cells 
To assess if FL-YB cells were an appropriate model to carry out functional analysis of 
the selected miRNAs, it was first important to know whether the cells expressed the 
selected miRNAs. To this end miRNA northern analysis was carried out using RNA 
extracted from FL-YB cells. Following 4 days of culture without TNFα supplementation 
FL-YB cells were plated out in complete media supplemented with 5ng/ml recombinant 
murine TNFα. RNA was isolated from the cells 48, 72, and 96 hours later. 3μg of the 
extracted RNA was used for miRNA northern analysis. The miRNA northern 
membranes were probed with radiolabelled anti-sense LNA oligonucleotides to miR-
100-5p, miR-138-5p, and miR-2137. All three of these miRNAs were found to be 
expressed by the FL-YB cells under these conditions (Figure 5.1). These data imply that 
the decrease in expression of those miRNA in vivo following LTβR-blockade may be due 
to loss of mature FDC. These data also suggest that FL-YB cells are a useful model to 
study the function of these miRNAs in a FDC-like cell.  
5.3.2. Expression of typical FDC related genes by FL-YB cells 
Next, the expression of characteristic FDC related genes by FL-YB cells was 
characterised by quantitative real-time PCR (qPCR). For comparison the expression 
levels of the same transcripts were also measured in Raw264.7 cells, which are a virus 
transformed murine macrophage cell line (Raschke et al., 1978). Raw 264.7 cells were 
chosen for comparison here because many of the functions of FDCs are immunological 
so it was logical to compare the gene expression levels of FL-YB to another immune cell 
type. One of the most typical markers of FDCs, MFGE8, has also been described to be 















FL-YB and Raw 264.7 cells were grown in 6-well plates in the appropriate complete 
media (see materials and methods section 2.11). The cells were harvested 48 hours 
later and RNA extracted. After purification 5ug of RNA was used to synthesise cDNA. 
This cDNA was used in qPCR assays with primers designed to amplify Mfge8, Prnp, 
Vcam-1 and Ltβr (Figure 5.2)which are all typical markers of FDCs (Kranich et al., 2008; 
Brown et al., 1999; van Dinther-Janssen et al., 1991; Murphy et al., 1998). MFGE8 is 
secreted by FDCs and opsonises apoptotic cells for engulfment by macrophages 
(Kranich et al., 2008). The prion protein, PrPc (encoded by Prnp), has an unknown 
function but it has been shown that expression of PrPc by FDCs is obligatory in FDC for 
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Figure 5.1 Expression of miRNAs identified from in vivo analysis by FL-YB cells. 
FL-YB cells were cultured for 4 days without TNFα before being harvested and 
plated out in a 6-well plate with 5ng/ml of TNFα. Cells were harvested 48, 72, or 
96 hours later for RNA. 3μg of the resulting RNA was used for miRNA northern 
analysis. LNA/DNA probes against the full length miRNAs were radiolabelled 








Vascular cell adhesion molecule 1 (encoded by Vcam-1) is an adhesion molecule 
expressed on the surface of FDC that is bound by the VLA-4 intergrin on B-cells, 
preventing the apoptosis of the B-cells (Koopman et al., 1994). LTβR signalling as 
previously described is needed for maintenance of mature FDC networks. The 
expression levels of these four typical mature FDC markers were as expected shown by 
t-test to be significantly higher in FL-YB cells when compared to Raw 264.7 cells 
(Figure 5.2). In the case of Vcam-1, expression was undetectable in the Raw264.7 cells. 
These data show that FL-YB express abundant levels of typical FDC-related genes 
Mfge8, Prnp, Vcam-1 and LTβR. 
5.3.3. The effect of different activation stimuli on gene expression 
To assess the effect of different stimuli on FL-YB cells the expression levels of genes 






































Figure 5.2 Expression of typical FDC markers in FL-YB and Raw264.7 cells. Quantitative 
real-time PCR was carried out on cDNA created from RNA extracted from FL-YB and 
Raw264.7 cells. Light grey bars = FL-YB cells, Dark grey bars = Raw264.7 cells. Ct values 
were normalised against HPRT levels in the same samples and are displayed relative to 
the normalised Ct value for Mfge8 in one of the four independent experiments carried 
out. P values were calculated by independent student’s t-tests. The transcripts were 
seen to be expressed at statistically significantly higher levels in FL-YB cells compared to 














carried out in 6-well tissue culture plates. Individual wells were either not 
supplemented, or supplemented with 5ng/ml TNFα, both 5ng/ml TNFα and 5ng/ml IL-
4, or both 5ng/ml TNFα and 2.5μg/ml anti-LTβR. Cells were cultured with these 
treatments for 96 hours before being harvested for RNA. 2μg of RNA was used to create 
15ul of cDNA for qPCR analysis. Each treatment was carried out twice independently of 
the other. This meant that statistical analysis was not possible however the results 
from the two independent experiments were seen to correlate well indicating a 
biological trend with each treatment.  
IL-6 has been described to be produced by  immune complex activated FDCs (Wu et al., 
2009) and plays a role in IgG responses and somatic hypermutation (SHM). In line with 
previous findings in FL-Y cells (Nishikawa et al., 2006), the level of expression of the 
ll-6 transcript was seen to be enhanced ~3-fold  in the FL-YB cells by TNFα treatment 
(Figure 5.3a).  The addition of IL-4 to FL-YB cells cultured in the presence of TNFα 
further increases the expression of Il-6, whereas addition of agonistic LTβR MAb causes 
no enhancement of Il-6 expression. 
IL-15 is another cytokine that is produced by FDC and acts to up-regulate proliferation 
of germinal centre B cells (Park et al., 2004). It also acts in a positive feedback loop to 
enhance both proliferation and chemokine secretion of FDC (Gil et al., 2010). TNFα 
treatment of FL-YB cells caused no change in the expression level of Il-15 however the 
addition of IL-4 caused a moderate increase in expression of Il-15 (Figure 5.3b). 
Additional LTβR signalling had no substantial effect on Il-15 expression levels.  
The integrin VCAM-1 has been described to be up-regulated on FDCs upon germinal 
centre formation (Balogh et al., 2002) and immune complex-mediated activation (Wu 




upon treatment of cells with TNFα and further up-regulated upon additional treatment 
of the cells with agonistic antibody to LTβR (Figure 5.3c). 
Cyclooxygenase 2 (encoded by Ptgs2) is an enzyme that converts arachidonic acid to 
PGH2 which is then converted into prostaglandis or prostacyclin, a process which has 
been described in human FDCs (Lee et al., 2007, 2008; Cho et al., 2011a). Prostacyclin is 
involved in various roles including control of T cell numbers (Lee et al., 2005) and 
enhancement of B cell antigen presenting capability (Kim et al., 2012a). Here, the 
expression of Ptgs transcripts (1 and 2) were assessed by qPCR and it was found that 
expression increases two-fold in FL-YB cells treated with TNFα compared to cells given 
no supplements. Again it was also seen that the addition of IL-4 to the cultures further 
increases the expression levels of Cox transcript (Figure 5.3d). Expression levels of the 
prostacyclin receptor (PtgiR) in FL-YB cells were seen to increase (> 2-fold) in cultures 
treated with TNFα. Once more the addition of IL-4 to the cultures was seen to further 
enhance PtgiR expression levels, while LTβR signalling had no further effect (Figure 
5.3e). 
Toll-like receptor 4 (TLR4), the receptor for the endotoxin lipopolysaccharide, has been 
described to be expressed by FDCs in vivo(El Shikh et al., 2007b; Garin et al., 2010; 
Milićević et al., 2011) and TLR4 signalling has been shown to up-regulate various 
markers of FDC activation (El Shikh et al., 2007b). Here, it was found that although 
there was no substantial increase in Tlr4 transcription by FL-YB cells treated with 
TNFα, the addition of IL-4 to the cultures increased Tlr4 transcription ~3-fold. The 
addition of TNFα and LTβR MAb had no further effect on Tlr4 levels compared to TNFα 
alone (Figure 5.3f). Overall this data suggests that culture of FL-YB cells in the presence 
of TNFα increases the expression of several genes that are related to FDC activation. 






































Figure 5.3 The effect of various external stimuli on the expression level of typical FDC 
transcripts in FL-YB cells. FL-YB cells were grown in 6-well plates in complete media 
alone, or supplemented with TNFα at 5ng/ml, TNFα and IL-4 both at 5ng/ml, or TNFα at 
5ng/ml and agonistic anti-LTβR at 2.5μg/ml. Cells were cultured under these conditions 
for 96 hours before being harvested for RNA. cDNA was synthesised from 2μg RNA, and 
qPCR was carried out on the cDNA using primers specific for the indicated transcripts. 
Bars indicate the mean of three technical replicates in each of the two experiments 
shown. Once Ct values were normalised to the housekeeping gene beta-actin, the levels 
of each transcript are shown relative to the level of the transcript in TNFα treated cells 









































































































































































Figure 5.4 The growth and morphology profiles of FL-YB cells measured by the 
xCELLigence system. Cells were grown with or without TNFα supplementation in a 
96-well E-plate and monitored using the xCELLigence system.  The addition of TNF to 
FL-YB cell cultures was seen to facilitate a sustained higher cell index measurement. 
This indicates greater growth, survival, adhesion or spreading of the cells in the 
presence of TNFα. The lines indicate the mean of 8 replicates on the same plate with 
standard deviation indicated. 
expression levels, suggesting further activation of the FL-YB cells. Additional signalling 
through the LTβR caused more subtle effects on most of the genes examined, perhaps 
because there is some redundancy between TNFR1 and LTβR signalling. 
5.3.4. Growth and morphological characteristics of FL-YB cells 
Next, normal growth and morphology characteristics of the FL-YB cell line were 
investigated under steady-state conditions. To gain real time measurement of FL-YB 
cell growth and morphology, the Roche xCELLigence system was used. FL-YB cells were 
plated out into a 96-well xCELLigence E-plate at a density of 4,000 cells/well. Cells 
were grown in complete media and half the wells were supplemented with 5ng/ml 
TNFα. Cells were analysed for approx. 8 d. Figure 5.4 shows the cell index plot from this 
experiment. It can be seen that the cell index measurement is enhanced with the 
addition of TNFα to the FL-YB cell cultures, indicating that TNFα enhances FL-YB cell 





















































































To assess whether the effect of TNFα treatment is a general effect which would occur 
with other stromal cell types, the xCELLigence profiles of FL-YB cells were compared to 
those of NIH 3T3 cells, an embryonic fibroblast cell line (Todaro and Green, 1963). Cells 
were plated out into a 96-well xCELLigence E-plate at a density of 4,000 cells/well. The 
wells for the NIH 3T3 cells were coated with fibronectin (section 2.11) as in its absence 
a very low cell index was observed. Cells were grown in the recommended media and 
parallel wells for each cell type were supplemented with 5ng/ml TNFα.  Figure 5.5 
shows the cell index plot from this experiment. Unlike in FL-YB cells (Figure 5.5a), the 
3T3 cells do not respond with a positive increase in cell index measurement when 
supplemented with TNFα (Figure 5.5b). Further, when supplemented with TNFα, the 
FL-YB cells reach a much higher cell index than the 3T3 cells (Figure 3.4a). The higher 
cell index value seen with the FL-YB cells in response to TNFα is likely to be due to 
these cells being a larger, more adherent cell type than 3T3s. Overall, these data 
indicate that the FL-YB cells are responding in a positive manner to TNFα as expected 
for FDCs. Furthermore, this response was specific to the FL-YB cells suggesting they are 







































































































































































Figure 5.5 Comparison of the growth and morphology of FL-YB cells and NIH3T3 
cells. Cells were grown with (top graph) or without (bottom graph) TNFα 
supplementation in a 96-well E-plate and monitored using the xCELLigence system.  
FL-YB cells are seen to have a much higher cell index compared to 3T3 cells, indicating 
a larger/ more adherent cell type. The addition of TNF to 3T3 cell cultures resulted in a 
lower cell index with an earlier decrease which is the opposite effect to that seen on 
the FL-YB cells. This indicates that FL-YB cells thrive in the presence of TNF, but that 
this is not a general effect of TNF on all cell types. Lines shown indicate the mean of 4 







5.3.5. Response of FL-YB cells to different activation stimuli 
The obvious response of the FL-YB cells to TNFα treatment seen from the cell index 
measurement opened up the possibility of being able to use this as a way to measure 
cell response to other treatments that have previously been described to affect FDCs. 
Experiments were set up as before (section 5.2.4). Cells were grown in complete media, 
supplemented with 5ng/ml TNF, 2.5μg/ml agonistic LTβR MAb, 5ng/ml TNFα and 
2.5μg/ml LTβR MAb, 5ng/ml TNF and 5ng/ml IL-4 or 5ng/ml TNF and 100ng/ml LPS 
(8 replicate wells with each treatment). The experiment was repeated three times, the 
curves in Figure 5.6 represent the mean and standard error of these three experiments. 
The cell index measurements from the differentially treated FL-YB cells reveals that the 
agonistic anti-LTβR in these experiments does not have the same sustaining effect on 
the cell index measurement as TNFα treatment does (Figure 5.6a). Furthermore, cells 
treated with both TNFα and anti-LTβR do not show the same sustained cell index 
profile that cells treated with TNFα alone, indicating that although the TNFα and anti-
LTβR both ultimately result in NFκB activation, the different modulation of this through 
the two receptors also affects the ultimate cellular response.  
LPS has been shown to enhance accessory activity of FDCs in vivo (El Shikh et al., 
2007b). TNFα and LPS have also been described to similarly up-regulate the expression 
of prostaglandins by HK cells in vitro whereas IL-4 abrogates this up-regulation of 
prostaglandins (Lee et al., 2008). LPS treatment (Figure 5.6b) does not afford any 
further effect on the cell index measurement when the cells are treated with TNFα and 
LPS than when treated with TNFα alone.  
The IL-4 treatment has a dramatic effect upon the cell index measurement at later 
stages of monitoring. As seen in Figure 5.5c after approx. 90 hours of culture a sharp 




treated with TNFα alone. IL-4 has previously been described to enhance the 
proliferation of the human FDC-like cell line HK (Lee et al., 2003a). It is not clear from 
this experiment if this dramatic decrease in cell index is due to cell death, or change in 










































































































































































































































Figure 5.6 The response of FL-YB cells to various external stimuli. FL-YB cells 
were grown in a 96-well E-plate and monitored on the xCELLigence system. Cells 
were treated as indicated and any difference in cell index measurement from the 
normal growth conditions (5ng/ml TNFα) was noted. Curves represent the mean 
of three independent experiments (each with 6 replicates) with error bars 







5.3.6. The effect of IL-4 treatment on FL-YB cells 
To investigate the possibility of the sudden decrease in cell index seen in the FL-YB 
cells treated with IL-4 being due to cell death or decreased proliferation,  the cell 
viability was measured using the CyQUANT® direct cell proliferation assay (Life 
Technologies). FL-YB cells were either grown in complete media with no supplements, 
with 5ng/ml TNFα, with 5ng/ml of IL-4, or with both TNFα and IL-4. Measurements 
were taken every 24 hours for 6 days. Each treatment was performed in quadruplicate 
for each time point. Figure 5.7 shows the average fluorescent reading from three 
independent experiments. A two-factor analysis of variance indicated that there is no 
difference in the fluorescent intensity (and therefore live cell number) between any of 
the treatments at the respective time points. This reveals that the sudden drop in cell 
index value seen at later time points in the TNF and IL-4 treated cells was not due to 


















































Figure 5.7 Measurement of live cell numbers after treatment of FL-YB cells with TNF 
and/ or IL-4. Cells were grown in 96-well plates under the indicated conditions before a 
cyQUANT cell proliferation assay was carried out. No statistical significance was found by 
paired student’s t-test in the measured fluorescent intensity between any of the 
treatment groups at 72, 96 or 120 hours. A drop in cell index is generally seen between 60 
and 80 hours in the TNF and IL-4 treated group as measured on the xCELLigence system. 




To investigate whether this effect of IL-4 is cell density dependent, cells at two different 
densities were monitored by the xCELLigence system. Figure 5.8 shows that the effect 
that IL-4 confers on cell index value at later stages is cell density dependent, with cells 






Similar experiments were conducted to look into the effect of different doses of IL-4. 
Figure 5.9a clearly shows that the effect of IL-4 treatment on FL-YB cells is dose-
dependent. Figure 5.9b shows that the maximal effective dose is between 20 and 
40ng/ml. Figure 5.9c shows that the addition of IL-4 to FL-YB cells that were grown 
without TNFα has no substantial effect on the cell index measurement. This indicates 
that TNFα creates a phenotype in the FL-YB cells that IL-4 changes. 
8000 TNF + IL-4
























































































Figure 5.8 The effect of cell density during IL-4 treatment of FL-YB cells. Cells were plated 
at either 4,000 or 8,000 cells per well and treated with 5ng/ml TNFα and IL-4. Cells were 
monitored over 7 days. Cells plated at a lower density (purple curve) underwent the 
sudden drop in cell index at a later time point than the cells plated at a higher density (red 
curve) indicating that this effect is cell density –dependent. Lines indicate the mean of 8 
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Figure 5.9 FL-YB cells respond in a dose dependent manner to IL-4 treatment and the 
response is TNFα-dependent. Cells were grown in 96-well E-plates and monitored using 
the xCELLigence system. Increasing doses of IL-4 caused a correspondingly sharper 
decrease in the cell index measurement from around 60-65 hours (a). The maximal 
effect of IL-4 is seen between 20 and 40ng/ml (b). The response to IL-4 is dependent on 
TNFα (c). Lines represent the mean of 8 replicates from the same plate, with standard 







Live cell imaging was carried out to try and see if there were any changes in cell 
morphology that could explain the drop in cell index seen. Cells were plated out at high 
density, one well was supplemented with 5ng/ml TNFα and the other with 5ng/ml 
TNFα and IL-4. Images were taken at the same point of both wells every 5min, 10 min 
or 30 min, in a series of movies captured over a period of 5 days. No obvious difference 
in morphology was seen between the cells with the two different treatments. Images 
taken from 74.5 hours to 92.5 hours suggest that the cells treated with TNFα and IL-4 
do not have such a flat morphology compared to those treated with TNFα only. Cells 



















TNF TNFα + IL-4 
Figure 5.10 The effect of IL-4 on FL-YB cell morphology. A slightly flatter 
morphology of cells treated with TNFα only was observed. Additionally a slightly 
more granular appearance was apparent for cells treated with TNFα and IL-4 





In this chapter it was shown that the miRNAs selected for further study were expressed 
at easily detectable levels in the FL-YB cells. These miRNAs were identified from the in 
vivo model of FDC de-differentiation and confirmation of their expression in FL-YB cells 
indicated that the model successfully identified miRNAs that were expressed in FDCs. 
The observations that FL-YB cells expressed typical markers of FDC, including Mfge8, 
Prnp and Vcam-1, at considerably higher levels than Raw 264.7 cells , and the 
xCELLigence data that showed a positive response of the FL-YB cells, but not NIH-3T3 
cells, to TNFα indicated that the FL-YB cells were a good in vitro model for FDCs.  
Gene enrichment analysis on genes predicted to be targeted by at least one of the three 
miRNAs, revealed enrichment for genes involved in cell migration, locomotion, 
regulation of proliferation and cell to cell communication. For this reason it was 
decided to use the Roche xCELLigence system in loss- and gain-of-function of miRNA 
experiments. By measuring electrical impedance caused by cellular attachment to 
electrodes on the bottom of the wells of a specialised tissue culture plate, the system 
gives a measure of the cell number, size, any changes in morphology and adherence of 
cells. xCELLigence measurements under normal conditions were first characterised 
and then the response to some further activation stimuli was also assessed using the 
system. These measurement will provide a basis for miRNA gain- and loss-of-function 
studies. 
An obvious signalling/ activation pathway that the miRNAs would be likely to play a 
role in is LTβR signalling, as they were identified in vivo following blockade of this 
pathway. Supplementing the cells with 2.5μg/ml of an agonistic LTβR MAb (as used in 
(Magari et al., 2011)) resulted in a slightly lower cell index value at later time points 




previously reported that TNFα and LTβR signalling synergistically increased FL-YB cell 
proliferation (Nishikawa et al., 2006). However because the xCELLigence cell index 
value is a measurement of a combination of different growth characteristics, the 
slightly lower cell index values seen with LTβR signalling could well indicate that the 
proliferation of LTβR MAb treated cells is enhanced, but this means that they will 
generally be slightly smaller and more rounded up with decreased adhesion to the 
plate. As the xCELLigence system is combining all these things in one measurement it 
could be that the cell index value is actually lower for cells that are proliferating more 
quickly. 
LPS treatment did not alter the cell index value of FL-YB cells, LPS has previously been 
described to increase number and size of FDC in vivo (Milićević et al., 2011). This was in 
an in vivo situation and it is likely that the increase in number of mature FDC described 
could be due to maturation of immature cells, rather than proliferation of the existing 
cells. 
IL-4 treatment had the most dramatic effect on cell index values, at later time points a 
significant decrease in cell index value was seen. It was found that this decrease in cell 
index was cell density dependent as when plated at higher densities the decrease 
occurred at an earlier time point. The effect was also IL-4 dose-dependent with a more 
pronounced decrease seen at higher doses of IL-4. IL-4 did not affect the cell index 
when the cells were not also treated with TNFα indicating that TNFα induces changes 
in the cells that are disturbed by IL-4. Cell proliferation assays revealed that the 
decrease in cell index was not due to a decrease in proliforation. This phenotype only 
occurred once cells were confluent making it difficult to assess cell morphology. Live 
cell imaging did suggest that TNFα and IL-4 treated cells were more granular and had a 




cell imaging was only performed once for one field of view, it is not possible to tell if 
this really is an effect of IL-4 treatment.  
In order to look at the response to these activation stimuli at a molecular level, 
quantitative PCR was performed for a number of gene transcripts that have previously 
been reported to change in activated FDCs. Treatment of FL-YB cells with TNFα caused 
up-regulation of IL-6, PtgiR and Cox (Ptgs2). IL-6 is known to be important in regulation 
IgG responses (Deng et al., 2002) as it induces T-cells to produce cytokines such as IL-4 
and IFN-γ which then induces isotype switching to IgG (Wu et al., 2009). Both PTGIR 
and PTGS are involved in the prostaglandin system, PTGIR is the receptor for 
prostacyclin while, cyclooxygenases (Ptgs1/2) are involved in the synthesis of 
prostaglandins. Prostaglandins can have wide ranging effects depending on the 
cytokine milieu. They can promote both survival and apoptosis of germinal centre B 
cells depending on other signals received by the B cells. 
Addition of TNFα and IL-4 to cultures caused further up-regulation of Il-6, Tlr4, PtgiR, 
Cox and Il-15. IL-6 and IL-15 have previously been described to be up-regulated in 
immune complex activated FDC (Wu et al., 2009; Gil et al., 2010) and in HK cells treated 
with TNFα and LTα1β2 (Husson et al., 2000). The up-regulation of both of these 
cytokines in TNFα and IL-4 treated cells suggests that IL-4 is activating the FL-YB cells. 
In agreement with this is the up-regulation of Cox, PtgiR and Tlr4 with TNFα and IL-4 
treatment of FL-YB cells. The up-regulation of Tlr4 following IL-4 stimulation is an 
interesting result because IL-4 decreases the expression of TLR4 on macrophages and 
PBMCs but it has been found that IL-4 causes up-regulation of TLR4 on B cells (Mita et 
al., 2002; Ganley-Leal et al., 2010). As FDCs are so closely associated with B cells it 
could be that the increase of TLR4 that is promoted by IL-4 has a role in the humoral 




that indicate activation could also be a reason why cells treated with TNFα and IL-4 
appeared more granular. 
Only Vcam-1 showed any increase in expression in FL-YB cells cultured with TNFα and 
agonistic LTβR MAb compared to cells cultured with TNFα alone. The cell adhesion 
molecule VCAM-1 is important for FDC-B cell synapse formation and prevention of GC-
B cell apoptosis (Koopman et al., 1994)  and up-regulation of VCAM-1 is often used as a 
marker of FDC activation (Balogh et al., 2002; El Shikh et al., 2007b). 
The data in this chapter has shown that the FL-YB cell line will be a good model for 
functional analysis of the miRNAs identified from the in vivo model.  FL-YB cells express 
miRNAs of interest at easily detectable levels, they also express many typical markers 
of FDC and respond positively to TNFα stimulation. Gene expression analysis has 
indicated that they are activated by TNFα, and further activated by the addition of 
recombinant IL-4. The phenotype induced in the FL-YB cells by TNFα is modified by 
IL-4 once the cells reach confluence. The FL-YB cells will be used in the next chapter for 
functional analysis of the selected miRNAs, using the phenotypes characterised in this 
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Chapter 6: Identifying the potential role of selected microRNAs in follicular dendritic cell 
biology 
6.1. Introduction 
One method widely used for functional analysis of miRNAs is the analysis of a biological 
system after loss-of-function of the miRNA(s) of interest, and conversely after 
overexpression of the miRNA(s) of interest (Martinez-Sanchez and Murphy, 2013).  
The nature of loss and gain of function studies means that phenotypic studies can be 
carried out to determine what biological processes the miRNA(s) of interest might be 
involved in (Wang et al., 2008b; Elia et al., 2009; Akhtar et al., 2010). In chapter 5 a 
number of cellular phenotype signatures for the FL-YB cells were established using the 
xCELLigence system as a measure of these (section 5.2.5). In this chapter any deviation 
from these signature phenotypes will be assessed following knock down or 
overexpression of the miRNAs identified to be expressed in the FL-YB cell line (section 
5.2.1).  The aim was to give a broad indication of the types of cellular processes that the 
miRNAs may help regulate. 
More specific analyses after gain-or loss-of-function studies involve analysis of effects 
on gene and protein expression levels. The targeting of a gene transcript by miRNA(s) 
may also cause changes in expression level of the transcript (Lim et al., 2005; Valencia-
Sanchez et al., 2006). This means the expression level of mRNA after miRNA 
knockdown or overexpression can often reveal miRNA regulated genes. Often the gene 
targets identified in this manner are relatively strongly suppressed by the miRNA of 
interest (Baek et al., 2008; Selbach et al., 2008). Analysis of the transcriptome is often 







Using FL-YB cells as an in vitro model, the aim of this chapter was to identify the 
potential roles that the miRNAs identified in previous chapters have in FDC biology. To 
achieve this both miRNA loss- and gain-of-function studies were undertaken. The cell 
proliferation, morphology and adhesion were measured in cells with loss or 
overexpression of specific miRNAs using real-time cell analysis. The transcript levels of 


















6.2.1. Assessment of cytotoxicity of different transfection reagents on FL-YB 
cells 
First, experiments were undertaken to determine how the FL-YB cells would respond 
to treatment with transfection reagents. The xCELLigence system was used to assess 
the effect of three different transfection reagents on the FL-YB cells; lipofectamine 
2000, lipofectamine LTX and Fugene HD. FL-YB cells were plated out in a 96-well 
xCELLigence plate at a density of 4,000 cells/well. The cell index was measured 
overnight as the cells were left to adhere. Four replicate wells were then treated with 
either an anti-miR-294 LNA, or a transfection mix of Lipofectamine 2000 and the anti-
miR-294 LNA, Lipofectamine LTX and the anti-miR-294 LNA or Fugene HD and the 
anti-miR-294 LNA. An anti-miR-294 LNA was used as this miRNA was not found to be 
expressed in the spleen samples. The cell index values were once again measured, after 
four hours before the transfection media was replaced with complete media 
supplemented with 5ng/ml TNFα. The plate was then monitored for another five days 
to assess any potential toxic effects of the transfection reagents on the cells. An uneven 
loss of cells was seen to occur during the two media replacements before and after the 
transfection. The cell index values were therefore normalised to the first cell index 
measurement after replacement of the transfection media. Figure 6.1 shows that there 
is no substantial difference in the cell index curves between any of the transfection 
reagents or the cells treated only with the LNA. These data suggest there is little toxic 
effect of any of the transfection reagents on the FL-YB cells. For all subsequent 










6.2.2. Assessment of the efficiency of miRNA knock down and over expression 
in FL-YB cells 
To assess the efficiency of knock down and overexpression of the miRNAs, northern 
analyses were carried out on RNA collected from FL-YB cells that had been transfected 
with LNAs directed against miR-100-5p, miR-138-5p and miR-2137, or miRNA mimics 
for miR-100-5p and miR-2137. Cells were transfected for four hours before dilution of 
the transfection reagents with complete media and incubation for a further 24 hours. 
RNA was then harvested from the cells and 2μg used for miRNA northern analysis. 
Images of autoradiography films exposed to hybridised membranes and 
phosphoimager quantification data are shown in Figure 6.2. All miRNAs were found to 
be decreased by at least 80% when the specific anti-sense LNA was transfected. In 
contrast, the miRNA mimics caused at least a 5-fold increase in the amount of the 































































































Figure 6.1 Transfection reagents are well tolerated by FL-YB cells. FL-YB cells were 
plated out at 4,000 cells per well in a 96-well xCELLigence plate after 24 hours the cells 
were transfected in quadruplicate with an anti-miR-294 LNA using the transfection 
reagents indicated for four hours before replacement of the media with complete media. 
The cells were monitored on the xCELLigence system for another five days. It can be seen 
that there was very little difference in the cell index curves indicating minimal 
cytotoxicity from any of the transfection reagents. Lines indicate the mean of 8 replicates 








Figure 6.2 miRNAs are efficiently and specifically knocked down or overexpressed in 
FL-YB cells using anti-sense LNA oligonucleotides and miRNA mimics. Cells were 
transfected with either anti-sense LNA oligonucleotides for the miRNAs indicated to 
knockdown the miRNAs or double stranded RNA mimics to overexpress the indicated 
miRNAs. Cells were harvested 24 hours following transfection and 2ug of RNA from each 
sample was run on the gel for northern analysis. The LNAs caused efficient and specific 
knockdown of all the miRNAs whereas the mimics caused at least a 5-fold increase in the 
amount of mature miRNA detected. The graph represents phosphorimager quantitation 
of the miR-100-5p knock down and over expression, normalised to the lipofectamine 
control, indicating a 5-fold decrease in miR-100 upon following transfection of a specific 
LNA and a 7-fold increase in miR-100 following transfection of a specific mimic. No 





6.2.3. The effect of miRNA knockdown or overexpression on cell viability 
 After miRNA knockdown or overexpression in FL-YB cells, live cell numbers were 
assessed to determine whether the specific LNAs or mimics adversely affected cell 
proliferation or viability. FL-YB cells were plated out at 4,000 cells per well in a 96-well 
tissue culture plate and incubated at 37°C for 18 hours. The media was then replaced 
with transfection media: 100μl optiMEM with 15ρmol anti-sense LNA, or 2ρmol miRNA 
mimic and 1μl of lipofectamine 2000. Cells were incubated at 37°C for four hours 
before the transfection media was replaced with complete media. Live cell numbers 
were estimated using the Invitrogen CyQuant direct cell proliferation assay 
immediately or after 18 or 24 hours further incubation.  This data is represented in 
Figure 6.3. Student’s independent t-tests showed that only cells treated with miR-100 
mimics or miR-2137 inhibitors had significantly different levels of fluorescence at the 
24 hour time point (p=0.0001 and p=0.017 respectively). Overall, these data indicate 
that in general, transfection with LNA oligos or miRNA mimics is well tolerated by 
FL-YB cells. These results also indicate that miR-100-5p and miR-2137 may have an 
effect on cell viability and/or proliferation; further experiments were used to examine 












6.2.4. miRNA target prediction using web based algorithms  
The three miRNAs that were selected for their pattern of decreased expression levels 
following the loss or absence of FDCs in LTβR-Ig treated or LTβΔ/Δ mice (miR-100-5p, 
miR-2137 and miR-138-5p) were all found to be expressed in FL-YB cells (Figure 5.1). 
Furthermore, it was shown that expression levels of these miRNAs could be 
successfully manipulated in FL-YB cells (Figure6.2). For these reasons, these three 
miRNAs were selected to carry out functional analysis using the FL-YB cells as a model 
system. To gain a more focused prediction of targets for just these three miRNAs, the 














































Figure 6.3 Knock-down or overexpression of miRNAs causes no significant change in 
cell proliferation or death. FL-YB cells were transfected with miRNA mimics or 
inhibitors as indicated. CyQuant direct cell proliferation assay was performed in 
quadruplicate for each treatment immediately following transfection and at 18 hours 
and 24 hours following transfection. The measured fluorescent intensity was 
normalised to that at the 0h time point for each transfection. The bars represent the 
mean of the four replicates with error bars indicating standard deviation. Student’s 
independent t-test showed that miR-100-5p overexpression (P=0.0001) and miR-2137 
knockdown (p=0.017) showed statistically significant difference from the lipofectamine 




three miRNAs was re-analysed. Those genes that were predicted to be targeted by one 
of the miRNAs by at least two of the four algorithms used were listed. This list of 319 
genes was used as input for the gene enrichment software ToppFun (Chen et al., 2009). 
This analysis revealed that the top 20 biological processes that the genes were enriched 
for could be grouped into seven categories according to biological function 1) 
Chromatin functions, 2) Response to oxygen, 3) Axon and synapse regulation, 4) Cell 
motility, 5) Cell communication and signalling, and 7) protein modification (see table 
6.1, genes in appendix C). As these three miRNAs showed a very similar pattern of 
expression in response to LTβR-Ig treatment and in the LTβΔ/Δ mice, it is plausible that 
they target the same pathways or the same genes.  These gene lists were therefore 
cross referenced with each other to find any genes that were predicted to be targeted 
by more than one of these miRNAs. Five genes that were predicted to be targeted by 
two of the three miRNAs were found, and are set out in table 6.2. Four of the five genes 
in table 6.2 were either not expressed or expressed at very low levels in the gene 
expression array data from the untreated, LTβR-Ig treated and LTβΔ/Δ spleens (Ace, 
Nox4, Rara, Shroom1). One of the genes found not to be expressed was retinoic acid 
receptor alpha (Rara). This gene has previously been reported to be expressed in 
enriched populations of lymph node (LN) and Peyer’s patch (PP) FDC (Suzuki et al., 
2010). However, because of the lack of expression of this gene in any of the spleen 
samples, miRNA targeting of this gene in this system was unlikely. One, Obfc2a was 
expressed at moderate levels, the gene encodes for a protein that is a nucleic acid 
binding protein that forms part of a complex involved in DNA repair at the G2/M phase 
checkpoint (Richard et al., 2008). This is therefore unlikely to be something that is 
involved in FDC specific functions. It was therefore decided to try some broader 
functional studies using the Roche xCELLigence system. As mentioned many of the 




changes in either of these should result is a different cell index profile when monitored 
on the xCELLigence system. It was therefore decided to carry out overexpression and 
knock down studies for the miRNAs in FL-YB cells and to monitor the cells using the 
xCELLigence system. 
Go: Biological process P-value Hit Total 
chromatin modification 3.06E-06 24 435 
response to decreased oxygen levels 6.71E-06 17 252 
response to oxygen levels 1.43E-05 17 267 
axon guidance 1.89E-05 20 360 
regulation of synapse organization 2.36E-05 7 46 
chromatin organization 3.01E-05 25 532 
locomotion 5.02E-05 44 1253 
regulation of synapse structure and activity 5.36E-05 7 52 
positive regulation of cell communication 8.29E-05 33 854 
regulation of cell proliferation 1.39E-04 41 1189 
histone methylation 1.51E-04 7 61 
cell migration 1.62E-04 32 847 
chromosome organization 1.71E-04 28 701 
protein alkylation 1.77E-04 8 83 
protein methylation 1.77E-04 8 83 
axonogenesis 1.89E-04 23 527 
positive regulation of intrinsic apoptotic signaling pathway 1.94E-04 4 16 
regulation of mitochondrial membrane permeability 1.94E-04 4 16 
positive regulation of protein oligomerization 1.94E-04 4 16 





Table 6.1 The top 20 biological processes which genes predicted to be targeted by 
miR-100-5p, miR-138-5p or miR-2137 are most highly enriched for as analysed by the 
ToppFun software. The processes fit into seven main catagories 1) Chromatin functions, 
2) Response to oxygen, 3) Axon and synapse regulation, 4) Cell motility, 5) Cell 




mmu-miR-100-5p mmu-miR-138-5p mmu-miR-2137 
  Ace (angiotensin I 
converting enzyme) 
Ace (angiotensin I 
converting enzyme) 
Nox4 (NADPH oxidase 4)   Nox4 (NADPH oxidase 4) 
Obfc2a (nucleic acid binding 
protein 1) 
Obfc2a (nucleic acid binding 
protein 1) 
  
  Rara (retinoic acid receptor, 
alpha) 
Rara (retinoic acid receptor, 
alpha) 
Shroom1 (shroom family 
member 1) 





6.2.5. The selected miRNAs do not have any significant effect on growth, 
morphology or adhesion of FL-YB cells 
CyQuant assays had previously indicated that miR-100-5p and miR-2137 may have an 
effect on cell viability and/or proliferation (Figure 6.3). It was therefore decided to 
monitor cell behaviour following knock down and overexpression of these miRNAs in 
FL-YB cells using the xCELLigence system. Since disproportionate cell loss occurred 
when the transfection media was changed it was decided to perform the transfections 
in 6-well plates and then subsequently transfer the transfected cells into the 96-well 
xCELLigence E-plates for monitoring. 8,000 FL-YB cells/well were plated into an 
xCELLigence E-view plate and grown in complete media in the presence of 5ng/ml 
TNFα. Cells were monitored over a five day period. Figure 6.4 shows the resulting cell 
index curves, from one representative experiment of four (at least 6 replicate wells in 
each experiment). The cell index values for each condition were normalised to the 
lipofectamine control and the mean value across the four experiments was taken for 
Table 6.2 Genes predicted to be targeted by two of the miRNAs confirmed to be 
expressed in FL-YB cells. Four target prediction programmes were used to predict gene 
targets for miR-100-5p, miR-138-5p and miR-2137. Listed are five genes that are predicted 




each condition at time intervals of 6 hours. A two-way analysis of variance indicated no 
difference between any of the conditions over the four experiments (p=0.76). 
Although the curves and cell index values were seen to be slightly different in each 
separate experiment, the values within each single experiment were very similar. This 
variation most likely reflects slight differences in the state of the cells at the time of 
analysis and small differences in the composition of the media used.      





6.2.6. The effect of miRNA knockdown and overexpression in FL-YB cells treated 
with IL-4 
It has recently been proposed that the majority of miRNAs confer robustness of 
biological networks (Ebert and Sharp, 2012). This makes the identification of miRNAs 
Figure 6.4 The effect on miRNA knock-down or over expression in FL-YB cells. 
Cells were transfected either with miRNA inhibitors or miRNA mimics, 
transfection media was diluted out after four hours of transfection. Cells were 
rested overnight before being plated out  in complete media with 5ng/ml TNFα at 
a density of 8,000 cells per well in a xCELLigence 96-well E-view plate, which was 
placed on the xCELLigence system with a measurement taken every 30 minutes 
for approximately five days. This experiment was repeated 4 times with at least 6 
technical replicates for every condition in every experiment. 2-factor ANOVA 
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under steady state conditions difficult and many researchers have found that the role of 
miRNAs only become  
apparent when the biological system of study is put under stress (Kagias et al., 2012; 
Sánchez-Jiménez et al., 2013). Although it is not clear what phenotype IL-4 is conferring 
upon the FL-YB cells, a dramatic and reproducible signature that was consistently 
observed (Figure 5.6). For this reason the knockdown and overexpression experiments 
were repeated using cells treated with both TNFα and IL-4 after transfection. Data from 
one representative experiment of four are shown in Figure 6.5. The data for the four 
experiments was analysed at 6 hour time intervals by two-factor ANOVA as before but 






Figure 6.5 The effect of miRNA knock-down or over expression on the IL-4 
treatment phenotype in FL-YB cells. Cells were transfected either with miRNA 
inhibitors or miRNA mimics, transfection media was diluted out after four 
hours of transfection. Cells were rested overnight before being plated out at a 
density of 8,000 cells per well in a xCELLigence 96-well E-view plate, with 
5ng/ml of recombinant TNFα and IL-4. Measurements were taken every 30 
minutes for approximately five days. This experiment was repeated 4 times 
with at least 6 technical replicates for every condition in every experiment. 2-
factor ANOVA revealed no statistical significant differences between the any of 















































































6.2.7. Assessment of the effect of miRNA knockdown and overexpression on 
gene expression in FL-YB cells. 
The effect of miRNA knock down or overexpression on gene expression in FL-YB cells 
was compared. Transient transfections of miRNA inhibitors or mimics were carried out 
as described previously (section 6.2.5). Following the four hour transfection, the media 
was changed to complete media with 5ng/ml TNFα and the cells were incubated at 
37°C for a further 24 hours. The expression levels of Cyclooxygenases 1 and 2 
(Ptgs1/2), toll-like receptor 4 (Tlr4), interleukin-6 (Il-6) and prostacyclin receptor 
(PtgiR) were compared by qPCR. Over three experiments it was found that there was a 
significant increase in the levels of Tlr4, Ptgs1/2, and Il-6 transcripts in the cells that 
had miR-100-5p knocked down (Figure 6.6). For all three of these transcripts the 
knockdown of miR-100-5p resulted in statistically significantly higher expression levels 
compared to those cells where miR-2137 expression was knocked down. Tlr4 p=0.05, 
Ptgs1/2 p=0.04, Il-6 p=0.01. The Il-6 transcript also showed an increase in expression in 
the cells in which miR-138-5p was knocked down however this was not statistically 
significant (p=0.26). Despite PtgiR being predicted to be a miR-100-5p target by three 
of the four target prediction programmes used (DIANA micro-T, microRNA.org and 
RNA22)(section6.2.4) no statistically signififcant differences were seen in any of the 



































Figure 6.6 Knockdown of miR-100-5p causes increased expression of Tlr4, Ptgs1/2 
and Il-6. RNA extracted from FL-YB cells were transfected with miRNA inhibitors or 
mimics was used to synthesise cDNA for qPCR analysis. Gene transcripts known to be 
important to normal FDC function were measured by qPCR analysis following 
transfection and a subsequent 24 h incubation in complete media supplemented with 
5µg/ml TNFα. Transcripts were normalised to the housekeeping transcript β-actin, 
and are shown relative to the levels seen in non-transfected, lipofectamine treated 
control cells. Student’s independent t-test revealed that miR-100 knockdown causes 
an increase in expression of Tlr4 (p=0.05), Ptgs1/2 (p=0.04), and Il-6 (p=0.01) 
transcripts compared to miR-2137 knockdown. There were no statistically significant 
changes in PtgiR expression with any miRNA knockdown or overexpression. The data 
































































































Data presented in this Chapter show that miR-100-5p appears to exert some level of 
control over pro-inflammatory gene expression in FL-YB cells. The genes that have 
been identified to be affected are all down-stream genes of the NFκB pathway 
(Libermann and Baltimore, 1990; Schmedtje et al., 1997; Yan, 2006). The LTβR signals 
through both the canonical and non-canonical NFκB pathways (Dejardin et al., 2002). 
Since LTβR blockade was the method used to identify miR-100-5p in vivo it is plausible 
that miR-100-5p targets genes in the LTβR/NFκB signalling pathway.  
Prostacyclin receptor was included in the study because three of the four target 
prediction algorithms used predicted this gene to be a target of miR-100-5p. No effect 
of either miR-100-5p knockdown or overexpression was seen on the expression levels 
of PtgiR in the FL-YB cells. It could be however that PTGIR is affected at the protein 
level, or as previously mentioned target prediction algorithms have been found to give 
many false positive results (Barbato et al., 2009; Zheng et al., 2013), of which PtgiR 
could be one. 
It has been found that FDC are the main cell type in the germinal centre (GC) that 
produce IL-6 (Kopf et al., 1998) and that IL-6 production is up-regulated by immune 
complex activated FDC (Wu et al., 2009). IL-6 is known to be important in terminal 
differentiation of B cells (Morse et al., 1997; Kopf et al., 1994) and SHM (Wu et al., 2009; 
Yan et al., 2012). This indicates that miR-100-5p potentially plays an important role in 
control of the germinal centre response by regulation of IL-6 production by FDC. 
IL-6 is also implicated in a number of autoimmune diseases including rheumatoid 
arthritis (RA)(Nawata et al., 1989) and systemic lupus erythematosus (SLE) (Ripley et 




treatment of  RA (Smolen et al., 2013) and for Castleman’s disease in Japan (Nishimoto 
et al., 2008). 
 TLR4 is the receptor for lipopolysaccharide (LPS) and signalling through the receptor 
results in NFκB activation (Pålsson-McDermott and O’Neill, 2004). Recently it has been 
discovered that FDC express TLR4 (El Shikh et al., 2007b) and that LPS causes FDC 
activation conferring an up-regulation of adhesion molecules and Fc receptors. It was 
later discovered that immunisation with a non-TLR4 agonist causes a similar co-
ordinated up-regulation of TLR4, VCAM-1, ICAM-1 and Fc receptors indicating that  
TLR4 is generally up-regulated upon activation (Garin et al., 2010). Oxidised 
phospholipids which are generated during apoptosis can also act as ligands for TLR4 
and it has been shown that these are present in germinal centres and are engaged by 
TLR4 on FDC showing that external pathogens are not needed to directly signal 
through TLR4 to drive activation of FDC (Garin et al., 2010). The same study also 
showed that TLR4 signalling by FDC is needed for high affinity Ig responses and SHM, 
indicating a critical role for TLR4 on FDC which impacts germinal centre reactions and 
the humoral immune response in vivo (Garin et al. 2010; N. M. Milićević et al. 2011; El 
Shikh et al. 2007). 
Cyclooxygenase 2 (encoded by Ptgs2) converts arachidonic acid to prostaglandin H2 
(PGH2) which can then be converted into different prostaglandins and prostacyclin. It 
has been shown that in the human FDC cell line, HK, that PTGS2 is responsible for the 
production of PGE2 and PGI2 by not prostacyclin (Cho et al., 2011a; Lee et al., 2007). It 
has recently be shown that prostaglandins produced by FDC promotes germinal centre 
B cell survival (Kim et al., 2013). It is well established in both macrophages and 
epithelium that LPS signalling through TLR4 results in up-regulation of PTGS2  (Fukata 




It is therefore clear that the genes that have been found to increase upon miR-100-5p 
knockdown in FDC all have key roles in the modulation of germinal centre responses by 
FDC, indicating miR-100-5p to have a critical role in control of FDC activity. 
Even though knock-down of miR-100-5p caused an increase in Il-6, Tlr4 and Ptgs1/2 
transcripts, overexpression of the same miRNA had no effect on the level of these 
transcripts. The levels of miR-100-5p appear to be relatively high in FL-YB cells based 
on the signal that was obtained from northern analysis. This along with the robust 
levels of knockdown needed to see the effect on the transcripts suggests that the miR-
100-5p is already in excess of what is functionally active in terms of regulation of this 
system. It would therefore not be expected that addition of more miR-100-5p would 
have any biological effect on this system. It should also be noted that overexpression 
indicated by northern analysis does not necessarily correspond to functional miRNA 
activity, as the miRNA may be free rather than interacting with miRNA machinery. A 
possible method of measuring functionality of the miRNA would be to look at 
expression levels of known targets. This was not carried out here because miRNA 
targeting has often shown to be cell specific and thus known targets of miR-100 in 
other cell types may not be targets of miR-100 in FDC. This meant that several known 
targets would have to be screened which would have been difficult due to time 
constraints. 
High levels of miR-100-5p in mature FDC and the down-regulation of pro-inflammatory 
genes by miR-100-5p could indicate that miR-100-5p acts as a mechanism for 
suppression of the FDC-driven immune reaction. This would be important for 
resolution of the immune response following clearance of the pathogen or trigger. This 
would mean that miR-100-5p plays an important role in avoidance of an inappropriate 




Alternatively, miR-100-5p may be at relatively high levels in FDC to “fine-tune” the 
expression of pro-inflammatory genes. Again, this could be important to prevent FDC 
from driving inappropriate levels of immune responses. This could also explain why the 
levels of miR-100-5p are high in the mature FDC as these will be activated by trapped 
immune complex, whereas de-differentiating FDC would not be activated. Activated 
FDC would need higher levels of miR-100-5p to regulate pro-inflammatory genes 
because the expression levels of the pro-inflammatory genes would be higher.  
Overall, the data presented in this chapter show that miR-100-5p plays a role in 
regulation of genes that are key in the regulation of GC response by FDC. The genes that 
have found to be regulated by miR-100-5p in FDC, TLR4, IL-6 and Ptgs2 are all induced 
by NFκB. miR-100-5p was identified in vivo following LTβR blockade, because LTβR 
signalling activates both canonical and non-canonical NFκB it is plausible that miR-100-
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 Chapter 7: General Discussion 
7.1. Introduction 
Follicular dendritic cells (FDCs) are key elements of secondary lymphoid organs where 
they form the stromal component of B-cell follicles (Guettier et al., 1986). FDCs possess 
extensive dendritic process that trap immune complexes which they then display to B-
cells to stimulate the production of high affinity antibodies (Radoux et al., 1984; Tew et 
al., 1990; Kosco and Gray, 1992; Fütterer et al., 1998; Wang et al., 2000). FDC also 
produce Mfge8 which is important for efficient clearance of low affinity B cells which 
have undergone apoptosis (Kranich et al., 2008). FDCs have been implicated in various 
disease processes, including prion diseases (Mabbott et al., 1998; Mcculloch et al., 
2011), HIV latency (Sprenger et al., 1995; Burton et al., 2002), and autoimmune 
diseases (Luzina et al., 2001; Vinuesa et al., 2009; Yau et al., 2013). The identity of the 
FDC precursor cell type has been a source of considerable debate, although evidence 
was recently put forward that indicates that they arise from perivascular precursors 
(Krautler et al., 2012). It is well established that lymphotoxin, produced by LTi cells and 
B-cells, is required for FDC differentiation and mature function (Alimzhanov et al., 
1997; Gonzalez et al., 1998; Mackay and Browning, 1998; Mabbott et al., 2003). These 
processes can ordinarily be regulated at a variety of different transcriptional and post-
transcriptional levels.  
The specific aim of this current study was to define the role that miRNAs play in the 
development and function of FDCs. MiRNAs are short non-coding RNAs that post-
transcriptionally control expression of a wide variety of genes by binding to mRNA, 
blocking translation into protein (Lagos-Quintana et al., 2003; Ambros, 2004). 
Identifying the miRNAs and target transcripts involved in FDC development and 
function will aid in understanding the pathways and mechanisms that are under tight 




7.2. Characterising the  effect of in vivo LTβR-Ig treatment on the murine spleen 
7.2.1. Immunostaining for markers of FDC function 
We wished to use an in vivo model of FDC de-differentiation to identify miRNAs 
associated with the development and function of FDCs. Previous studies have shown 
that a single in vivo injection with LTβR-Ig causes rapid, temporary de-differentiation of 
FDCs (Mackay and Browning, 1998; Mabbott et al., 2000). This approach was used in 
the present study (section 3.2.1) and spleens were collected from treated mice at 
various time points following LTβR-Ig treatment. Sections from each individual spleen 
were analysed by immunohistochemistry for the presence of the FDC markers, CD35 
and MFGE8, to determine the exact timing of FDC de-differentiation. No MFGE8 staining 
was seen in any of the spleens by 3 days following LTβR-Ig treatment, whereas CD35 
staining was seen in some of the day 3 spleens, but by day 5 no CD35 staining was 
detected in the spleens. Correspondingly, CD35 staining was observed to return from 
21 days after treatment but no MFGE8 staining was seen to return, even by d 28. This 
indicates that CD35 is retained for longer than MFGE8 in the de-differentiating FDC, 
and is expressed before MFGE8 in the re-differentiating FDC. As FDC precursors have 
been described to express MFGE8 (Krautler et al., 2012), data presented here suggest 
that following LTβR-Ig treatment, FDC are not completely lost and replaced by new 
precursor cells but rather de-differentiate to a less functional state. Previous 
observations using electron microscopy after TNFR signalling-blockade, which has a 
similar effect on FDC status to LTβR-blockade, shows that immuature FDC are still 
present but their dendrites have regressed (Mabbott et al., 2002). This suggests that 
following LTβR-Ig treatment, FDC de-differentiate to a minimally functional state. As 
MFGE8 is a secreted factor involved in clearance of apoptotic B cells it is possible that 
MFGE8 production is restricted to fully mature FDC, as it will only be required during a 




of maturation as it is required for initial immune complex capture before a germinal 
centre reaction (Fang et al., 1998). 
7.2.2. The effect of LTβR-Ig on FDC-associated gene expression in the spleen 
To identify gene expression changes resulting from LTβR-Ig treatment, RNA from (a) 
untreated spleens with full FDC networks, (b) spleens collected 2 days after LTβR-Ig 
treatment with partially de-differentiated FDC, (c) spleens collected 14 days after 
LTβR-Ig treatment with fully de-differentiated FDC, and (d) spleens from LTβ-/- mice 
which never develop mature FDC, was used in a gene expression microarray analysis 
experiment. This approach enabled the identification of genes that were either up-
regulated or down-regulated as a result of FDC de-differentiation (Table 3.2). These 
data were compared with data from an independent study previously carried out using 
mesenteric lymph node (mLN)  tissue (Huber et al., 2005). In the Huber et al. study, 
gene expression was assessed by microarray from mLN tissue 1, 2, 3, 27 and 35 days 
after LTβR-Ig treatment. In general, known FDC genes down-regulated in the mLN 
study correlated very well with the genes that were found to be decreased as a result of 
LTβR-Ig treatment in the spleen samples analysed here. Exceptions include 
glycosylation-dependent cell adhesion molecule 1 (Glycam-1), which, like MFGE8, has 
also been shown to be responsive to prolactin. In the present study Glycam-1 
expression was unchanged in the LTβR-Ig treated spleen (section 3.2.3) while the 
Huber study found it to be greatly down-regulated in the LTβR-Ig treated mesenteric 
lymph nodes (Huber et al., 2005). The same study also identified transcripts that were 
highly expressed in FDC enriched samples compared to FDC-depleted samples. The list 
of genes that were found to be down-regulated in LTβR-Ig treated and LTβ-/- spleens 
(section 3.2.4) correlated better with the FDC enriched genes from the Huber study 




One possible reason for this could be the less severe effect that loss of LTβR signalling 
in LTβ-/- mice has on mesenteric and cervical lymph nodes, as these tissues develop in 
LTβ-/- mice whereas other lymph nodes and Peyer’s patches do not (Koni et al., 1997). 
The authors also found no disruption of B cell location in mLN from LTβ-/- mice, 
whereas extensive disruption of B cells localisation was seen in the LTβR-Ig treated 
spleens (section 3.2.1) suggesting a more severe effect on splenic white pulp than on 
mesenteric lymph nodes. 
It has recently been proposed that FDC arise from perivascular precursors that express 
platelet derived growth factor receptor, beta polypeptide (PDGFRβ) (Krautler et al., 
2012). As these pericyte precursors differentiate into FDC they lose the pericyte-
associated genes PDGFRβ and chondroitin sulfate proteoglycan 4 (CSPG4). Because of 
these findings, the expression of Pdgfrβ and Cspg4 in the spleens collected following 
LTβR-Ig treatment were analysed. Pdgfrβ was seen to be highly expressed in the spleen 
samples but no real change was seen in the expression levels in the LTβR-Ig treated 
spleens, or the expression levels of Cspg4. This is in agreement with the hypothesis that 
LTβR-Ig treatment causes ‘de-activation’ of FDC rather than complete loss followed by 
replacement from precursors. 
It was seen in the spleens collected from two of the four mice 21 days following 
LTβR-Ig treatment that expression levels of FDC-associated genes were considerably 
higher than in the spleens collected 19 or 24 days following LTβR-Ig treatment (Figure 
3.3). A portion of the same spleens were analysed for FDC markers by IHC, and it was 
seen that two of the four spleens from this time point showed both CD35 and MFGE8 
immunostaining. This indicates that the spleens from these two mice contained mature 





7.2.3. The effect of LTβR-Ig treatment on lymphocyte and macrophage gene 
expression  
Although LTβ-/- mice do not develop peripheral lymph nodes,  they do develop 
mesenteric and cervical lymph nodes (Ngo et al., 1999). In our study the localisation of 
B cells was severely disrupted and this correlates with a decrease in expression of 
Cxcl13.  The Huber study found no evidence of differential localisation of B cells in the 
mLN despite gene expression data showing a strong down regulation of chemokines 
including Cxcl13 and Ccl19. The difference in B cell localisation between the present 
study and the Huber study may be accounted for by the fact that no time points 
between 3 days and 27 days after LTβR blockade was studied by Huber et al. (2005), 
which was when the largest disruption in the microarchitecture was evident in the 
spleen (Figure 3.2). Only limited disruption was evident at earlier time points. Data 
from the gene expression microarray data (section 3.2.3) showed that expression levels 
for general markers of B and T cells such as B220 (encoded by Ptprc) and CD3 were 
unchanged in the LTβR-Ig treated or LTβ-/- spleens (Figure 3.4). This suggests that 
LTβR signalling does not affect overall cell number in the short term but is necessary 
for localisation of B cells (Figure 3.2).  
Other cell types in the spleen could have been directly or in-directly affected by the 
LTβR blockade. For example expression levels of the lysozyme genes, Lyz1 and Lyz2, 
were found to be lower in the LTβR-Ig treated and LTβR-/- spleens compared to 
untreated spleens. This indicates a possible decrease in macrophage activity or 
numbers. The Huber study also identified a decrease in expression of lysozyme after 
LTβR-Ig treatment (Huber et al., 2005). It is possible that the reduction in Mfge8 that is 
seen causes a decrease in macrophage phagocytic activity and decreases the 




Overall, genes identified in the present study as showing decreased expression levels in 
LTβR-Ig treated and LTβ-/- spleens correlated well with those previously described to 
be highly expressed by mature FDC. This indicated that LTβR-Ig treatment was an 
effective method to identify FDC-associated genes and was likely to be a useful 
approach to identify FDC-associated miRNAs. 
7.3. Identification of LTβR-signalling dependent miRNAs in the spleen  
Illumina deep sequencing was first used to identify FDC-associated miRNAs in the 
spleen tissue collected from LTβR-Ig, LTβ-/- and untreated mice (chapter 4).  Total RNA 
was extracted from selected spleens, checked for sufficient quality and pooled (see 
section 2.6).  Multiplexed libraries were generated using adaptors designed by, and 
sourced directly from, the sequence service provider. It transpired that the use of this 
particular adaptor design resulted in severe sequencing bias. Around the same time 
that the sequencing bias was discovered (section 4.2.1) two independent studies were 
published describing bias caused by the same method. The first study (Alon et al., 
2011) found that introduction of a barcode sequence at the adapter ligation stage 
caused bias which they suggested to be bias in ligation of the modified adapters to the 
small RNAs (Alon et al., 2011). This study put forward an alternative barcoding method 
which introduced the 5 nucleotide sequence during the PCR amplification step which 
dramatically reduced bias. The  second study (Van Nieuwerburgh et al., 2011) 
suggested that the bias was introduced during the PCR amplification step and 
developed a method to ligate the barcode sequences to the small RNA libraries after 
this step. 
At this point it was decided to carry out identification of miRNAs by miRNA microarray. 
Intra-platform microarray variability has previously been described (Sato et al., 2009; 




array platforms, Exiqon and Affymetrix were used. 16 miRNA were identified from the 
Exiqon data as having an expression level of 50% or less in LTβ-/- spleens compared to 
untreated spleens and also a decreased expression level in the day 14 LTβR-Ig treated 
spleens. By the same criteria, 6 miRNA were identified as decreased in the Affymetrix 
data set. 7 miRNA from the Exiqon data were identified to have increased expression 
levels by at least 50% in the LTβ-/- spleens and also to have increased expression levels 
in the day 14 spleens. Again by the same criteria the 10 miRNAs were identified as 
decreased from the Affymetrix data. MiRNAs were chosen for further study on the basis 
of decreased expression levels in both the LTβR-Ig treated and LTβ-/- spleens. Three 
miRNAs (miR-100-5p, miR-2137 and miR-138-5p) were chosen because of decreased 
expression levels in the LTβR-Ig treated and LTβ-/- spleens on both platforms. The 
expression levels of these miRNA were analysed by northern analysis of RNA from 
spleens from untreated, LTβR-Ig treated and LTβ-/- mice. This analysis confirmed the 
changes in expression levels associated with de-differentiation of FDC. The expression 
of two star strand miRNAs that were identified to have decreased expression levels in 
treated and transgenic spleen compared to untreated spleen from the Exiqon data 
alone were also analysed by miRNA northern analysis. The expression of these star 
strand miRNA could not be confirmed by miRNA northern analysis. MiRNA qPCR 
suggested that these sequences were present only at very low expression levels and 
unchanged as a result of treatment (section 4.2.4). This supports the contention that 
the use of two different platforms can help avoid selection of false positive results, from 
systemic noise, for further study.  
Results from Chapter 4 show that while the levels of the majority of splenic miRNAs 
were not affected, a small number of miRNAs were differentially expressed following 
LTβR-Ig treatment. The effects on differentially expressed miRNAs were more 




collected 2 days after treatment correlating well with loss of FDC function. In contrast 
to the effects of LTβR-Ig treatment, a larger number of miRNAs were differentially 
expressed between the spleens of LTβ-/- transgenic and wild-type mice. This suggests 
that the permanent lack of mature FDC in the LTβ-/- mice may have had impacts on 
other cell types such as B cells and tingible body macrophages.  Because the use of 
LTβR-Ig only temporarily de-differentiated FDC it means that other cell types were only 
minimally affected. The use of LTβR-Ig treatment therefore allowed the selection of 
genes and miRNAs that are more likely to be FDC-associated. The gene expression 
array data showed that some of the transcripts that are most affected are from FDC-
associated genes, this suggests that FDC-associated miRNAs would also be some of the 
most affected. The finding that the three miRNAs that were selected for further study 
were all found to be expressed in FL-YB cells supports this contention. Given similar 
probe labelling efficiencies, northern analysis suggested that miR-100-5p was the most 
highly expressed of the three miRNAs examined in FL-YB cells.  
Although no data on miRNA expression by FDCs has been published to-date, two 
studies have been published describing changes in the expression level of miRNAs in B 
cell lymphoma cell lines when co-cultured with FDC. One of these studies examined the 
mechanism of terminal differentiation of B cells (Lin et al., 2011). Terminal 
differentiation of B cells into plasma cells or memory B cells is driven by suppression of 
the transcription factor Bcl-6 and the expression of the transcription factor Prdm1 
(Crotty et al., 2010; Shaffer et al., 2002). Lin et al. (2010) found that expression of the 
miR-30 family is up-regulated and expression of let-7a and miR-9 are down-regulated 
in human B cell lymphoma cells when co-cultured with a human FDC cell line. Targeting 
of Bcl6 by the miR-30a family and targeting of Prdm1 by let-7a and miR-9 was found to 
play a role in the terminal differentiation of B cells. These miRNA and genes were found 




expression of miR-30 family members were seen in the LTβ-/- mice but these changes 
were inconsistent between family members. This indicates that terminal differentiation 
of B cells is not hugely effected in the LTβR-Ig treated or LTβ-/- mice, which is consistent 
with reports that IgM and sometimes IgG responses are largely normal in LTβ-/- mice 
(Alimzhanov et al., 1997; Junt et al., 2006). 
The second study had also identified differentially expressed miRNA in B cell after co-
culture with the FDC cell line HK. In this study FDC co-culture was found to induce the 
expression of miR-181a which targeted the pro-apoptotic protein, BCL-2-interacting 
mediator of cell death (BIM) thus reducing apoptosis of the B cells (Lwin et al., 2010).  
In our analysis it was found that the expression levels of BIM (BCL2L11) were 
unchanged in the LTβR-Ig treated and the LTβ-/- mice. It was also seen that the LTβR-Ig 
treatment did not have any effect on the level of miR-181a expression in the spleen. 
This suggests that there is little change in the occurrence of BIM-mediated apoptosis in 
either LTβ-/- mice or LTβR-Ig treated mice. 
7.4. Characterisation of a murine FDC cell line 
Following the identification of miRNAs and confirmation of their expression in the 
spleen, it was necessary to perform functional analyses of those specific miRNA. As 
there are difficulties in the isolation of FDC (Munoz-Fernandez et al., 2006; Aguzzi and 
Krautler, 2010) it would be impractical to isolate sufficient FDCs to carry out loss-of-
function and gain-of-function studies. For this reason the murine FL-YB cell line  was 
used as an in vitro model of FDC (Magari et al., 2011). The FL-YB cell line is derived 
from murine FDC and is dependent on TNFα signalling to remain in a mature and 
functional state. All three of the miRNAs selected for further study were shown to be 




To assess whether FL-YB cells respond in a similar manner to in vivo FDC activation, the 
gene expression levels for Il-6, Il-15, Vcam-1, Ptgs1/2, PtgiR and Tlr4 were measured 48 
hours after addition of different stimuli. These ‘marker’ transcripts were selected on 
the following basis: IL-6 produced by FDC has been shown to promote germinal centre 
reactions and somatic hyper mutation (Wu et al., 2009); IL-15 produced by FDC causes 
increased proliferation of germinal centre B cells (Park et al., 2004); Expression of 
VCAM-1 by FDC promotes interaction with germinal centre B cells through VCAM-
1/VLA-4 binding which enables FDC-mediated prevention of B cell apoptosis  
(Koopman et al., 1994). It has been reported that FDC production of prostaglandins is 
supressed via reduction of Cyclooxygenase2 (Ptgs2)(Cho et al., 2011b, 2013). 
Expression of prostacyclin receptor (PtgiR) has been previously reported on FL-Y cells 
(Nishikawa et al., 2006) and was predicted by 3 miRNA target prediction algorithms to 
be a target of miR-100-5p (DIANA micro-T, microRNA.org and RNA22); and TLR4 has 
been shown to be up-regulated on activated FDC and TLR4 signalling by FDC has been 
found to be a key for initiation of the germinal centre response (Garin et al., 2010; El 
Shikh et al., 2007b).   
To maintain a mature FDC-like state, FL-YB cells are routinely cultured in the presence 
of recombinant TNFα (Nishikawa et al., 2006). We found that the addition of TNFα 
leads to an increase in the expression of Il-6, Vcam-1, PtgiR and cyclooxygenase (Ptgs) 
by the FL-YB cells. TNFα signalling activates canonical NFκB and leads to up-regulation 
of Il-6 transcription in a variety of cell types (Husson et al., 2000; Tseng et al., 2010). 
Cyclooxygenase2 is also known to be transcribed by NFκB (Tridon et al., 2005; Tak and 
Firestein, 2001) and cyclooxygenase 2 activates the prostacyclin receptor (PtgiR) 
through increased synthesis of prostacyclin. TNFα has also been shown to induce 




The transcriptional response of the FL-YB cells to TNFα treatment therefore correlates 
well with the current literature and understanding.  
Treatment with a monoclonal antibody against LTβR initiates signalling through the 
LTβR and activates both the canonical and non-canonical pathway of NFκB activation. 
In general, the addition of agonistic LTβR MAb to FL-YB cells cultured in the presence 
of TNFα, had only limited additional effects on the expression of genes assessed to be 
upregulated by TNFα alone. This suggests that the activation of NFκB through TNFα 
signalling is already high. Addition of agonistic LTβR MAb did however increase the 
expression level of Vcam-1, and this effect has previously been described in a variety of 
stromal cells (Matsumoto et al., 1999; Dejardin et al., 2002). 
Interestingly it was found in the present study that addition of IL-4 to the FL-YB 
cultures increased expression of many genes including Il-6, Il-15, Tlr4, PtgiR and 
cycloxygenase (Ptgs1/2). Zamorano et al. (2001) found that IL-4 enhances TNFα-
induced NFκB activation in the 32D myeloid cell line and a similar mechanism may also 
occur in the FL-YB cell line under these conditions to further increase expression of the 
above genes. However, as LTβR signalling, which induces activation of NFκB did not 
result in transcriptional increases of these genes (Figure 5.3), IL-4 may be mediating 
these effects through different pathways. It has previously been found that IL-4 inhibits 
the production of cycloxygenase 2 in the human cell line HK (Cho et al., 2011b, 2013; 
Lee et al., 2008, 2005). However this was upon pre-treatment of the FDC with IL-4, 
whereas in the experiments described in section 5.2.3, the cells were routinely cultured 
with TNFα and IL-4 was added in addition to TNFα. The functions of IL-4 are known to 
be dependent on cell type, on other signalling pathways and on factors in the 
microenvironment (Nelms et al., 1999). For example, IL-4 down-regulates TLR4 




TLR4 by B cells (Ganley-Leal et al., 2010). The results in section 5.2.3 also indicate that 
IL-4 up-regulates Tlr4 on FDC, perhaps indicating that this effect is associated with the 
germinal centre microenvironment. 
The effects of IL-4 on FL-YB cells were also monitored using the xCELLigence system. 
This equipment generates a resistance signature representing a combination of cellular 
characteristics; proliferation, adhesion, morphology and viability. Having established a 
basic cell-index signature for cells grown in the presence of TNFα, the present study 
showed that IL-4 stimulation had a dramatic effect on this signature. This effect was 
shown to be dependent on the presence of TNFα, on cell density and on the dose of IL-4 
(Figure 5.8 and 5.9). Analysis of cell number suggested that this effect was not due to a 
difference in proliferation or viability of the cells, and more likely a result of changes in 
adhesion and/or morphology (Figure 5.7). However, no morphological differences 
between cells cultured in the presence or absence of IL-4 cells were obvious by light 
microscopy. Live cell imaging of IL-4 treated cells showed a possible increase in 
granularity and a slightly more rounded-up cells shape (Figure 5.10). This could 
indicate a more activated phenotype in the TNFα and IL-4 treated cells than the cells 
treated with TNFα alone. Future work to reveal the phenotype modifying the cell-index 
signature of IL-4 treated FL-YB cells, would include further imaging of the cells to 
confirm if there is an increase in granularity and roundness of the cells treated with 
IL-4. As the effect could be a difference in cell adhesion, immunostaining of adhesion 








7.5. Functional analysis of miRNAs in FDC 
MiRNA northern analysis confirmed expression of miR-100-5p, miR-138-5p and 
miR-2137 in FL-YB cells (Figure 6.1). 
7.5.1   Known functions of miR-100-5p 
Previously established targets of miR-100-5p include the mammalian target of 
rapamysin (mTOR) gene transcript. This gene contributes to the regulation of 
neovascularisation in endothelial vascular smooth muscle cells (Grundmann et al., 
2011). Expression of miR-100 also leads to increased vascularisation of tumours and 
thus is associated with tumour progression and unfavourable prognosis of many types 
of cancer (Chen et al., 2013b; Wang et al., 2013) leading to miR-100-5p being described 
as an oncomiR (Leite et al., 2013; Petrelli et al., 2012; Zheng et al., 2012) . It has also 
been described that miR-100 and αv integrins play a role in regulation of 
neovascularisation during graft-versus-host disease (Leonhardt et al., 2013). In the 
present study expression of Mtor was unchanged in the LTβR-Ig treated and LTβ-/- 
spleens compared to untreated samples, and Mtor expression could not be detected in 
FL-YB cells by qPCR. This suggests that, at least in FL-YB cells, miR-100-5p targeting of 
Mtor is unlikely. Another reported target of miR-100-5p is the bone morphogenetic 
protein receptor, type II (Bmpr2), which regulates osteogenic differentiation of human 
adipose-derived mesenchymal stem cells. Again Bmpr2 expression levels were similar 
in the untreated, LTβR-Ig treated and LTβ-/- spleens. Lymphoid tissue organiser (LTo) 
cells can be derived from adipose derived mesenchymal stem cells (Bénézech et al., 
2012). LTo cells are the original stromal cell population in developing lymph nodes and 
share functions such as maturation through LTβR signalling and the production of 
Cxcl13 in common with FDC (Bénézech et al., 2010). It may be that the association of 




miR-100-5p in MSC differentiation. miR-100-5p has also been implicated in epithelial 
to mesenchymal transition (EMT) and increases the motility of cells (Shimamura et al., 
2011). EMT involves a loss of cell-cell contact and mobilisation of the cells, one of the 
defining features of FDC is direct cell-cell contact with B cells and their long-live 
immobile state. The role of miR-100-5p in EMT indicates a possible role in cell-cell 
contact or mobilisation of cells. miR-100-5p has also been found to be significantly up-
regulated in the blood of patients with multiple sclerosis (Keller et al., 2013) indicating 
association with an inflammatory phenotype. 
7.5.2   Known functions of miR-138-5p 
Like miR-100-5p, miR-138-5p has also been implicated in EMT, although in a 
suppressive role (Liu et al., 2011). In addition, miR-138-5p has also been described to 
attenuate bone formation by negative-regulation of osteogenic differentiation of human 
mesenchymal stem cells (MSC) (Eskildsen et al., 2011), and has also been described to 
inhibit MSC differentiation into adipocytes (Yang et al., 2011). FDC are stromal cells 
that have been reported to differentiate from pericytes (Krautler et al., 2012) that could 
be MSC (Uccelli et al., 2006) and so the decreased miR-138-5p expression seen with 
FDC de-differentiation (Table 4.2) could indicate a role for miR-138-5p in FDC 
differentiation. Inhibition of miR-138-5p in oesophageal squamous cell carcinoma 
causes sustained NFκB activation by targeting lipid-raft components (Gong et al., 2013), 
as FDC function relies heavily on NFκB activation through LTβR signalling a similar role 







7.5.3   Known functions of miR-2137 
miR-2137 is a recently described miRNA (Chiang and Schoenfeld, 2010), and to date 
expression of miR-2137 has only been reported in mouse, not other species. The 
expression levels of miR-2137 were found to be increased in mouse embryonic 
fibroblasts (MEF) following induction of endoplasmic reticulum (ER) stress (Behrman 
et al., 2011). In addition, a study of miRNAs in different B cell lineages and stages 
identified miR-2137 to only be expressed in the B1 B cell lineage and not the B2 lineage 
at any stage (Spierings et al., 2011).  
7.6. miR-100-5p regulates pro-inflammatory genes in FDC 
The levels of miR-100-5p, miR-138-5p and miR-2137 were manipulated in FL-YB cells 
by the use of either complementary LNA-modified oligonucleotide sequences or miRNA 
mimics. The effect of miRNA over-expression or depletion on the expression of selected 
FDC-associated transcripts was assessed by qPCR analysis. Functional analysis of miR-
100-5p, miR-138-5p and miR-2137 in FL-YB cells revealed that the loss of miR-100-5p 
resulted in an approximately 2-fold increase in the transcript levels of three pro-
inflammatory genes 24 hours later (section 6.2.7). Expression levels remained at this 
elevated level for a further 24 hours. These genes were Il-6 (encodes interlukin-6), 
Ptgs1/2 (encodes Cyclooxygenase 1 and 2) and Tlr4 (encodes toll-like receptor 4).  
IL-6 is a cytokine that is involved in many different processes. IL-6 plays a central role 
in the induction of acute phase protein synthesis (Castell et al., 1989; Heath et al., 
1993). It is also involved  in breakdown of bone and cartilage (Le Goff et al., 2010) and 
as such is involved in osteoporosis (Manolagas et al., 1995). IL-6 is an important 
cytokine for progression of the germinal centre reaction (Wu et al., 2009; Eto et al., 




al., 1998). Mice deficient in IL-6 do not develop full size germinal centres and IgG2 and 
IgG3 responses are considerably impaired (Kopf et al., 1998). IL-6 or IL-21, the 
production of which is induced by IL-6, are required for optimal follicular T cell 
differentiation (Eto et al., 2011). T follicular helper cells interact with naïve B cells and 
secrete cytokines that promote their differentiation into antibody secreting plasma 
cells. Increased IL-6 expression is found in tissues of patients with a variety of 
autoimmune diseases including systemic lupus erythematous (Ripley et al., 2005), 
rheumatoid arthritis (Nawata et al., 1989) and Sjogren syndrome (Hulkkonen et al., 
2001).  However, it has also been proposed that IL-6 has a role in a checkpoint of 
immune tolerance (Yan et al., 2012). IL-6 plays such a large role in autoimmune 
diseases that a neutralising antibody to IL-6 receptor (Tocilizumab) has been 
developed as a therapy and is now widely used in the treatment of RA patients (Smolen 
et al., 2013; Assier et al., 2010). 
Blocking the function of miR-100-5p in FL-YB cells caused an increase in levels of the 
Il-6 transcript. This suggests that the high levels of miR-100-5p usually found in FL-YB 
cells could have a role in preventing excessive IL-6 production by FDC. This could have 
important implications in the prevention of autoimmunity. In future work it will be 
important to confirm that the increase of IL-6 with miR-100-5p knockdown is seen at 
the protein as well as the transcript level in FL-YB cells. 
It is possible that the increased Il-6 levels seen in FL-YB cells depleted of miR-100-5p 
could be a result of increased Tlr4 levels. It was recently shown that FDCs express toll-
like receptor 4 (Tlr4) (El Shikh et al., 2007b) and that injection of mice with LPS caused 
up-regulation of activation markers, such as FcγRIIb, VCAM-1 and ICAM-1 on FDC in 
vivo. Increased expression of these markers was also seen on FDC treated with LPS in 




signalling in FDC which is a key driver for the germinal centre response (Garin et al., 
2010). Loss of TLR4 on FDCs leads to a decrease in both the number and size of 
germinal centres (GC), reduced IgM titres from GC B cells and a decrease in the 
proportion of germinal centre B cells in the GC. Experiments generating bone marrow 
chimeras revealed that it is the stromal cells in the germinal centre that express TLR4. 
Without TLR4 expression, minimal ICAM-1 was expressed on the FDC which reduces 
the frequency of FDC-GC B cell interactions and which in turn markedly reduces the 
selection of high affinity plasma cells. High affinity IgG1, IgG2a and IgG2b responses 
were substantially impaired in mice deficient for TLR4 on FDC and the rate of SHM was 
decreased. FDCs that did not express TLR4 showed a reduction in the expression levels 
of a number of other genes. These included LTβR, the cytokines IL-1b, IL-6, IL-10, IL-15 
and the chemokines CCL19, CCL21, and CXCL12. These deficiencies go some way to 
explaining the reduced number and size of GCs (LTβR and chemokines), the reduced 
isotype switching (IL-6) and the reduction in GC B cell numbers (IL-10 and IL-15). The 
increase in Tlr4 expression upon loss of miR-100-5p (section 6.2.7) in FL-YB cells 
indicates that miR-100-5p causes down-regulation of Tlr4 expression. As TLR4 
signalling in FDC has been found to be important for driving the germinal centre 
reaction the modulation of Tlr4 by miR-100-5p could have an important role in 
regulation of the germinal centre reaction to avoid inappropriate, autoimmune or over-
active immune responses. TLR4 signalling up-regulates IL-6 and aberrant expression of 
both of these genes has been implicated in autoimmune disease (Hwang et al., 2009; 
Assier et al., 2010). miR-100-5p may therefore have an important role in fine tuning the 
expression of these and other genes that drive and mediate germinal centre reactions 
to prevent the occurrence of autoimmune reactions. 
The final gene that was, shown to have increased expression levels after depletion of 




are responsible for converting arachidonic acid into prostaglandin H (PGH) which can 
then be converted into a variety of other prostaglandins. Arachidonic acid is released 
from membrane phospholipids by phospholipase A2 in response to inflammatory 
stimuli (Harris et al., 2002). Prostaglandins have many complex and often opposing 
roles depending on the situation and microenvironment of target cells. It has been 
shown in HK cells that whereas cyclooxygenase 1 is constitutively expressed as in many 
other tissue and cell types, cyclooxygenase 2 (Ptgs2) is up-regulated upon stimulation 
by TNFα, TGF-β or LPS (Lee et al., 2008). This indicates that cyclooxygenase 2 can be 
up-regulated by TLR4 signalling in FDCs, again providing the possibility that, like Il-6, 
the up-regulation of Ptgs2 upon miR-100-5p knockdown in FL-YB cells may also be 
secondary to the up-regulation of Tlr4. The increase in PTGS2 causes increased 
expression of prostaglandin E2 and I2 (PGE2 and PGI2) in HK cells (Lee et al., 2008). PGE2 
is known to inhibit the proliferation of T cells and also to protect T cells from TCR-
mediated activation-induced cell death (AICD) (Harris et al., 2002). It has been shown 
that prostaglandins produced by HK cells can carry out both of these functions on 
follicular T cells (Lee et al., 2008). PGE2 can also induce regulatory T cell function which 
in turn supress immune responses and maintain tolerance (Baratelli et al., 2005). 
Future work would be needed to determine if the increase in Ptgs transcript after mir-
100-5p knockdown correlates with an increase in the secretion of prostaglandins by 
the FL-YB cells and if so which prostaglandins. 
The gene expression microarray data (chapter 4) revealed that the expression levels of 
Il-6 and Ptgs2 transcripts were not above the threshold level that was set for the data 
set. Because the mice were not immunised this is not unexpected and could support the 
hypothesis of miR-100-5p acting to post-transcriptionally supress any transcript which 




all spleens but significantly reduced in the d14 and LTβ-/- mice, which is probably due 
to reduced FDC and the resulting reduce immune response. 
These results therefore indicate that miR-100-5p plays a role in regulating pro-
inflammatory genes in FDC. As previously mentioned miRNA often act to “fine-tune” the 
levels of their target gene. In this case, miR-100-5p is likely to have a role in 
maintaining the specific amounts of pro-inflammatory genes produced by FDC. These 
genes produced by FDC go on to play important roles in determining the level and 
efficiency of the humoral immune response generated within a germinal centre 
highlighting the potential importance of the role miR-100-5p plays in FDC.  
7.7. Future studies 
The proposed role of miR-100-5p in FDC development and/or function would be 
further supported by identification the miRNA expression in FDCs in vivo. One method 
that could be used for this is miRNA in situ hybridisation (Pena et al., 2009). In future 
studies it would also be interesting to compare the miR-100-5p levels in FDC in 
primary and secondary follicles, as the FDC within secondary follicles are more 
activated than those from primary follicles (Allen and Cyster, 2008).  As miR-100-5p is 
highly conserved and the human miR-100-5p has exactly the same sequence as the 
mouse it would be interesting to evaluate the human FDC cell line HK for expression of 
miR-100-5p. If hsa-miR-100-5p was found to be expressed in this cell line it would be 
interesting to see if knockdown had similar effects on the Il-6, Tlr4 and Ptgs transcripts. 
The HK cell line could also potentially be a useful further model. For example, when 
Vcam-1 and Icam-1 expression levels were evaluated in FL-YB cells in the present study 
some increases were seen upon loss of miR-100-5p. However, these observations were 
not consistent, possibly because the expression levels of Vcam-1 and Icam-1 were very 




molecules at functional levels (Kim et al., 1994) they may be a superior model to 
measure the effect of miR-100-5p on these transcripts. It should be noted however that 
although miR-100-5p sequence is highly conserved the targets in human and mouse 
cells may not be the same because of sequence and/or structural differences in the 
target transcripts.  As the actual target transcripts of miR-100-5p are unknown it is 
impossible, at this stage, to determine whether the function will be conserved between 
species (Friedman et al., 2009). 
As mentioned before the increase in Il-6 and Ptgs could be a down-stream consequence 
of the increase in Tlr4 expression and signalling. To investigate this, an inhibitor of 
TLR4 signalling such as a neutralising antibody or LPS-RS (invivoGen, UK) could be 
used in culture of the cells following miR-100-5p knockdown. It would also be 
interesting to measure whether addition of LPS to the cultures would cause further 
increased expression of Il-6 or Ptgs by FL-YB cells. 
The expression of TLR-4, Ptgs1/2 and IL-6 have all been described to be up-regulated 
upon NFκB activation (Libermann and Baltimore, 1990; Schmedtje et al., 1997; Yan, 
2006). To assess the possible involvement of NFκB in the up-regulation of the 
transcripts NFκB luciferase reporter assays or electrophoretic mobility shift assays 
(EMSA) could be carried out. The advantage of EMSA is that it would also allow the 
identification of the specific NFκB subunits that are being activated which would reveal 
if canonical, non-canonical or both signalling pathways were playing a role. 
No traditional (6-mer seed sequence or greater in the 3’UTR of the transcript) miR-
100-5p target sites have been identified in any of the transcripts that have been found 
to increase upon miR-100-5p knockdown (RNAhybrid, Targetscan). However, 
increasingly miRNA targets which do not fit these traditional criteria are being 




which is seen in the expression level of the transcripts 24 h following miR-100-5p 
knockdown does however suggest that miR-100-5p is not directly targeting these 
transcripts as most miRNAs only cause a fairly modest repression of their target 
transcripts. This coupled with the possibility of all these transcripts being under the 
control of the same pathway or even Il-6 and Ptgs expression being controlled by TLR4 
suggests that the transcripts are indirect targets of miR-100-5p. 
This raises the question of what transcript(s) miR-100-5p is targeting. Additional 
indirect targets as well as possible direct targets may be identified by proteome or 
transcriptome analysis of FL-YB cells following miR-100-5p knockdown. The 
identification of additional transcriptional changes in FL-YB cells upon miR-100-5p 
knockdown would also help to infer the functional consequences of this miRNA. To 
identify direct targets of miR-100-5p comparison of cells with and without miR-100-5p 
knockdown could be carried out by a method such as Ago HITS-CLIP (high throughput 
sequencing by crosslinking and immunoprecipitation) which involves cross-linking of 
the RISC protein Ago with any bound RNA i.e. miRNA and their target sequences. 
To further investigate the impact of miR-100-5p knockdown on the function of FL-YB 
cells, it would be useful to look at the impact on B cell co-culture in experiments similar 
to those previously carried out between FL-YB and B cells (Nishikawa et al., 2006). 
The other miRNAs identified to be differentially regulated upon FDC de-differentiation 
are also likely to have important roles in FDC function. Functional effects of the other 
two miRNAs identified to be expressed in FL-YB cells (miR-2137 and miR-138-5p) 
were not discovered in this thesis. However the functional analysis carried out to date 
is limited and further analysis would have to be carried out on different aspects of FDC 
function to determine the role of these miRNA. Target identification could also be 




Target prediction was carried out both for individual miRNAs and for the group of eight 
miRNAs which were all identified to have decreased expression levels with FDC de-
differentiation. MiRNAs often function in networks, with many miRNAs regulating gene 
expression at different levels or expression of related genes in a way that tightly 
regulates a certain biological process. It would therefore be interesting to develop that 
work, as several miRNAs that display the same pattern of expression upon de-
diffentiation of FDC were identified in this thesis. One way of looking at the co-
ordinated effect of several miRNAs would be to transfect cells with pools of several 
miRNA inhibitors to knock-down several miRNAs at once. This work was started, 
where miR-100-5p, miR-138-5p and miR2137 antisense LNAs were transfected into 
cells which were then monitored by the xCELLigence system, early results did not 
indicate any significant effect on the cell index measurements and the work was not 
continued due to time constraints. It would be valuable to study knock-down of more of 
the miRNAs and also monitoring more specific and functions (such as proliferation) 
and outputs (such as the genes already looked at following individual miRNA 
inhibition) of the cells. 
7.8. Conclusions 
In conclusion, the data presented in this thesis suggests that the miRNA, miR-100-5p, 
plays a role in the regulation of pro-inflammatory gene expression in murine FDC. 
 The in vivo blockade of LTβR signalling caused rapid de-differentiation of FDC and 
comparisons of spleen samples with FDC at different stages of de-differentiation 





Three of these miRNA were selected on the basis of their expression pattern, and 
shown to be expressed in the murine FDC cell line FL-YB.  
The FL-YB cell line was found to respond to TNFα by up-regulating the expression of a 
number of genes associated with FDC activation and IL-4 treatment was found to 
increase the expression levels of many of the activation-associated transcripts. 
Functional analysis of the identified miRNAs in the FL-YB cells revealed that depletion 
of miR-100-5p resulted in an increase in expression of a number of gene transcripts of 
pro-inflammatory genes. Increased expression of these genes, Il-6, Tlr4 and Ptgs, has 
been implicated in autoimmune diseases. These genes are all also down-stream genes 
of the transcription factor NFκB, raising the possibility of miR-100-5p having a role in 
the regulation of the TNFR/LTβR-NFκB pathway at some level. 
Together these data suggest that miR-100-5p has a role in the regulation of pro-
inflammatory genes in FDC, which may have important implications in the progression 
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R scripts used for illumina miRNA sequencing analysis 
 
# creating text files of updated data, deleting any rows that 
dont have a mature mouse hit 
 
# read the file 
  dat <- read.delim("491_at1.txt") 
# select only those rows with a mature mouse hit 
  dat <- subset(dat, Best.human.mature.hit !="") 
# write the new data to a file 
  write.table(dat,file="at1.txt") 
 
# make this into a general function 
 
processrows <- function(filename){ 
 
  dat <- read.delim(filename) 
  dat <- subset(dat, Best.human.mature.hit !="") 
  return(dat) 
} 
 




































# collapsing data (sum coverage values from same mature hits) 
 
 
# Read data in 
  x <- read.table("dt4.txt") 
# select the subset you want 
  x <- subset(x, select = c(Best.human.mature.hit, 
Coverage.of.mature.hit)) 
<# write that to a file 
  write.table(x, file="dt4S.txt")> 
# sum the coverage values of the same micros 
  y <- aggregate(x$Coverage.of.mature, 
by=list(Best.human.mature.hit=x$Best.human.mature.hit), FUN=sum) 
# write that to a file 
  write.table (y, file="dt4Y.txt") 
 
collapse <- function(filename) { 
  # Read in data 
  # Select the apt. cols 
  # Sum the coverage values of the same micros 
 
 dat <- read.delim(filename) 
 dat <- subset(dat, select = c(Best.human.mature.hit, 
Coverage.of.mature)) 
 dat <- aggregate(dat$Coverage.of.mature, 
by=list(Best.human.mature.hit=dat$Best.human.mature.hit), 
FUN=sum) 
































# merging miR data 
 
 
zeroF <- read.table("at4Y.txt") 
zeroM <- read.table("dt2Y.txt") 
zero <- merge(zeroF, zeroM, by = "Best.human.mature.hit", 
all=TRUE) 
names(zero)[2] <- "zeroF" 
names(zero)[3] <- "zeroM" 
 
oneF <- read.table("at3Y.txt") 
oneM <- read.table("dt1Y.txt") 
one <- merge(oneF, oneM, by = "Best.human.mature.hit", all=TRUE) 
names(one)[2] <- "oneF" 
names(one)[3] <- "oneM" 
 
threeF <- read.table("at2Y.txt") 
threeM <- read.table("dt4Y.txt") 
three <- merge(threeF, threeM, by = "Best.human.mature.hit", 
all=TRUE) 
names(three)[2] <- "threeF" 
names(three)[3] <- "threeM" 
 
fiveF <- read.table("at1Y.txt") 
fiveM <- read.table("dt3Y.txt") 
five <- merge(fiveF, fiveM, by = "Best.human.mature.hit", 
all=TRUE) 
names(five)[2] <- "fiveF" 
names(five)[3] <- "fiveM" 
 
fourteenF <- read.table("bt3Y.txt") 
fourteenM <- read.table("ct1Y.txt") 
fourteen <- merge(fourteenF, fourteenM, by = 
"Best.human.mature.hit", all=TRUE) 
names(fourteen)[2] <- "fourteenF" 
names(fourteen)[3] <- "fourteenM" 
 
twentyoneF <- read.table("bt2Y.txt") 
twentyoneM <- read.table("ct4Y.txt") 
twentyone <- merge(twentyoneF, twentyoneM, by = 
"Best.human.mature.hit", all=TRUE) 
names(twentyone)[2] <- "twentyoneF" 
names(twentyone)[3] <- "twentyoneM" 
 
twentyeightF <- read.table("bt1Y.txt") 
twentyeightM <- read.table("ct3Y.txt") 
twentyeight <- merge(twentyeightF, twentyeightM, by = 
"Best.human.mature.hit", all=TRUE) 
names(twentyeight)[2] <- "twentyeightF" 
names(twentyeight)[3] <- "twentyeightM" 
 
LTbF <- read.table("bt4Y.txt") 




LTb <- merge(LTbF, LTbM, by = "Best.human.mature.hit", all=TRUE) 
names(LTb)[2] <- "LTbF" 
names(LTb)[3] <- "LTbM" 
 
zeroone <- merge(zero, one, by = "Best.human.mature.hit", 
all=TRUE) 
threefive <- merge(three, five, by = "Best.human.mature.hit", 
all=TRUE) 
fourteentwentyone <- merge(fourteen, twentyone, by = 
"Best.human.mature.hit", all=TRUE) 
twentyeightLTb <- merge(twentyone, LTb, by = 
"Best.human.mature.hit", all=TRUE) 
all1 <- merge(zeroone, threefive, by = "Best.human.mature.hit", 
all=TRUE) 
all2 <- merge(fourteentwentyone, twentyeightLTb, by = 
"Best.human.mature.hit", all=TRUE) 













































# Using edgeR package to calculate normalisation factors 
 
# load edgeR 
  library(edgeR) 
 
# read in counts data 
  D <- read.table("xlmerge.txt") 
 
# Take off miR coloum and change into matrix 
  D <- D[ ,-1] 
  D <- as.matrix(D) 
 
# Create a DGEList 
  d <- DGEList(counts = D, group = substr(colnames(D), 1, 16)) 
 
# check samples output 
  d$samples 
 
# OUTPUT 
     group lib.size norm.factors 
X0f    X0f  2615192            1 
X0m    X0m  2818664            1 
X1f    X1f   915598            1 
X1m    X1m   502000            1 
X3f    X3f  3749696            1 
X3m    X3m  1722589            1 
X5f    X5f   991678            1 
X5m    X5m  1224624            1 
X14f  X14f   635175            1 
X14m  X14m   921157            1 
X21f  X21f  2741291            1 
X21m  X21m  2291138            1 
X28f  X28f   404405            1 
X28m  X28m   873814            1 
ltbf  ltbf  1844101            1 
ltbm  ltbm  3247595            1 
 
# calculate the normalization factors 
  d <- calcNormFactors(d) 
 
# check samples output 
  d$samples 
 
# OUTPUT 
     group lib.size norm.factors 
X0f    X0f  2615192    0.6124565 
X0m    X0m  2818664    0.5152068 
X1f    X1f   915598    1.9378149 
X1m    X1m   502000    1.3194413 
X3f    X3f  3749696    0.3662188 
X3m    X3m  1722589    1.3499490 
X5f    X5f   991678    1.4875536 
X5m    X5m  1224624    1.6431315 




X14m  X14m   921157    1.3976537 
X21f  X21f  2741291    0.5301450 
X21m  X21m  2291138    0.6728704 
X28f  X28f   404405    1.5800473 
X28m  X28m   873814    2.0315369 
ltbf  ltbf  1844101    0.7911965 
ltbm  ltbm  3247595    0.4875362 
 
#use cpm function to get counts per million from DGEList 
counts <- cpm(d, normalized.lib.size=TRUE) 
head(counts) 























































#read in data 
 D <- read.delim("del.142-3p.txt") 
 
#Take off miR coloum and change to matrix 
 D <- D[ ,-1] 
 D <- as.matrix(D) 
 
#create DGElist 






 group lib.size norm.factors 
X0f    X0f   822999            1 
X0m    X0m   758462            1 
X1f    X1f   880010            1 
X1m    X1m   486996            1 
X3f    X3f   692047            1 
X3m    X3m   914581            1 
X5f    X5f   957081            1 
X5m    X5m  1170790            1 
X14f  X14f   612302            1 
X14m  X14m   887932            1 
X21f  X21f   675716            1 
X21m  X21m   611892            1 
X28f  X28f   381622            1 
X28m  X28m   836199            1 
ltbf  ltbf   675328            1 
ltbm  ltbm   737251            1 
 
 
#calculate normalisation factors 






 group lib.size norm.factors 
X0f    X0f   822999    1.1092514 
X0m    X0m   758462    1.0368655 
X1f    X1f   880010    1.0661379 
X1m    X1m   486996    0.8187085 
X3f    X3f   692047    1.0842188 
X3m    X3m   914581    1.2498697 
X5f    X5f   957081    0.7366625 




X14f  X14f   612302    0.9729092 
X14m  X14m   887932    0.5895419 
X21f  X21f   675716    1.1095535 
X21m  X21m   611892    1.2223025 
X28f  X28f   381622    0.8840909 
X28m  X28m   836199    0.9978496 
ltbf  ltbf   675328    1.2911265 






















































# normalisation with data only from tag 1 and 3 time points 
 
# read in the xlmerge file 
  D <- read.delim("xlmerge.txt") 
# delete coloums don't want   
  D <- D[ ,-1] 
  D <- D[ ,-2] 
  D <- D[ ,-2] 
  D <- D[ ,-4] 
  D <- D[ ,-4] 
  D <- D[ ,-8] 
  D <- D[ ,-8] 
  D <- D[ ,-10] 
  D <- D[ ,-10] 
# write file 
  write.table(D, file="raw1&3.txt") 
# load edgeR 
  library(edgeR) 
# Take off miR column and change into matrix 
  D <- D[ ,-1] 
  D <- as.matrix(D) 
  is.matrix(D) 
# Create a DGEList 
  d <- DGEList(counts = D, group = substr(colnames(D), 1, 8)) 
# check samples output 
  d$samples 
 
# OUTPUT 
     group lib.size norm.factors 
X1f    X1f   915598            1 
X1m    X1m   502000            1 
X5f    X5f   991678            1 
X5m    X5m  1224624            1 
X14f  X14f   635175            1 
X14m  X14m   921157            1 
X28f  X28f   404405            1 
X28m  X28m   873814            1 
 
# calculate the normalisation factors 
  d <- calcNormFactors(d) 
# check samples output 
  d$samples 
 
# OUTPUT 
     group lib.size norm.factors 
X1f    X1f   915598    1.2957730 
X1m    X1m   502000    0.8488325 
X5f    X5f   991678    0.8626299 
X5m    X5m  1224624    1.0344219 
X14f  X14f   635175    1.1038309 
X14m  X14m   921157    0.7842650 
X28f  X28f   404405    0.9162668 





# REPEAT BUT TAKE OFF 142-3p... 
 
# DGEList output 
     group lib.size norm.factors 
X1f    X1f   880010            1 
X1m    X1m   486996            1 
X5f    X5f   957081            1 
X5m    X5m  1170790            1 
X14f  X14f   612302            1 
X14m  X14m   887932            1 
X28f  X28f   381622            1 
X28m  X28m   836199            1 
 
# normfactors output 
     group lib.size norm.factors 
X1f    X1f   880010    1.3007873 
X1m    X1m   486996    0.8441690 
X5f    X5f   957081    0.8623671 
X5m    X5m  1170790    1.0441264 
X14f  X14f   612302    1.1065248 
X14m  X14m   887932    0.7850813 
X28f  X28f   381622    0.9347188 
X28m  X28m   836199    1.2455533 
 
# REPEAT FOR TAGs 2&4... 
 
# output for DGEList 
     group lib.size norm.factors 
X0f    X0f  2615192            1 
X0m    X0m  2818664            1 
X3f    X3f  3749696            1 
X3m    X3m  1722589            1 
X21f  X21f  2741291            1 
X21m  X21m  2291138            1 
ltbf  ltbf  1844101            1 
ltbm  ltbm  3247595            1 
 
# output for calcNormFactors 
     group lib.size norm.factors 
X0f    X0f  2615192    1.0240848 
X0m    X0m  2818664    0.8516186 
X3f    X3f  3749696    0.6101051 
X3m    X3m  1722589    1.9834753 
X21f  X21f  2741291    0.8386001 
X21m  X21m  2291138    0.9677108 
ltbf  ltbf  1844101    1.3495629 
ltbm  ltbm  3247595    0.8651549 
 
# REPEAT but without 142-3p... 
 
# output for DGEList 
     group lib.size norm.factors 
X0f    X0f   822999            1 
X0m    X0m   758462            1 
X3f    X3f   692047            1 




X21f  X21f   675716            1 
X21m  X21m   611892            1 
ltbf  ltbf   675328            1 
ltbm  ltbm   737251            1 
 
# output from calcNormFactors 
  group lib.size norm.factors 
X0f    X0f   822999    0.9445184 
X0m    X0m   758462    0.9113083 
X3f    X3f   692047    0.9231458 
X3m    X3m   914581    1.0808624 
X21f  X21f   675716    0.9854850 
X21m  X21m   611892    1.0570229 
ltbf  ltbf   675328    1.0359653 


























R scripts used for the analysis of miRNA microarray data  
 
 
# ExiMiR  
 
# set working directory 
setwd("M:/Array stuff/Raw data files") 
 
# Install makecdfenv package 
source("http://www.bioconductor.org/biocLite.R") 
    biocLite("makecdfenv") 
 
# Create array annotation environment 
library(makecdfenv) 
cdfenv <- make.cdf.env(cdf.path = "Affymetrix", filename = 
"miRNA-2_0.cdf") 
 
# load the CEL files into R 
library(affy) 
abatch <- ReadAffy(cdfname = 'cdfenv', celfile.path = 
'Affymetrix') 
 
# Can use RMA normalisation applied to abatch 
eset.rma <-rma(abatch) 
 
# Or can use spike-in probe-based approach in ExiMiR which may 
give better results 




eset.spike <- NormiR(abatch) 
# OUTPUT 
# No Exiqon Spike Control probes, trying with Affy Spike Control 
probes... 
# Not enough common variance to guarantee good performance of 
spike-in normalization (0.28 < 0.5). 
# Using median normalization... 
 
# Exiqon from text files to expressionsets 
library(ExiMiR) 
 
# create array annotation environment 
galenv <- make.gal.env(gal.path = "Exiqon") 
 
# read raw txt files into R 
ebatch <- ReadExi(galname = 'galenv', txtfile.path = "Exiqon") 
 
# load affy package and apply RMA normalisation 
library(affy) 
eset.rma <- rma(ebatch, background = FALSE) 
 




eset.spike <- NormiR(ebatch) 
 
# ExiMiR doesn't seem to work for all datasets therefore will go 
back to RMA 
Aff.eset.rma <- rma(abatch) 
Exi.eset.rma <- rma(ebatch) 
a <- exprs(Aff.eset.rma) 
e <- exprs(Exi.eset.rma) 
write.table(a, file = "affy.rma.txt") 
write.table(e, file = "exiq.rma.txt") 
 
# Edit data files in excel as appropriate 
# read the data back in 
affy <- read.table("affy.rma.txt", header = TRUE) 




# make into a matrix 
affy <- as.matrix(affy) 
exiq <- as.matrix(exiq) 
 
# create a function to draw barplots from affy data 
customBar <- function(dataname, rowname) { 
  print(barplot(dataname[rowname, ], col= 
c("lightblue1","lightblue1","skyblue2","skyblue2","mediumblue","m

















Affymetrix miRNA microarray data 
The RMA-normalised miRNA expression values and fold-change of the mean expression value for each of the time points are shown with the mean 
expression value of the Day 0 samples set as a baseline value of 1.00. The data shown is threshold filtered, with miRNAs that did not have an 
expression value of at least 10 for both duplicates from at least one time point excluded. The table is ordered with those miRNAs showing the most 
significant decrease in expression in the LTb
-/-
 samples compared to the Day 0 samples first and those with the most significant increase last. Those 
miRNAs with a 2-fold or greater difference in expression between Day 0 and LTb
-/-
 samples, with a change in the same direction at day 2 and day 14 
were considered for further analysis and are highlighted in yellow. Before selection of miRNAs for further study similarity of the duplicates from each 
time point was also assessed, miRNAs that had a 2-fold difference or greater within any of the duplicates (in red) were excluded from further analysis. 
  Expression values   Fold change from Day  0 
miRNA ID 0a 0b 2a 2b 14a 14b LTa LTb   Day 0-0 Day 2-0 Day 14-0 LTb-0 
mmu-miR-708 77 71 61 54 72 23 17 12   1.00 0.78 0.64 0.20 
mmu-miR-138 446 713 535 597 260 299 199 213   1.00 0.98 0.48 0.36 
mmu-miR-138* 28 57 32 33 17 40 11 22   1.00 0.76 0.66 0.40 
mmu-miR-2137 14440 8194 9958 9273 6505 6490 5349 4038   1.00 0.85 0.57 0.41 
mmu-miR-124 22 15 10 8 6 5 7 9   1.00 0.48 0.28 0.42 
mmu-miR-466d-
3p 12 13 14 12 16 17 6 5   1.00 1.06 1.36 0.45 
mmu-miR-187 298 374 363 259 161 185 156 152   1.00 0.93 0.52 0.46 
mmu-miR-290-5p 19 14 7 10 7 14 8 7   1.00 0.52 0.64 0.47 
mmu-miR-491 19 14 10 13 12 13 8 8   1.00 0.71 0.75 0.49 
mmu-miR-466h 59 42 63 39 98 46 32 18   1.00 1.02 1.43 0.49 
mmu-miR-1893 90 43 69 38 57 32 27 40   1.00 0.80 0.66 0.50 




mmu-miR-762 1939 716 1229 796 1054 509 817 522   1.00 0.76 0.59 0.50 
mmu-miR-100 569 745 502 520 446 502 306 345   1.00 0.78 0.72 0.50 
mmu-miR-1937c 23 14 9 12 10 13 8 11   1.00 0.56 0.63 0.52 
mmu-miR-1224 1084 947 476 785 576 661 576 524   1.00 0.62 0.61 0.54 
mmu-miR-1937a 327 204 328 162 244 175 161 135   1.00 0.92 0.79 0.56 
mmu-miR-297a* 9 13 16 11 9 8 7 6   1.00 1.19 0.77 0.56 
mmu-miR-27a* 37 48 43 27 36 33 28 20   1.00 0.83 0.81 0.56 
mmu-miR-139-3p 79 134 133 123 77 88 69 51   1.00 1.20 0.77 0.56 
mmu-miR-1894-
3p 220 107 120 95 129 99 106 82   1.00 0.66 0.69 0.57 
mmu-miR-1937b 245 124 210 101 188 113 103 112   1.00 0.84 0.82 0.58 
mmu-miR-711 29 15 23 15 21 12 10 15   1.00 0.88 0.77 0.59 
mmu-miR-2133 1926 1155 1873 1170 982 967 825 1024   1.00 0.99 0.63 0.60 
mmu-miR-151-3p 674 737 519 664 482 554 522 345   1.00 0.84 0.73 0.61 
mmu-miR-193b 209 224 267 208 153 132 138 130   1.00 1.10 0.66 0.62 
mmu-miR-335-5p 11 6 3 13 13 10 5 5   1.00 0.97 1.39 0.63 
mmu-miR-467b 12 9 13 4 13 22 4 10   1.00 0.78 1.63 0.63 
mmu-miR-1959 289 164 186 83 195 113 117 170   1.00 0.59 0.68 0.63 
mmu-miR-542-5p 13 35 69 30 23 24 13 17   1.00 2.06 0.97 0.64 
mmu-miR-296-5p 11 13 17 8 8 12 7 8   1.00 1.04 0.86 0.65 
mmu-miR-698 25 19 6 16 15 22 15 14   1.00 0.51 0.84 0.65 
mmu-miR-30a* 111 129 115 107 106 127 93 66   1.00 0.93 0.97 0.66 
mmu-miR-184 9 29 21 15 12 20 10 16   1.00 0.94 0.83 0.66 
mmu-miR-466f 129 91 140 125 159 89 93 53   1.00 1.20 1.12 0.66 
mmu-miR-455 595 909 629 837 613 793 634 368   1.00 0.97 0.94 0.67 





3p 22 50 15 67 36 45 36 13   1.00 1.15 1.13 0.67 
mmu-miR-29b 62 33 58 30 49 50 30 34   1.00 0.93 1.05 0.68 
mmu-miR-1940 72 82 43 61 65 66 64 41   1.00 0.68 0.85 0.69 
mmu-miR-330* 67 97 80 78 57 84 58 54   1.00 0.96 0.86 0.69 
mmu-miR-503 140 141 298 165 134 115 100 93   1.00 1.65 0.89 0.69 
mmu-miR-212 53 55 70 58 54 44 39 36   1.00 1.18 0.90 0.69 
mmu-miR-2141 447 247 400 200 340 231 264 217   1.00 0.86 0.82 0.69 
mmu-miR-467a 284 348 351 379 374 362 227 210   1.00 1.16 1.17 0.69 
mmu-miR-468 38 38 18 33 30 24 24 28   1.00 0.68 0.71 0.69 
mmu-miR-296-3p 110 95 153 159 95 120 85 59   1.00 1.52 1.05 0.70 
mmu-miR-674 1891 2442 2039 2425 1475 1769 1679 1409   1.00 1.03 0.75 0.71 
mmu-miR-672 44 76 47 40 39 29 45 42   1.00 0.73 0.57 0.72 
mmu-miR-301a 23 19 43 22 25 36 18 13   1.00 1.54 1.43 0.72 
mmu-miR-669b 23 13 22 12 44 16 17 9   1.00 0.95 1.65 0.72 
mmu-miR-3474 13 15 14 14 11 11 12 8   1.00 1.00 0.77 0.72 
mmu-miR-669a 75 39 76 54 93 79 42 40   1.00 1.14 1.50 0.72 
mmu-miR-297a 42 23 38 25 66 26 32 15   1.00 0.96 1.40 0.73 
mmu-miR-467f 45 50 65 67 86 68 53 17   1.00 1.38 1.61 0.73 
mmu-miR-669d 17 8 17 10 26 11 11 8   1.00 1.05 1.45 0.74 
mmu-miR-712 58 28 65 39 46 29 29 35   1.00 1.20 0.86 0.74 
mmu-miR-2135 2576 1879 2295 1735 1695 1596 1754 1561   1.00 0.90 0.74 0.74 
mmu-miR-877 37 25 44 32 35 30 21 26   1.00 1.21 1.03 0.75 
mmu-miR-500 698 977 812 845 569 731 637 624   1.00 0.99 0.78 0.75 
mmu-miR-326 180 156 206 147 143 98 110 144   1.00 1.05 0.72 0.76 




mmu-miR-149 170 220 202 153 174 175 147 150   1.00 0.91 0.89 0.76 
mmu-miR-712* 17 15 36 6 11 16 15 9   1.00 1.32 0.87 0.76 
mmu-miR-151-5p 2931 3065 2626 2548 2145 2382 2295 2301   1.00 0.86 0.75 0.77 
mmu-miR-3472 116 37 52 48 39 48 55 63   1.00 0.65 0.57 0.77 
mmu-miR-1941-
5p 55 85 64 64 53 58 52 56   1.00 0.92 0.80 0.77 
mmu-miR-2145 4177 2368 4068 2415 2293 2049 2252 2814   1.00 0.99 0.66 0.77 
mmu-miR-345-3p 53 56 49 63 53 47 47 38   1.00 1.02 0.92 0.77 
mmu-miR-320 1180 1805 1296 1699 1136 1353 1221 1097   1.00 1.00 0.83 0.78 
mmu-miR-541 49 39 57 55 46 43 31 38   1.00 1.27 1.00 0.78 
mmu-miR-501-3p 164 202 197 156 135 147 134 155   1.00 0.96 0.77 0.79 
mmu-miR-467a-
1* 60 69 69 83 95 101 51 51   1.00 1.18 1.51 0.79 
mmu-miR-30c-2* 64 96 85 52 71 58 62 66   1.00 0.86 0.80 0.80 
mmu-miR-30a 779 779 924 774 733 732 602 638   1.00 1.09 0.94 0.80 
mmu-miR-223 300 168 297 157 340 216 184 191   1.00 0.97 1.19 0.80 
mmu-miR-188-5p 51 58 56 78 33 52 47 41   1.00 1.22 0.78 0.80 
mmu-miR-1943 11 11 9 9 10 13 7 10   1.00 0.82 1.07 0.80 
mmu-miR-1187 359 337 315 356 417 299 343 218   1.00 0.96 1.03 0.81 
mmu-miR-125a-
3p 74 60 64 74 46 53 54 56   1.00 1.03 0.74 0.82 
mmu-miR-1196 1046 1245 847 1195 950 1015 1011 863   1.00 0.89 0.86 0.82 
mmu-miR-1964 37 33 43 34 41 29 28 29   1.00 1.11 1.01 0.82 
mmu-miR-34a 434 374 374 295 329 273 348 319   1.00 0.83 0.75 0.82 
mmu-miR-214* 30 47 42 51 42 37 27 37   1.00 1.20 1.02 0.83 
mmu-miR-1839-
5p 862 799 602 670 659 724 727 657   1.00 0.77 0.83 0.83 




mmu-miR-181d 240 260 356 299 293 383 204 219   1.00 1.31 1.35 0.85 
mmu-miR-17* 1294 1698 1523 1605 1219 1357 1301 1235   1.00 1.05 0.86 0.85 
mmu-miR-324-3p 119 164 152 156 127 157 109 132   1.00 1.09 1.00 0.85 
mmu-miR-466j 73 71 103 92 122 71 73 49   1.00 1.35 1.34 0.85 
mmu-miR-339-3p 63 69 62 55 57 67 52 60   1.00 0.89 0.94 0.85 
mmu-miR-574-5p 455 550 385 560 453 424 440 419   1.00 0.94 0.87 0.85 
mmu-miR-99b 1736 2799 2014 2644 1629 2099 1876 2006   1.00 1.03 0.82 0.86 
mmu-miR-135a* 37 14 24 17 17 22 17 27   1.00 0.81 0.77 0.86 
mmu-miR-207 56 45 59 51 63 37 45 42   1.00 1.08 0.99 0.86 
mmu-miR-22 4753 4356 4115 4152 3886 3752 4193 3637   1.00 0.91 0.84 0.86 
mmu-let-7e 3817 4709 4437 4331 3742 3862 3570 3764   1.00 1.03 0.89 0.86 
mmu-miR-744* 12 16 11 5 15 11 11 13   1.00 0.58 0.92 0.86 
mmu-miR-125b-
3p 31 27 34 20 26 21 21 29   1.00 0.94 0.82 0.86 
mmu-miR-125a-
5p 3079 3342 3023 3181 2868 3163 2693 2870   1.00 0.97 0.94 0.87 
mmu-miR-466b-3-
3p 48 47 55 47 49 57 31 50   1.00 1.09 1.12 0.87 
mmu-miR-680 8 16 10 11 9 8 10 10   1.00 0.85 0.73 0.87 
mmu-miR-652 3220 3738 3253 3590 2539 2905 2991 3051   1.00 0.98 0.78 0.87 
mmu-miR-674* 135 147 150 118 136 141 120 125   1.00 0.95 0.99 0.87 
mmu-miR-466b-
3p 61 36 57 61 63 70 38 46   1.00 1.22 1.38 0.87 
mmu-let-7d* 83 97 97 98 99 126 89 68   1.00 1.09 1.25 0.87 
mmu-miR-140 170 144 183 130 171 165 152 123   1.00 1.00 1.07 0.87 
mmu-miR-346 167 252 133 270 155 265 174 192   1.00 0.96 1.00 0.87 
mmu-miR-181a 5284 6842 7276 7164 5392 6216 5400 5213   1.00 1.19 0.96 0.88 




mmu-miR-143 7910 8512 8282 8669 7908 7638 7178 7250   1.00 1.03 0.95 0.88 
mmu-miR-181b 1290 1744 1938 1874 1387 1389 1303 1387   1.00 1.26 0.91 0.89 
mmu-miR-574-3p 583 888 702 900 614 756 673 632   1.00 1.09 0.93 0.89 
mmu-miR-466c-
5p 78 41 88 71 127 59 62 44   1.00 1.33 1.56 0.89 
mmu-miR-665 16 10 13 7 22 6 11 12   1.00 0.75 1.10 0.89 
mmu-miR-298 81 101 121 136 92 116 96 67   1.00 1.41 1.13 0.89 
mmu-miR-194 840 856 790 805 774 796 761 754   1.00 0.94 0.93 0.89 
mmu-miR-20b* 10 11 12 12 17 13 8 11   1.00 1.13 1.41 0.89 
mmu-miR-362-5p 260 356 332 292 284 304 282 269   1.00 1.01 0.95 0.89 
mmu-miR-669c 308 269 276 278 337 278 278 237   1.00 0.96 1.07 0.89 
mmu-miR-24 14674 15832 15016 15422 14701 14121 14220 13094   1.00 1.00 0.94 0.90 
mmu-miR-429 12 11 11 9 8 18 10 11   1.00 0.88 1.10 0.90 
mmu-miR-667 22 6 16 15 9 11 14 11   1.00 1.08 0.70 0.90 
mmu-miR-185 2580 2854 2675 2926 2576 2721 2558 2319   1.00 1.03 0.97 0.90 
mmu-miR-455* 19 12 22 10 14 11 14 13   1.00 1.05 0.82 0.90 
mmu-miR-130b 1033 1533 1635 1722 1255 1373 1194 1118   1.00 1.31 1.02 0.90 
mmu-miR-497 325 425 401 350 390 401 305 372   1.00 1.00 1.05 0.90 
mmu-miR-484 55 54 97 52 51 67 45 53   1.00 1.38 1.09 0.91 
mmu-miR-345-5p 87 146 121 130 85 114 98 113   1.00 1.07 0.85 0.91 
mmu-miR-93* 268 316 269 323 294 313 285 244   1.00 1.01 1.04 0.91 
mmu-miR-466g 154 161 157 296 202 225 171 116   1.00 1.44 1.36 0.91 
mmu-miR-339-5p 506 714 504 482 437 495 552 559   1.00 0.81 0.76 0.91 
mmu-miR-195 3091 3071 2576 2902 2920 3324 2772 2852   1.00 0.89 1.01 0.91 
mmu-miR-378 2663 3290 2969 3248 2713 2856 2809 2625   1.00 1.04 0.94 0.91 




mmu-miR-1981 218 315 261 262 234 240 265 222   1.00 0.98 0.89 0.91 
mmu-miR-103 8620 10582 9383 9805 8676 9177 8931 8677   1.00 1.00 0.93 0.92 
mmu-miR-1195 3452 2625 3998 3081 4089 2961 2846 2730   1.00 1.16 1.16 0.92 
mmu-miR-193* 55 81 79 76 70 68 59 66   1.00 1.14 1.02 0.92 
mmu-miR-466f-3p 534 802 445 1016 732 935 737 492   1.00 1.09 1.25 0.92 
mmu-miR-27a 1989 1908 2589 2000 1759 1888 1764 1825   1.00 1.18 0.94 0.92 
mmu-miR-582-3p 11 11 13 12 14 10 11 10   1.00 1.08 1.06 0.92 
mmu-miR-2138 10151 7661 8197 8475 7301 6721 8421 8020   1.00 0.94 0.79 0.92 
mmu-miR-2861 7411 5100 4267 5597 4231 4232 5889 5684   1.00 0.79 0.68 0.93 
mmu-miR-328 185 189 214 156 183 170 170 175   1.00 0.99 0.94 0.93 
mmu-miR-532-5p 1227 1784 1391 1615 1223 1409 1430 1362   1.00 1.00 0.87 0.93 
mmu-miR-29b* 35 12 10 4 14 6 30 14   1.00 0.29 0.43 0.93 
mmu-miR-199a-
5p 524 607 695 497 585 585 513 540   1.00 1.05 1.03 0.93 
mmu-miR-342-5p 788 1017 917 846 857 874 871 815   1.00 0.98 0.96 0.93 
mmu-miR-214 690 1108 987 1023 772 963 820 862   1.00 1.12 0.97 0.94 
mmu-miR-30c-1* 66 73 60 52 72 48 67 63   1.00 0.80 0.86 0.94 
mmu-miR-145 14557 15451 14890 15121 14252 14974 13224 14918   1.00 1.00 0.97 0.94 
mmu-miR-467c 64 52 64 63 95 78 48 60   1.00 1.10 1.50 0.94 
mmu-miR-125b-
5p 5140 5307 5230 4420 4648 4710 4403 5428   1.00 0.92 0.90 0.94 
mmu-miR-1935 185 114 224 125 255 139 155 127   1.00 1.17 1.32 0.94 
mmu-miR-3471 18 14 19 16 15 16 16 13   1.00 1.11 1.02 0.94 
mmu-miR-485* 19 11 6 8 8 17 10 19   1.00 0.45 0.79 0.95 
mmu-miR-192 227 240 271 237 275 294 237 205   1.00 1.09 1.22 0.95 
mmu-miR-106b 4348 4636 4743 5230 4943 5047 4784 3747   1.00 1.11 1.11 0.95 





5p 305 459 290 498 342 451 433 298   1.00 1.03 1.04 0.96 
mmu-miR-15a* 47 42 35 87 40 45 37 48   1.00 1.36 0.95 0.96 
mmu-miR-27b* 51 41 41 38 53 48 39 49   1.00 0.86 1.10 0.96 
mmu-miR-139-5p 1794 2337 2132 2045 1779 1911 1976 1993   1.00 1.01 0.89 0.96 
mmu-miR-466a-
3p 43 45 64 51 66 76 33 51   1.00 1.30 1.61 0.96 
mmu-miR-2132 24345 24522 33205 26835 25128 22997 23208 23822   1.00 1.23 0.98 0.96 
mmu-let-7f* 10 15 13 32 7 19 12 12   1.00 1.82 1.05 0.96 
mmu-miR-24-2* 443 495 469 455 467 442 455 451   1.00 0.98 0.97 0.97 
mmu-miR-423-5p 318 536 473 442 392 443 411 414   1.00 1.07 0.98 0.97 
mmu-miR-182 81 100 104 88 122 125 88 87   1.00 1.06 1.37 0.97 
mmu-miR-466i 123 121 136 159 237 191 142 93   1.00 1.21 1.76 0.97 
mmu-miR-20b 1666 1898 1987 2329 2060 2185 1879 1574   1.00 1.21 1.19 0.97 
mmu-miR-191 16972 18510 17306 18766 17193 18713 17628 16749   1.00 1.02 1.01 0.97 
mmu-miR-709 26840 28121 29089 28548 30301 27816 27036 26251   1.00 1.05 1.06 0.97 
mmu-miR-23b 11968 13026 12737 13298 12490 12584 12141 12136   1.00 1.04 1.00 0.97 
mmu-miR-30e 313 193 434 316 337 327 255 238   1.00 1.48 1.31 0.97 
mmu-miR-221 1963 1869 1744 1682 1839 1763 1885 1843   1.00 0.89 0.94 0.97 
mmu-miR-877* 20 17 15 19 18 21 16 20   1.00 0.92 1.04 0.97 
mmu-miR-24-1* 15 12 15 9 13 20 12 15   1.00 0.87 1.23 0.98 
mmu-miR-99b* 56 75 83 81 57 81 68 60   1.00 1.25 1.05 0.98 
mmu-miR-31 188 218 238 198 275 221 228 170   1.00 1.07 1.22 0.98 
mmu-miR-107 6991 8069 7550 7100 7111 6973 7452 7336   1.00 0.97 0.94 0.98 
mmu-miR-714 198 87 154 119 128 106 121 159   1.00 0.96 0.82 0.98 
mmu-miR-26a 20364 20264 20184 20373 20166 20405 20156 19818   1.00 1.00 1.00 0.98 




mmu-miR-669e 20 10 11 16 25 11 19 11   1.00 0.89 1.17 0.99 
mmu-miR-152 825 931 909 933 778 856 879 865   1.00 1.05 0.93 0.99 
mmu-miR-27b 1839 1819 1816 1936 2060 2019 1875 1761   1.00 1.03 1.12 0.99 
mmu-miR-720 126 82 126 55 137 97 87 120   1.00 0.87 1.12 1.00 
mmu-miR-297c* 9 7 6 8 23 11 9 7   1.00 0.83 2.09 1.00 
mmu-miR-411 9 9 9 8 12 11 9 10   1.00 0.94 1.23 1.00 
mmu-let-7i 8409 5875 7269 6141 7892 6826 7470 6829   1.00 0.94 1.03 1.00 
mmu-miR-466f-5p 156 119 177 138 203 120 163 113   1.00 1.14 1.17 1.00 
mmu-miR-361 2640 3152 2902 3133 2717 3198 2782 3028   1.00 1.04 1.02 1.00 
mmu-miR-20a 4681 4570 5372 5479 5386 5383 5078 4210   1.00 1.17 1.16 1.00 
mmu-miR-181c 109 223 148 247 186 156 195 138   1.00 1.19 1.03 1.00 
mmu-miR-10b 63 64 64 66 63 71 62 66   1.00 1.03 1.06 1.01 
mmu-miR-130a 453 463 598 439 484 453 437 487   1.00 1.13 1.02 1.01 
mmu-miR-342-3p 10530 11724 11494 12143 11389 11442 11088 11367   1.00 1.06 1.03 1.01 
mmu-miR-331-3p 69 57 78 42 56 59 56 71   1.00 0.96 0.92 1.01 
mmu-miR-874 21 29 29 34 26 25 23 27   1.00 1.27 1.03 1.01 
mmu-miR-743b-
5p 18 20 22 18 21 23 20 18   1.00 1.08 1.16 1.01 
mmu-miR-17 6819 7082 6964 7924 7464 7566 7554 6531   1.00 1.07 1.08 1.01 
mmu-miR-466c-
3p 50 43 50 57 60 73 50 45   1.00 1.15 1.43 1.01 
mmu-miR-140* 3883 5335 4939 5135 3807 4333 4531 4855   1.00 1.09 0.88 1.02 
mmu-miR-99a 650 784 688 665 648 625 636 825   1.00 0.94 0.89 1.02 
mmu-let-7d 16056 14935 16016 14858 16258 15545 15831 15783   1.00 1.00 1.03 1.02 
mmu-miR-340-5p 10 6 13 7 18 13 8 8   1.00 1.20 1.86 1.02 
mmu-miR-93 5853 6609 6761 6882 6430 6816 6492 6266   1.00 1.09 1.06 1.02 




mmu-miR-2146 4876 3317 4619 3283 3694 2933 4056 4387   1.00 0.96 0.81 1.03 
mmu-miR-106a 2251 2501 2527 2876 2630 2692 2635 2261   1.00 1.14 1.12 1.03 
mmu-miR-713 29 13 24 41 33 40 26 18   1.00 1.53 1.71 1.03 
mmu-miR-16 17049 15502 15977 17486 19196 17672 17697 15960   1.00 1.03 1.13 1.03 
mmu-let-7c 18632 17123 18076 16464 17672 16330 18087 19008   1.00 0.97 0.95 1.04 
mmu-miR-30d 1564 1785 1703 1679 1768 1661 1736 1741   1.00 1.01 1.02 1.04 
mmu-miR-1906 90 66 92 77 78 61 78 84   1.00 1.08 0.89 1.04 
mmu-miR-18a 641 621 883 916 798 809 726 584   1.00 1.43 1.27 1.04 
mmu-miR-678 14 12 12 13 13 11 15 11   1.00 0.99 0.92 1.04 
mmu-miR-706 26 87 8 74 36 60 85 32   1.00 0.72 0.86 1.04 
mmu-miR-29a 4659 4035 4106 3948 4795 4306 4629 4418   1.00 0.93 1.05 1.04 
mmu-miR-128 173 149 176 153 194 184 147 188   1.00 1.02 1.17 1.04 
mmu-miR-689 110 83 31 68 33 65 55 147   1.00 0.51 0.51 1.04 
mmu-miR-363 30 40 50 33 57 48 29 44   1.00 1.19 1.52 1.05 
mmu-miR-671-5p 98 108 107 116 68 81 104 111   1.00 1.09 0.73 1.05 
mmu-miR-30b* 76 88 83 58 77 78 87 85   1.00 0.86 0.94 1.05 
mmu-miR-126-3p 7692 7022 6907 6858 7121 7908 7775 7673   1.00 0.94 1.02 1.05 
mmu-miR-666-5p 6 13 8 11 11 11 10 10   1.00 1.00 1.13 1.05 
mmu-miR-92a 5564 5874 6593 5563 6569 5913 5829 6300   1.00 1.06 1.09 1.06 
mmu-miR-1955 14 35 37 35 25 35 28 24   1.00 1.47 1.23 1.06 
mmu-miR-19b 2616 2739 3182 3028 3484 3256 3122 2563   1.00 1.16 1.26 1.06 
mmu-miR-23a 13298 13023 13200 12665 13566 13096 13517 14471   1.00 0.98 1.01 1.06 
mmu-miR-700 110 145 148 174 143 144 143 130   1.00 1.26 1.12 1.07 
mmu-miR-532-3p 217 350 304 335 292 376 299 308   1.00 1.13 1.18 1.07 
mmu-miR-199a-




mmu-miR-18a* 41 37 40 32 42 57 37 46   1.00 0.93 1.28 1.07 
mmu-miR-129-3p 11 12 13 11 11 11 14 11   1.00 1.01 0.94 1.08 
mmu-let-7g 3199 2110 2624 2106 3162 2514 2921 2818   1.00 0.89 1.07 1.08 
mmu-miR-2140 437 333 321 293 356 380 389 447   1.00 0.80 0.96 1.09 
mmu-miR-15b 6275 6023 5697 5837 6982 7149 6312 7075   1.00 0.94 1.15 1.09 
mmu-miR-338-5p 41 29 31 29 40 31 43 33   1.00 0.86 1.01 1.09 
mmu-miR-30c 3826 3461 3788 3804 4261 4102 3722 4223   1.00 1.04 1.15 1.09 
mmu-miR-7a 27 23 34 13 33 16 28 26   1.00 0.95 0.99 1.09 
mmu-miR-425 3616 4542 3887 4469 3915 4346 4365 4545   1.00 1.02 1.01 1.09 
mmu-miR-15a 817 644 817 810 930 872 844 754   1.00 1.11 1.23 1.09 
mmu-miR-21 705 500 822 533 877 688 699 627   1.00 1.12 1.30 1.10 
mmu-miR-467d* 71 57 77 88 100 92 81 60   1.00 1.28 1.50 1.10 
mmu-miR-871 10 9 9 11 12 11 11 11   1.00 1.01 1.15 1.10 
mmu-let-7a 10366 8263 9317 7662 10399 9684 10088 10474   1.00 0.91 1.08 1.10 
mmu-miR-676 174 210 230 188 221 220 217 208   1.00 1.09 1.15 1.11 
mmu-miR-322 63 60 95 54 78 86 70 66   1.00 1.21 1.33 1.11 
mmu-miR-210 108 133 213 122 132 142 138 131   1.00 1.39 1.13 1.11 
mmu-miR-1944 360 295 325 324 441 413 367 362   1.00 0.99 1.30 1.11 
mmu-miR-26b 235 177 211 197 288 236 222 237   1.00 0.99 1.27 1.11 
mmu-miR-324-5p 137 183 196 213 128 201 161 196   1.00 1.28 1.03 1.12 
mmu-miR-434-3p 37 47 53 38 55 55 46 48   1.00 1.09 1.31 1.12 
mmu-miR-760 12 7 17 6 8 8 10 11   1.00 1.22 0.83 1.12 
mmu-miR-199b 1525 1411 1372 1373 1721 1683 1682 1629   1.00 0.93 1.16 1.13 
mmu-miR-150* 386 514 492 554 473 494 486 532   1.00 1.16 1.07 1.13 
mmu-miR-7a* 47 49 37 43 57 57 58 51   1.00 0.83 1.20 1.13 




mmu-miR-132 374 354 382 370 375 375 380 450   1.00 1.03 1.03 1.14 
mmu-miR-1895 179 221 140 262 211 263 276 184   1.00 1.00 1.18 1.15 
mmu-miR-146a 6307 4157 4590 3837 5421 5331 5906 6150   1.00 0.81 1.03 1.15 
mmu-miR-29c 53 36 58 27 78 58 44 59   1.00 0.95 1.51 1.15 
mmu-miR-98 88 86 83 59 81 96 83 119   1.00 0.81 1.02 1.16 
mmu-miR-101b 25 33 58 34 55 20 35 32   1.00 1.58 1.28 1.16 
mmu-miR-744 566 734 760 800 667 804 782 733   1.00 1.20 1.13 1.17 
mmu-miR-106b* 1066 1169 1033 1245 1259 1318 1316 1310   1.00 1.02 1.15 1.17 
mmu-miR-3473 121 78 125 60 152 73 108 127   1.00 0.93 1.13 1.18 
mmu-miR-1306 35 53 46 53 51 57 58 46   1.00 1.12 1.22 1.18 
mmu-miR-92b 82 48 87 69 90 54 71 83   1.00 1.19 1.10 1.18 
mmu-miR-127 95 149 182 195 124 129 134 154   1.00 1.55 1.04 1.19 
mmu-miR-28 438 534 413 474 477 541 574 579   1.00 0.91 1.05 1.19 
mmu-miR-486 5230 3610 3782 4961 6389 5718 5628 4895   1.00 0.99 1.37 1.19 
mmu-miR-327 9 12 13 15 12 11 12 14   1.00 1.30 1.07 1.19 
mmu-miR-148a 125 85 128 101 109 138 142 108   1.00 1.09 1.18 1.19 
mmu-miR-1982* 49 39 39 29 36 28 49 56   1.00 0.78 0.73 1.20 
mmu-miR-350 105 123 143 120 142 147 116 158   1.00 1.15 1.26 1.20 
mmu-miR-467b* 56 48 60 123 103 92 75 51   1.00 1.75 1.87 1.20 
mmu-miR-18b 11 8 16 10 21 11 10 12   1.00 1.43 1.69 1.21 
mmu-miR-322* 65 69 110 74 79 80 79 82   1.00 1.38 1.19 1.21 
mmu-miR-10a 237 189 239 158 216 214 239 277   1.00 0.93 1.01 1.21 
mmu-let-7g* 7 9 17 12 7 11 8 11   1.00 1.76 1.17 1.21 
mmu-miR-200c 607 871 754 811 747 878 893 907   1.00 1.06 1.10 1.22 
mmu-miR-1198 350 434 349 353 395 452 482 478   1.00 0.89 1.08 1.22 




mmu-miR-1966 14 5 10 15 12 8 9 14   1.00 1.31 1.09 1.23 
mmu-miR-362-3p 26 11 29 16 22 27 19 25   1.00 1.24 1.35 1.23 
mmu-miR-669n 92 72 97 100 144 100 121 82   1.00 1.20 1.49 1.23 
mmu-let-7f 2133 1485 1993 1605 2242 1938 2175 2272   1.00 0.99 1.16 1.23 
mmu-miR-379 29 43 70 52 49 50 41 49   1.00 1.68 1.36 1.23 
mmu-miR-2134 5825 3541 5855 3876 3827 3660 5425 6146   1.00 1.04 0.80 1.24 
mmu-miR-141* 10 17 17 13 16 20 17 16   1.00 1.16 1.36 1.24 
mmu-miR-30b 1411 1293 1482 1238 1695 1591 1620 1768   1.00 1.01 1.21 1.25 
mmu-miR-1951 12 19 14 22 13 14 21 18   1.00 1.17 0.87 1.25 
mmu-miR-1892 268 179 213 227 288 191 315 247   1.00 0.98 1.07 1.26 
mmu-miR-150 12664 13219 13664 13099 14851 15657 15236 17379   1.00 1.03 1.18 1.26 
mmu-miR-3072* 229 217 137 274 182 235 331 238   1.00 0.92 0.94 1.28 
mmu-miR-383 63 75 35 47 44 40 101 76   1.00 0.59 0.60 1.28 
mmu-miR-2183 19 18 20 19 23 14 21 27   1.00 1.03 0.98 1.28 
mmu-miR-25 2244 2038 2345 2161 2918 2620 2477 3012   1.00 1.05 1.29 1.28 
mmu-miR-3475 9 10 11 11 10 12 10 14   1.00 1.19 1.21 1.30 
mmu-miR-2182 14 11 25 31 33 22 20 13   1.00 2.23 2.20 1.30 
mmu-miR-1896 37 31 21 44 32 44 40 50   1.00 0.94 1.11 1.31 
mmu-miR-421 257 248 292 241 319 360 343 320   1.00 1.06 1.35 1.31 
mmu-miR-28* 517 596 497 645 596 711 714 754   1.00 1.03 1.18 1.32 
mmu-miR-146b 234 188 256 199 343 265 290 268   1.00 1.08 1.44 1.32 
mmu-let-7b* 34 44 45 80 41 66 50 54   1.00 1.60 1.38 1.32 
mmu-miR-291b-
5p 13 31 22 60 21 35 31 27   1.00 1.86 1.27 1.32 
mmu-miR-21* 9 7 11 8 13 14 8 14   1.00 1.18 1.62 1.33 




mmu-miR-1965 90 53 79 58 97 73 101 90   1.00 0.96 1.19 1.33 
mmu-miR-337-5p 17 10 13 16 11 16 19 17   1.00 1.09 1.01 1.33 
mmu-miR-705 781 590 562 665 715 582 980 919   1.00 0.89 0.95 1.39 
mmu-miR-1907 48 15 53 30 53 38 48 40   1.00 1.33 1.45 1.39 
mmu-miR-467e 17 9 26 15 31 28 21 16   1.00 1.63 2.30 1.40 
mmu-miR-30e* 53 36 53 46 56 75 61 65   1.00 1.11 1.46 1.41 
mmu-miR-199b* 16 14 57 20 22 21 20 23   1.00 2.56 1.41 1.44 
mmu-miR-34c* 18 17 24 29 24 25 27 26   1.00 1.47 1.37 1.46 
mmu-miR-691 47 18 33 26 46 19 46 49   1.00 0.91 1.00 1.48 
mmu-miR-155 2042 1419 1815 1277 2087 2232 2232 2902   1.00 0.89 1.25 1.48 
mmu-miR-466e-
3p 47 18 50 47 51 68 53 44   1.00 1.49 1.85 1.51 
mmu-miR-501-5p 39 21 35 38 38 51 34 58   1.00 1.20 1.47 1.52 
mmu-miR-1949 265 285 324 280 313 350 359 480   1.00 1.10 1.21 1.53 
mmu-miR-1931 43 44 51 38 54 31 55 78   1.00 1.03 0.98 1.54 
mmu-miR-1946b 35 15 32 35 61 34 44 33   1.00 1.37 1.92 1.56 
mmu-miR-142-5p 16 11 23 10 22 10 28 14   1.00 1.26 1.20 1.62 
mmu-miR-200b 9 21 23 12 28 18 25 23   1.00 1.20 1.57 1.63 
mmu-miR-432 11 7 5 13 6 17 15 14   1.00 1.03 1.32 1.65 
mmu-miR-1971 506 661 489 679 541 487 896 1028   1.00 1.00 0.88 1.65 
mmu-miR-148b 60 27 80 58 82 70 68 78   1.00 1.59 1.75 1.68 
mmu-miR-92a* 13 6 20 8 18 12 19 12   1.00 1.50 1.60 1.68 
mmu-miR-374 45 39 53 52 87 76 68 73   1.00 1.25 1.94 1.68 
mmu-miR-1839-
3p 55 45 56 26 56 68 56 113   1.00 0.82 1.24 1.69 
mmu-miR-494 149 118 98 124 120 137 165 295   1.00 0.83 0.96 1.73 




mmu-miR-483 22 23 17 35 35 23 52 27   1.00 1.16 1.28 1.74 
mmu-miR-1930 6 7 5 13 9 8 12 11   1.00 1.40 1.30 1.76 
mmu-miR-451 899 453 732 654 1449 1039 1097 1436   1.00 1.02 1.84 1.87 
mmu-miR-200a 12 9 34 23 20 32 24 15   1.00 2.72 2.51 1.88 
mmu-miR-2136 9 7 18 11 16 6 13 16   1.00 1.84 1.41 1.89 
mmu-miR-382 9 5 23 8 8 6 10 17   1.00 2.26 0.98 1.96 
mmu-miR-770-3p 21 33 18 36 23 23 48 58   1.00 1.00 0.86 1.97 
mmu-miR-669f 19 12 28 36 38 51 35 27   1.00 2.09 2.89 2.04 
mmu-miR-1946a 54 24 65 50 88 48 87 73   1.00 1.47 1.75 2.05 
mmu-miR-3099* 6 5 15 15 22 11 11 13   1.00 2.69 2.88 2.14 
mmu-miR-181a-
1* 11 24 32 27 39 27 38 39   1.00 1.70 1.89 2.21 
mmu-miR-216b 11 11 16 7 16 21 41 11   1.00 1.04 1.64 2.27 
mmu-miR-3470a 6 11 9 7 10 4 16 30   1.00 0.94 0.89 2.77 
mmu-miR-872* 19 8 21 24 31 23 32 45   1.00 1.65 2.00 2.86 











Exiqon miRNA microarray data 
Shown are the expression values and fold-change of the mean expression value for each of the time points with the mean expression value of the Day 
0 samples set as a baseline value of 1.00. The data shown is threshold filtered, with miRNAs that did not have an expression value of at least 50 for 
both duplicates of at least one time point (to give similar numbers of miRNA as seen in the affymetrix data set). The table is ordered with those 
miRNAs showing the most significant decrease in expression in the LTb
-/-
 samples compared to the Day 0 samples first and those with the most 
significant increase last. Those miRNAs with a 2-fold or greater difference in expression between Day 0 and LTb
-/-
 samples, with a change in the same 
direction at day 2 and day 14 were considered for further analysis and are highlighted in yellow. Before selection of miRNAs for further study 
similarity of the duplicates from each time point was also assessed, miRNAs that had a 2-fold difference or greater within any of the duplicates (in red) 
were excluded from further analysis. 
  Expression values   Fold-change from Day 0 
miRNA ID Day 0 a Day 0 b Day 2 a  Day 2 b Day 14 a Day 14 b LTb-/- a LTb-/- b   Day 0/0 Day 2/0 Day 14/0 LTb/0 
mmu-miR-100 69 105 63 79 59 59 28 19   1.00 0.82 0.68 0.27 
mmu-miR-592* 151 68 96 48 71 52 41 22   1.00 0.66 0.56 0.29 
mmu-miR-2137 833 464 725 454 385 413 259 181   1.00 0.91 0.62 0.34 
mmu-miR-3102* 174 117 120 119 99 104 63 36   1.00 0.82 0.70 0.34 
mmu-miR-335-5p 51 68 55 86 44 64 26 14   1.00 1.19 0.91 0.34 
mmu-miR-762 333 163 194 161 145 177 105 68   1.00 0.72 0.65 0.35 
mmu-miR-33 347 262 469 486 197 329 154 68   1.00 1.57 0.86 0.36 
mmu-miR-138 95 134 99 122 66 68 47 40   1.00 0.97 0.59 0.38 
mmu-miR-3090* 140 94 105 97 84 92 58 36   1.00 0.86 0.75 0.40 
mmu-miR-487b 148 123 126 172 117 187 81 30   1.00 1.10 1.12 0.41 
mmu-miR-138-2* 338 267 253 386 298 439 193 58   1.00 1.06 1.22 0.41 
mmu-miR-2861 89 51 65 48 39 49 36 22   1.00 0.81 0.63 0.42 
mmu-miR-1983 2477 1682 2611 2799 1306 2525 1126 656   1.00 1.30 0.92 0.43 




mmu-miR-290-5p 503 361 473 436 286 389 220 165   1.00 1.05 0.78 0.45 
mmu-miR-193 50 43 61 62 34 41 26 16   1.00 1.34 0.80 0.45 
mmu-miR-32 435 442 499 536 385 435 266 138   1.00 1.18 0.93 0.46 
mmu-miR-187 67 80 55 66 40 39 35 34   1.00 0.83 0.54 0.47 
mmu-miR-99a 106 155 95 121 103 95 77 45   1.00 0.83 0.76 0.47 
mmu-miR-10b 68 90 54 68 58 63 47 27   1.00 0.78 0.77 0.47 
mmu-miR-101b 365 425 363 429 334 399 246 130   1.00 1.00 0.93 0.48 
mmu-miR-301a 215 224 335 329 241 268 145 64   1.00 1.51 1.16 0.48 
mmu-miR-711 89 66 77 68 58 60 44 31   1.00 0.94 0.76 0.48 
mmu-miR-151-5p 220 269 167 215 193 180 161 87   1.00 0.78 0.76 0.51 
mmu-miR-130a 695 818 823 921 631 650 471 305   1.00 1.15 0.85 0.51 
mmu-miR-467b 120 168 137 191 178 167 96 54   1.00 1.14 1.20 0.52 
mmu-miR-152 122 160 122 154 123 121 101 48   1.00 0.98 0.86 0.53 
mmu-miR-30a 588 645 604 680 490 595 407 243   1.00 1.04 0.88 0.53 
mmu-miR-145* 79 112 64 87 78 88 61 40   1.00 0.79 0.87 0.53 
mmu-miR-497 98 125 99 133 95 118 73 45   1.00 1.04 0.96 0.53 
mmu-miR-181d 173 227 220 263 197 192 139 77   1.00 1.21 0.98 0.54 
mmu-miR-3072 96 96 100 107 105 108 73 31   1.00 1.08 1.10 0.54 
mmu-miR-29c 881 909 695 815 635 767 599 371   1.00 0.84 0.78 0.54 
mmu-miR-362-3p 118 162 163 172 127 146 93 60   1.00 1.20 0.97 0.54 
mmu-miR-365 98 140 102 126 105 110 82 48   1.00 0.96 0.91 0.55 
mmu-miR-361* 82 90 86 89 78 80 60 34   1.00 1.02 0.92 0.55 
mmu-miR-29a* 166 207 147 194 186 171 142 63   1.00 0.91 0.96 0.55 
mmu-miR-450a 80 87 102 114 97 99 61 32   1.00 1.29 1.17 0.56 
mmu-miR-1839-5p 63 80 46 66 59 66 51 30   1.00 0.78 0.87 0.56 




mmu-miR-101a 1336 1498 1428 1502 1096 1327 981 618   1.00 1.03 0.86 0.56 
mmu-miR-199b* 218 264 241 272 221 244 171 102   1.00 1.06 0.96 0.57 
mmu-miR-140 482 598 433 576 529 504 385 227   1.00 0.93 0.96 0.57 
mmu-miR-199a-5p 399 517 465 555 454 445 316 203   1.00 1.11 0.98 0.57 
mmu-miR-674 151 164 135 172 147 135 117 62   1.00 0.97 0.90 0.57 
mmu-miR-19a 931 962 1269 1250 898 1145 682 395   1.00 1.33 1.08 0.57 
mmu-miR-99b 93 131 92 116 109 96 79 49   1.00 0.92 0.91 0.57 
mmu-miR-181b 96 128 125 137 112 115 79 49   1.00 1.16 1.01 0.57 
mmu-miR-130b 165 200 202 220 206 187 138 71   1.00 1.16 1.08 0.57 
mmu-miR-27b 780 843 703 814 665 764 566 372   1.00 0.93 0.88 0.58 
mmu-miR-3104-3p 59 64 59 69 61 59 44 27   1.00 1.05 0.98 0.58 
mmu-miR-141 41 49 60 60 40 48 34 19   1.00 1.33 0.98 0.59 
mmu-miR-322 230 290 289 305 238 258 187 118   1.00 1.14 0.95 0.59 
mmu-miR-142-5p 8466 8321 10645 9465 6869 9735 5763 4169   1.00 1.20 0.99 0.59 
mmu-miR-1249 73 86 103 101 83 81 62 33   1.00 1.28 1.03 0.59 
mmu-miR-10a 364 473 275 351 324 290 306 192   1.00 0.75 0.73 0.60 
mmu-miR-221 212 244 176 210 210 199 167 106   1.00 0.85 0.90 0.60 
mmu-miR-532-5p 48 60 37 50 52 54 42 23   1.00 0.80 0.98 0.60 
mmu-miR-148b 173 218 169 203 199 195 156 80   1.00 0.95 1.01 0.60 
mmu-miR-195 1141 1357 1136 1303 1043 1166 850 654   1.00 0.98 0.88 0.60 
mmu-miR-144 1939 937 2177 1845 1367 1722 1098 638   1.00 1.40 1.07 0.60 
mmu-miR-652 279 332 231 294 290 279 228 144   1.00 0.86 0.93 0.61 
mmu-miR-1186b 1025 824 685 1025 969 1207 745 400   1.00 0.93 1.18 0.62 
mmu-miR-320 147 178 136 185 166 156 130 71   1.00 0.99 0.99 0.62 
mghv-miR-M1-2-3p 48 46 54 50 46 43 36 22   1.00 1.11 0.94 0.62 




mmu-miR-1961 149 181 127 176 146 166 129 77   1.00 0.92 0.95 0.62 
mmu-miR-30e* 269 356 230 314 310 291 242 148   1.00 0.87 0.96 0.62 
mmu-miR-222 219 242 186 227 230 207 178 110   1.00 0.90 0.95 0.62 
mmu-miR-199a-3p 446 530 405 492 454 496 370 240   1.00 0.92 0.97 0.62 
mmu-miR-1264-3p 317 236 302 384 254 352 198 150   1.00 1.24 1.10 0.63 
mmu-miR-128 48 56 46 50 52 51 42 23   1.00 0.92 0.99 0.63 
mmu-miR-181a 758 907 920 943 803 789 610 444   1.00 1.12 0.96 0.63 
mmu-miR-296-5p 43 50 51 56 47 45 38 21   1.00 1.15 1.00 0.63 
mmu-miR-107 361 407 300 376 329 347 298 189   1.00 0.88 0.88 0.63 
mmu-miR-1195 40 49 27 48 51 48 35 22   1.00 0.85 1.12 0.63 
mmu-miR-29b 3548 2851 3150 3229 1969 2854 2205 1867   1.00 1.00 0.75 0.64 
mmu-miR-433* 393 293 276 364 336 442 271 168   1.00 0.93 1.13 0.64 
mmu-miR-27a 679 675 692 721 557 671 509 356   1.00 1.04 0.91 0.64 
mmu-miR-143 4206 6025 3777 5642 3773 3768 3251 3289   1.00 0.92 0.74 0.64 
mmu-miR-24-2* 123 160 130 158 139 128 110 71   1.00 1.02 0.94 0.64 
mmu-miR-21 1489 1519 1486 1286 1172 1290 1238 702   1.00 0.92 0.82 0.65 
mmu-miR-339-5p 323 409 259 311 326 323 297 176   1.00 0.78 0.89 0.65 
mmu-miR-194 89 110 87 118 100 98 80 50   1.00 1.03 0.99 0.65 
mmu-miR-145 1099 1242 1096 1138 872 1007 771 754   1.00 0.95 0.80 0.65 
mmu-miR-103 759 912 655 756 724 740 638 452   1.00 0.84 0.88 0.65 
mmu-miR-5097 1360 966 1205 1235 1160 1486 1046 483   1.00 1.05 1.14 0.66 
mmu-miR-20b 853 935 886 1051 925 995 734 452   1.00 1.08 1.07 0.66 
mmu-miR-26a 714 865 634 739 625 711 600 450   1.00 0.87 0.85 0.67 
mmu-miR-338-5p 71 75 46 65 74 83 56 41   1.00 0.76 1.07 0.67 
mmu-miR-186 84 91 81 96 106 106 77 40   1.00 1.01 1.21 0.67 




mmu-miR-30e 1973 1859 2335 2266 1540 1972 1515 1050   1.00 1.20 0.92 0.67 
mmu-miR-340-5p 353 418 333 398 342 369 291 226   1.00 0.95 0.92 0.67 
mmu-miR-30d 734 865 653 808 660 800 649 425   1.00 0.91 0.91 0.67 
mmu-miR-350 268 349 268 349 313 296 260 155   1.00 1.00 0.99 0.67 
mmu-miR-3069-5p 135 155 111 148 191 167 131 64   1.00 0.89 1.24 0.67 
mmu-miR-92a 78 92 73 95 92 107 73 42   1.00 0.99 1.17 0.67 
mmu-miR-484 48 52 51 56 52 58 43 24   1.00 1.07 1.10 0.67 
mmu-miR-142-3p 34485 38001 38446 38368 32089 33804 27404 21621   1.00 1.06 0.91 0.68 
mmu-miR-770-5p 66 72 47 59 74 78 65 32   1.00 0.77 1.10 0.70 
mmu-miR-425 358 431 333 409 389 400 328 223   1.00 0.94 1.00 0.70 
mmu-miR-126-5p 693 738 625 745 595 682 614 387   1.00 0.96 0.89 0.70 
mmu-miR-29a 12894 13434 8981 12998 11428 11217 9664 8762   1.00 0.83 0.86 0.70 
mmu-miR-125b-5p 2160 2623 2048 2176 1665 1605 1600 1758   1.00 0.88 0.68 0.70 
mmu-miR-21* 173 135 188 111 110 100 109 108   1.00 0.97 0.68 0.70 
mmu-miR-1843-5p 411 486 305 428 443 433 370 261   1.00 0.82 0.98 0.70 
mmu-miR-340-3p 62 75 53 66 66 66 56 41   1.00 0.87 0.96 0.70 
mmu-miR-423-3p 156 186 128 185 186 168 153 89   1.00 0.92 1.04 0.71 
mmu-miR-675-5p 238 267 228 243 226 237 220 137   1.00 0.93 0.92 0.71 
mghv-mir-M1-3* 63 62 58 70 65 75 48 41   1.00 1.02 1.11 0.71 
mmu-miR-17* 171 186 161 188 185 178 145 109   1.00 0.98 1.02 0.71 
mmu-miR-374 374 375 316 343 387 371 353 184   1.00 0.88 1.01 0.72 
mmu-miR-677 112 111 112 130 137 144 110 51   1.00 1.08 1.26 0.72 
mmu-miR-3096-5p 820 837 752 904 964 879 752 445   1.00 1.00 1.11 0.72 
mmu-miR-326 82 85 72 87 79 80 69 52   1.00 0.95 0.95 0.72 
mmu-miR-106a 1074 1121 1187 1228 1106 1205 990 605   1.00 1.10 1.05 0.73 




mmu-miR-767 335 279 218 292 321 347 273 175   1.00 0.83 1.09 0.73 
mmu-miR-378 585 658 530 640 667 597 519 388   1.00 0.94 1.02 0.73 
mmu-miR-361 366 422 323 396 396 367 338 238   1.00 0.91 0.97 0.73 
mmu-miR-3084* 882 885 701 913 995 990 804 488   1.00 0.91 1.12 0.73 
mmu-miR-668 134 113 64 114 118 131 105 76   1.00 0.72 1.01 0.73 
mmu-miR-744 163 189 184 204 191 164 157 102   1.00 1.10 1.01 0.73 
mmu-miR-98 1320 1489 1220 1407 1129 1293 1225 867   1.00 0.94 0.86 0.74 
mmu-miR-140* 774 921 744 890 889 803 737 536   1.00 0.96 1.00 0.75 
mmu-miR-677* 352 344 284 310 384 367 319 205   1.00 0.85 1.08 0.75 
mmu-miR-125a-5p 929 1129 781 958 892 827 777 772   1.00 0.84 0.84 0.75 
mmu-miR-24-1* 208 234 209 247 215 207 181 154   1.00 1.03 0.96 0.76 
mmu-miR-19b 1886 2128 2386 2354 1886 2450 1739 1317   1.00 1.18 1.08 0.76 
mmu-miR-511-3p 109 107 87 94 98 87 115 49   1.00 0.84 0.85 0.76 
mmu-miR-3103* 77 77 50 109 92 104 60 58   1.00 1.03 1.27 0.76 
mmu-miR-23b 5175 6851 3586 5258 5060 4495 4409 4845   1.00 0.74 0.79 0.77 
mmu-miR-712 71 61 58 53 80 75 66 35   1.00 0.84 1.17 0.77 
mmu-miR-16 13598 15437 11964 14625 13807 14053 11368 11055   1.00 0.92 0.96 0.77 
mmu-miR-374 654 682 610 605 735 617 644 392   1.00 0.91 1.01 0.78 
mmu-miR-185 183 205 169 213 230 190 177 124   1.00 0.98 1.08 0.78 
mmu-miR-3069-3p 355 364 264 385 443 422 334 227   1.00 0.90 1.20 0.78 
mmu-miR-15a 3032 3282 3150 3583 3027 3063 2643 2294   1.00 1.07 0.96 0.78 
mmu-miR-22* 99 123 104 110 111 101 101 73   1.00 0.97 0.95 0.78 
mmu-miR-342-3p 1110 1126 995 1066 1019 1074 970 786   1.00 0.92 0.94 0.78 
mmu-miR-17 1237 1397 1336 1504 1388 1385 1242 828   1.00 1.08 1.05 0.79 
mmu-miR-466a-3p 113 142 126 164 146 145 102 99   1.00 1.14 1.14 0.79 




mmu-miR-22 2221 2527 2204 2357 1744 1666 1963 1838   1.00 0.96 0.72 0.80 
mmu-let-7c 2356 2779 2143 2572 2092 2231 2036 2119   1.00 0.92 0.84 0.81 
mmu-miR-25 688 688 634 764 788 766 639 476   1.00 1.02 1.13 0.81 
mmu-let-7f 1781 1904 1584 1648 1439 1811 1631 1360   1.00 0.88 0.88 0.81 
mmu-miR-92b 97 105 91 94 101 113 96 68   1.00 0.92 1.06 0.81 
mmu-miR-342-5p 55 67 48 62 70 64 55 44   1.00 0.90 1.09 0.81 
mmu-let-7a 2161 2625 2082 2389 1755 2119 1921 1990   1.00 0.93 0.81 0.82 
mmu-miR-709 24103 30069 22340 28564 28789 23924 21754 22534   1.00 0.94 0.97 0.82 
mmu-miR-720 27189 26973 28217 26774 26433 27814 25164 19317   1.00 1.02 1.00 0.82 
mmu-miR-155 529 587 433 530 582 568 528 400   1.00 0.86 1.03 0.83 
mmu-miR-24 3275 3489 2836 3298 3106 3208 2990 2664   1.00 0.91 0.93 0.84 
mmu-miR-200c 38 56 35 48 56 54 49 29   1.00 0.89 1.17 0.84 
mmu-miR-337-3p 150 140 115 167 158 172 143 99   1.00 0.97 1.14 0.84 
mmu-miR-328 111 130 103 124 124 112 110 92   1.00 0.94 0.98 0.84 
mmu-miR-28* 45 57 46 51 62 52 50 36   1.00 0.96 1.12 0.84 
mmu-miR-493* 379 282 247 382 390 421 338 220   1.00 0.95 1.23 0.84 
mmu-let-7g 4032 4943 3342 4818 4132 4024 3767 3845   1.00 0.91 0.91 0.85 
mmu-miR-93 1192 1323 1267 1469 1414 1317 1246 914   1.00 1.09 1.09 0.86 
mmu-miR-7a 327 333 339 390 433 373 316 253   1.00 1.11 1.22 0.86 
mmu-miR-200b 64 85 68 75 75 73 67 61   1.00 0.97 0.99 0.86 
mmu-miR-30b 3241 3844 2832 3402 3303 3389 3134 2993   1.00 0.88 0.94 0.86 
mmu-let-7b 1851 2224 1710 2092 1752 1747 1684 1845   1.00 0.93 0.86 0.87 
mmu-miR-23a 2878 3218 2464 2781 2741 2626 2727 2567   1.00 0.86 0.88 0.87 
mmu-miR-30c 3150 3639 2808 3422 3276 3372 2972 2935   1.00 0.92 0.98 0.87 
mmu-let-7i 2741 2998 2717 3220 2767 2797 2650 2345   1.00 1.03 0.97 0.87 




mmu-miR-691 6584 6164 4517 8519 6425 7875 4811 6309   1.00 1.02 1.12 0.87 
mmu-let-7d 1990 2343 1854 2131 1816 1957 1893 1888   1.00 0.92 0.87 0.87 
mmu-miR-503 157 124 167 129 113 114 116 129   1.00 1.05 0.81 0.87 
mmu-miR-664 167 178 152 194 173 189 172 129   1.00 1.00 1.05 0.87 
mmu-miR-1949 610 636 618 747 769 773 606 485   1.00 1.10 1.24 0.88 
mmu-miR-20a 1815 2013 2249 2383 2026 2144 1791 1596   1.00 1.21 1.09 0.89 
mmu-miR-26b 2684 3095 2471 2829 2649 2801 2683 2446   1.00 0.92 0.94 0.89 
mmu-miR-1971 136 157 138 113 118 116 124 136   1.00 0.86 0.80 0.89 
mmu-miR-138-1* 211 221 205 263 212 282 200 186   1.00 1.08 1.14 0.89 
mmu-miR-1839-3p 404 444 373 527 500 481 406 352   1.00 1.06 1.16 0.90 
mmu-miR-139-5p 305 371 262 308 325 292 328 280   1.00 0.84 0.91 0.90 
mmu-miR-3096-3p 1629 1624 1648 1699 1853 1784 1614 1316   1.00 1.03 1.12 0.90 
mmu-miR-106b* 86 100 86 111 127 112 96 73   1.00 1.06 1.29 0.91 
mmu-miR-144* 123 86 77 118 188 191 131 63   1.00 0.93 1.81 0.92 
mmu-miR-223 2094 2200 2235 1832 1613 1831 2009 1978   1.00 0.95 0.80 0.93 
mmu-miR-34a 830 711 697 808 644 740 724 708   1.00 0.98 0.90 0.93 
mmu-miR-15b 3404 3891 3025 3946 4044 3887 3412 3368   1.00 0.96 1.09 0.93 
mmu-miR-106b 2364 2533 2408 2614 2606 2520 2399 2156   1.00 1.03 1.05 0.93 
mmu-miR-191 1819 2406 1933 2145 1974 1923 1924 2024   1.00 0.97 0.92 0.93 
mmu-miR-214 207 253 222 236 261 249 219 214   1.00 1.00 1.11 0.94 
mmu-miR-1843-3p 945 1022 769 970 994 979 986 889   1.00 0.88 1.00 0.95 
mmu-miR-500 143 182 143 168 153 137 143 167   1.00 0.96 0.89 0.95 
mmu-miR-582-3p 309 268 318 354 283 360 274 279   1.00 1.16 1.11 0.96 
mmu-miR-875-3p 2207 1868 2200 2313 1800 2470 1904 2025   1.00 1.11 1.05 0.96 
mmu-miR-710 76 73 60 55 62 63 65 80   1.00 0.77 0.84 0.98 




mmu-miR-3107 331 213 186 273 427 399 329 209   1.00 0.84 1.52 0.99 
mmu-miR-423-5p 263 303 232 285 318 265 271 296   1.00 0.91 1.03 1.00 
mmu-let-7e 1621 1673 1629 1819 1510 1853 1442 1860   1.00 1.05 1.02 1.00 
mmu-miR-690 19189 20878 18811 17521 20786 19865 20154 20241   1.00 0.91 1.01 1.01 
mmu-miR-146a 2216 2148 1780 1772 1804 1882 2301 2124   1.00 0.81 0.84 1.01 
mmu-miR-1186 181 194 144 207 198 210 186 196   1.00 0.93 1.09 1.02 
mmu-miR-207 2481 1725 2178 2290 1808 2532 2104 2189   1.00 1.06 1.03 1.02 
mmu-miR-185* 122 147 131 98 113 107 125 150   1.00 0.85 0.82 1.02 
mmu-miR-146b 1681 1651 1356 1465 1451 1562 1768 1660   1.00 0.85 0.90 1.03 
mghv-miR-M1-8 803 742 631 778 790 855 778 816   1.00 0.91 1.07 1.03 
mmu-miR-299* 268 210 219 184 196 208 221 278   1.00 0.84 0.85 1.04 
mmu-miR-467d* 82 103 98 121 99 104 90 106   1.00 1.18 1.09 1.06 
mmu-miR-665 170 128 143 124 117 119 200 117   1.00 0.90 0.79 1.07 
mmu-miR-466d-3p 229 272 253 274 269 254 233 313   1.00 1.05 1.04 1.09 
mmu-miR-1935 146 150 148 153 152 166 150 173   1.00 1.02 1.07 1.09 
mmu-miR-700* 54 58 44 58 67 61 57 68   1.00 0.91 1.14 1.11 
mmu-miR-34b-3p 298 260 222 264 269 309 290 332   1.00 0.87 1.04 1.11 
mmu-miR-705 86 83 90 85 89 87 86 106   1.00 1.03 1.04 1.13 
mmu-miR-34c 58 60 40 69 65 48 69 67   1.00 0.93 0.96 1.15 
mmu-miR-3095-3p 71 59 63 49 56 57 59 91   1.00 0.86 0.87 1.16 
mmu-miR-130b* 57 59 49 62 71 61 59 77   1.00 0.95 1.13 1.16 
mghv-mir-M1-8* 481 480 598 505 461 491 482 635   1.00 1.15 0.99 1.16 
mmu-miR-669a-5p 114 130 136 147 139 126 125 160   1.00 1.16 1.08 1.16 
mmu-miR-1903 133 136 116 128 149 136 137 177   1.00 0.91 1.06 1.17 
mmu-miR-466a-3p 272 320 331 339 317 313 292 409   1.00 1.13 1.06 1.18 




mmu-miR-503* 1092 965 831 944 1008 1106 1073 1412   1.00 0.86 1.03 1.21 
mmu-miR-872* 439 384 402 443 434 470 442 554   1.00 1.03 1.10 1.21 
mmu-miR-297a 69 79 78 85 79 76 75 104   1.00 1.10 1.04 1.21 
mmu-miR-1947* 529 369 475 319 402 368 434 671   1.00 0.88 0.86 1.23 
mmu-miR-294* 140 132 132 129 116 119 143 192   1.00 0.96 0.86 1.23 
mmu-miR-290-3p 124 80 129 88 92 73 104 150   1.00 1.07 0.81 1.24 
mmu-miR-451 27215 19090 21394 23255 28430 27514 31970 25653   1.00 0.96 1.21 1.24 
mmu-miR-150 3669 5017 2852 3995 5277 5421 5225 5662   1.00 0.79 1.23 1.25 
mmu-miR-3068* 1608 1475 1459 1538 1422 1677 1603 2299   1.00 0.97 1.01 1.27 
mmu-miR-574-3p 53 69 72 61 60 63 63 92   1.00 1.09 1.01 1.28 
mmu-let-7d* 88 92 76 81 96 92 102 134   1.00 0.87 1.04 1.31 
mmu-miR-669a-3p 472 511 570 549 505 527 483 813   1.00 1.14 1.05 1.32 
mmu-miR-320* 108 113 110 112 133 122 131 163   1.00 1.00 1.16 1.33 
mmu-miR-3103 426 440 411 437 493 425 451 718   1.00 0.98 1.06 1.35 
mmu-miR-3076-3p 60 51 50 51 61 62 62 90   1.00 0.91 1.11 1.37 
mmu-miR-155* 147 156 149 170 172 157 176 238   1.00 1.05 1.09 1.37 
mmu-miR-485* 143 137 129 125 155 143 161 227   1.00 0.91 1.07 1.39 
mmu-miR-467b* 90 109 113 120 110 109 117 162   1.00 1.17 1.10 1.40 
mmu-miR-297c 87 97 106 96 106 90 106 153   1.00 1.10 1.07 1.41 
mmu-miR-466j 165 176 189 185 174 164 189 293   1.00 1.10 0.99 1.41 
mmu-miR-329 58 68 66 70 67 58 80 100   1.00 1.08 0.99 1.42 
mghv-miR-M1-4 211 195 209 198 205 220 240 353   1.00 1.00 1.05 1.46 
mmu-miR-466m-
5p 158 170 184 180 170 157 179 300   1.00 1.11 1.00 1.46 
mmu-miR-544-5p 51 53 46 60 54 65 64 89   1.00 1.01 1.14 1.47 
mmu-miR-669m-




mmu-miR-467h 127 155 162 160 147 137 163 254   1.00 1.14 1.01 1.48 
mghv-mir-M1-2-5p 66 72 75 84 82 72 78 127   1.00 1.15 1.11 1.48 
mmu-miR-1941-3p 85 87 93 86 100 90 106 151   1.00 1.03 1.10 1.49 
mmu-miR-1224* 156 149 158 148 155 148 196 263   1.00 1.00 0.99 1.50 
mmu-miR-3473 556 536 653 468 503 527 658 1013   1.00 1.03 0.94 1.53 
mmu-miR-466f-5p 140 160 175 163 161 140 176 290   1.00 1.12 1.00 1.55 
mmu-miR-467a* 350 393 426 397 390 385 419 734   1.00 1.11 1.04 1.55 
mmu-miR-882 189 195 210 175 175 172 216 387   1.00 1.00 0.90 1.57 
mmu-miR-204* 101 97 104 90 101 92 125 186   1.00 0.98 0.98 1.58 
mmu-miR-669f-3p 690 803 840 792 718 734 776 1584   1.00 1.09 0.97 1.58 
mmu-miR-669o-5p 463 495 538 507 505 475 518 999   1.00 1.09 1.02 1.58 
mmu-miR-877 55 50 54 48 50 48 64 103   1.00 0.98 0.94 1.59 
mmu-miR-291a-5p 37 37 42 24 32 26 51 67   1.00 0.89 0.79 1.60 
mmu-miR-467e 104 125 128 135 138 138 144 222   1.00 1.15 1.21 1.60 
mmu-miR-1900 472 379 498 341 384 349 611 751   1.00 0.99 0.86 1.60 
mmu-miR-466i-3p 238 277 296 266 287 272 316 509   1.00 1.09 1.09 1.60 
mmu-miR-669i 35 49 41 36 43 40 55 79   1.00 0.93 1.00 1.61 
mmu-miR-465b-5p 68 65 59 72 61 71 85 130   1.00 0.98 0.99 1.62 
mmu-miR-1943* 117 122 142 132 138 127 157 230   1.00 1.15 1.11 1.62 
mmu-miR-466e-5p 242 263 315 265 282 249 309 511   1.00 1.15 1.05 1.63 
mmu-miR-466n-5p 178 202 223 203 211 177 226 395   1.00 1.12 1.02 1.63 
mmu-miR-669l 368 391 410 385 396 378 420 821   1.00 1.05 1.02 1.64 
mmu-miR-1895 44 45 48 46 43 41 59 86   1.00 1.06 0.95 1.64 
mmu-miR-466a-5p 225 238 264 242 260 215 283 476   1.00 1.09 1.02 1.64 
mmu-miR-669e* 125 152 167 157 139 141 174 280   1.00 1.17 1.01 1.64 




mmu-miR-335-3p 896 761 1002 815 738 846 961 1775   1.00 1.10 0.96 1.65 
mmu-miR-665* 305 315 325 316 355 306 374 661   1.00 1.03 1.06 1.67 
mmu-miR-466b-5p 318 326 368 334 337 306 374 706   1.00 1.09 1.00 1.68 
mmu-miR-466c-5p 348 371 401 367 370 327 406 802   1.00 1.07 0.97 1.68 
mmu-miR-669e 235 286 269 281 279 236 321 557   1.00 1.06 0.99 1.68 
mmu-miR-881* 70 72 84 76 74 68 97 146   1.00 1.12 1.00 1.71 
mmu-miR-883a-5p 593 538 689 577 550 638 697 1237   1.00 1.12 1.05 1.71 
mmu-miR-667 379 316 401 313 319 365 444 756   1.00 1.03 0.98 1.73 
mmu-miR-3077 60 62 68 66 65 65 85 125   1.00 1.11 1.07 1.73 
mmu-miR-468 101 112 126 129 124 108 137 234   1.00 1.20 1.09 1.74 
mmu-miR-669a-3-
3p 696 772 867 771 726 725 808 1758   1.00 1.12 0.99 1.75 
mmu-miR-669d-2* 67 87 99 82 79 87 84 184   1.00 1.18 1.08 1.75 
mmu-miR-2183 56 62 87 60 62 57 82 125   1.00 1.25 1.01 1.76 
mmu-miR-467f 349 382 420 364 384 366 446 842   1.00 1.07 1.03 1.76 
mmu-miR-669d* 374 400 499 408 405 416 465 899   1.00 1.17 1.06 1.76 
mmu-miR-669b* 414 496 526 473 483 462 532 1073   1.00 1.10 1.04 1.76 
mmu-miR-574-5p 473 500 555 514 522 464 566 1171   1.00 1.10 1.01 1.79 
mmu-miR-467c* 122 148 165 141 143 150 178 313   1.00 1.13 1.09 1.82 
mmu-miR-669l* 354 397 456 374 394 389 474 897   1.00 1.11 1.04 1.83 
mmu-miR-883b-5p 42 38 39 28 34 35 53 92   1.00 0.84 0.87 1.83 
mmu-miR-466a-5p 414 431 485 448 456 419 503 1048   1.00 1.10 1.04 1.84 
mmu-miR-505-5p 47 55 63 57 55 50 72 116   1.00 1.19 1.04 1.85 
mmu-miR-297a* 286 353 397 322 346 328 406 789   1.00 1.12 1.05 1.87 
mmu-miR-678 41 53 52 44 46 43 68 108   1.00 1.02 0.94 1.87 




mmu-miR-467g 486 559 619 524 552 508 647 1353   1.00 1.09 1.01 1.92 
mmu-miR-669d 476 492 575 516 507 499 583 1288   1.00 1.13 1.04 1.93 
mmu-miR-466d-5p 449 468 566 500 495 447 558 1228   1.00 1.16 1.03 1.95 
mghv-miR-M1-3 65 77 79 83 77 79 108 169   1.00 1.15 1.10 1.96 
mmu-miR-669f-5p 492 542 643 546 549 505 681 1342   1.00 1.15 1.02 1.96 
mmu-miR-669c* 680 737 884 735 754 715 884 1972   1.00 1.14 1.04 2.02 
mmu-miR-881 39 41 44 38 45 39 58 105   1.00 1.01 1.04 2.02 
mmu-miR-669p* 674 719 840 672 731 719 899 1939   1.00 1.09 1.04 2.04 
mmu-miR-490-3p 34 35 40 36 36 41 55 89   1.00 1.09 1.11 2.07 
mmu-miR-1192 493 550 660 543 550 542 709 1456   1.00 1.15 1.05 2.08 
mmu-miR-693-5p 72 75 99 81 85 83 120 195   1.00 1.21 1.13 2.13 
mmu-miR-1957 61 47 80 76 83 88 105 124   1.00 1.46 1.59 2.13 
mmu-miR-669k* 468 511 555 503 529 473 607 1489   1.00 1.08 1.02 2.14 
mmu-miR-1196 759 634 764 620 745 779 961 2039   1.00 0.99 1.09 2.15 
mmu-miR-467e* 759 846 1119 811 825 798 1100 2374   1.00 1.20 1.01 2.16 
mmu-miR-466f-3p 544 593 688 577 582 580 742 1720   1.00 1.11 1.02 2.17 
mmu-miR-758* 46 49 59 44 51 46 72 141   1.00 1.08 1.01 2.24 
mmu-miR-466f 691 711 922 751 721 682 942 2260   1.00 1.19 1.00 2.28 
mmu-miR-3470b 57 61 82 58 63 62 98 171   1.00 1.19 1.06 2.29 
mmu-miR-325 238 223 293 227 257 266 391 697   1.00 1.13 1.13 2.36 
mmu-miR-30b* 79 86 107 87 90 85 133 264   1.00 1.17 1.05 2.39 
mmu-miR-669c 926 989 1273 953 975 895 1354 3244   1.00 1.16 0.98 2.40 
mmu-miR-1929 72 85 105 78 86 86 135 244   1.00 1.16 1.10 2.41 
mmu-miR-1958 57 57 57 48 58 56 94 184   1.00 0.93 1.00 2.45 
mmu-miR-32* 555 589 727 582 596 576 801 2022   1.00 1.15 1.03 2.47 




mmu-miR-1897-5p 731 756 1056 774 699 790 1108 2585   1.00 1.23 1.00 2.48 
mmu-miR-3082-5p 807 883 1162 866 933 794 1250 2993   1.00 1.20 1.02 2.51 
mmu-miR-1934 33 22 38 18 22 21 58 82   1.00 1.01 0.76 2.53 
mmu-miR-302a 139 124 163 107 122 121 252 426   1.00 1.03 0.92 2.58 
mmu-miR-466i-5p 1127 1160 1524 1071 1181 1092 1563 4472   1.00 1.13 0.99 2.64 
mmu-miR-3098-3p 151 150 179 132 171 162 287 530   1.00 1.04 1.11 2.72 
mmu-miR-495* 51 54 82 54 58 52 100 188   1.00 1.30 1.05 2.76 
mmu-miR-1981* 35 34 53 26 36 36 79 148   1.00 1.13 1.04 3.26 
mmu-miR-300* 280 299 391 261 269 263 618 1315   1.00 1.12 0.92 3.34 
mghv-miR-M1-6* 273 202 379 180 203 184 451 1145   1.00 1.18 0.81 3.36 
mmu-miR-3474 131 90 180 86 83 77 318 441   1.00 1.20 0.72 3.43 
mmu-miR-1907 19 23 28 12 18 18 52 90   1.00 0.97 0.88 3.46 
mmu-let-7a-2* 40 35 69 30 39 38 98 189   1.00 1.32 1.03 3.84 
mmu-miR-1952 255 215 506 197 225 222 575 1279   1.00 1.49 0.95 3.94 
mmu-miR-1954 29 29 48 31 31 31 77 171   1.00 1.36 1.08 4.29 
mmu-miR-491* 6440 4270 17480 4270 4468 5893 19475 40274   1.00 2.03 0.97 5.58 
mmu-miR-763 19 11 32 7 9 12 99 89   1.00 1.34 0.71 6.41 
mmu-miR-706 310 333 679 298 373 330 1106 3442   1.00 1.52 1.09 7.08 








Table showing genes from ToppFun: biological processes in which predicted target 








3.06E-06 24 435 JMJD1C, RBM14, SUV420H1, SIRT1, TP53, 
KMT2E, DNMT3A, PKN1, CHD9, CHD6, 
ZMYND11, EZH2, KMT2C, RSF1, CHD5, IL1B, 
SMARCA5, BAZ2A, MECP2, CECR2, KDM4A, 









1.43E-05 17 267 CHAT, NPPC, KCNMA1, CHRNB2, SIRT1, TP53, 
OXTR, SMAD3, MTOR, IL1B, NPEPPS, MECP2, 
SCNN1G, PMAIP1, RHOC, BBC3, NKX3-1 
neural nucleus 
development 
1.68E-05 5 18 CHRNB2, PHOX2B, HOXA1, KIRREL3, CDK5R1 
axon guidance 1.89E-05 20 360 ST8SIA2, DCX, NTN3, EPHB3, HOXA1, NCK2, 
CDK5R1, ANK1, SEMA6A, ANK3, SEMA5A, 
UNC5D, RELN, COL4A2, EPHA8, RHOC, 
LAMC1, PLCG1, TRIO, EFNB3 
chromatin 
silencing 




2.29E-05 16 249 CHAT, NPPC, KCNMA1, CHRNB2, SIRT1, TP53, 
SMAD3, MTOR, IL1B, NPEPPS, MECP2, 























locomotion 5.02E-05 44 125
3 




























regulation of cell 
communication 












1.15E-04 6 41 TP53,CDK5R1,PMAIP1,RHOC,BBC3,MAP3K11 
neuron 
development 



























1.51E-04 7 61 SUV420H1,KMT2E,EZH2,KMT2C,BAZ2A,MECP
2, DOT1L 




















1.77E-04 8 83 SUV420H1,KMT2E,ICMT,EZH2,KMT2C,BAZ2A, 
MECP2,DOT1L 
























2.31E-04 5 30 CHRNB2,OXTR,EPHB3,MECP2,CBLN1 
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